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 1The last two centuries, the increased life expectancy has led to a shift in the age distribu-
tion towards higher ages, in high-income countries [1, 2]. Although the total number of 
older people is increasing and people reach a higher age, the additional life years are 
not always healthy years. As a consequence, both individuals and society have to deal 
with age-related health problems including chronic diseases, cognitive decline, social 
isolation and disabilities in daily functioning. As Clegg and coauthors recently stressed 
in the Lancet, eventually, the accumulation of such problems may lead to the onset of 
frailty, a phenomenon receiving increased attention in both science and health care [3]. 
Frail individuals are more likely to deteriorate in their daily functioning, develop mobility 
limitations, are more often hospitalized, develop more often chronic diseases and have 
shorter survival probabilities [3]. With increased longevity, the number of frail older per-
sons is increasing, making frailty one of the major health care problems in high-income 
countries [3-5].
There are reasons to believe that frailty may be more notable in people with intellectual 
disabilities (ID), who are characterized by limitations in both intellectual functioning (IQ 
below 70) and in adaptive behavior, that have started before the age of 18. In addition to 
general aging problems, people with ID have, from a young age forwards, an increased 
risk of motor and sensory disabilities, chronic diseases, mental health problems and 
syndrome-specific complications, which could make them extra vulnerable to develop 
frailty [6-9]. The improved quality of residential and healthcare has also increased the life 
expectancy of people with ID [10-12] which could possibly result in a disproportionally 
high number of age-related problems. Even so, there was very little known about frailty 
in people with ID.
People with ID are more and more living and participating in the community. This 
trend is further stimulated by the transition of long-term care that will take place in 
the Netherlands. Until 2014, specialized long-term care was financed under the Dutch 
Act on Exceptional Medical Expenses (AWBZ). In 2014 a transition took place from the 
AWBZ to the Social Support Act (Wmo). With this transition the Dutch government 
wants to achieve affordable, good and accessible care that allows people to live in their 
own homes for as long as possible. This transition also applies to people with mild and 
moderate levels of ID. In order to stimulate healthy aging and to provide information to 
parties responsible for their care, solid epidemiological research is required. Therefore, 
this thesis focuses on the measurement, frequency, determinants, and consequences of 
frailty in older people with ID.
10 Chapter 1
oPerationalization oF Frailty
A frail individual will have difficulties recovering from a stressor event, for example a 
bone fracture. A non-frail individual may, e.g. temporarily lose some independency, be-
come a little frustrated and lose (or gain) some weight, after which he or she makes a full 
recovery. In contrast, a frail individual, has a high risk of losing considerable muscle mass, 
getting depressed, remain dependent and get cognitive problems, and, although he or 
she will partly recover, there may be a permanent deterioration in function. Although, 
experts agree that frailty is a condition in which older people are more vulnerable to ad-
verse health outcomes as a result of age-related decline in many physiological systems, 
there is no agreed-upon definition nor a broadly accepted measurement strategy [3, 5]. 
There are several operational definitions and measurement methods that identify the 
frail individual.
The two most frequently used operational definitions of frailty are the ‘frailty pheno-
type’[13] and the ‘frailty index’ [14], both introduced during the first decade of this 
century. The frailty phenotype, introduced by Fried and colleagues in the Cardiovascular 
Health Study, is based on five core clinical features that are used to identify frailty (unin-
tentional weight loss, weakness, slow walking speed, self-reported exhaustion, and low 
physical activity). The fundamental basis of the frailty phenotype is a cycle, representing 
a downward spiral of age-associated physiologic factors that eventually lead to the on-
set of the five core clinical elements of frailty. The frailty phenotype has been validated, 
in terms of predicting adverse health outcomes, in several older populations (nursing 
home, hospitalized, and living in the community) [15]. The major advantage of this 
operationalization is its applicability in clinical practice, because the five core elements 
can be measured in a short physical assessment. However, disabilities (e.g mobility 
limitations, cognitive impairments) can affect the reliability of the frailty phenotype. It 
has therefore been suggested that the frailty phenotype produces meaningful results 
for non-disabled older people only [16].
The second approach, the frailty index, defines frailty as the accumulation of a broad 
spectrum of non-specific age-related impairments (deficits), including symptoms, 
signs, diseases, disabilities or laboratory measurements [14, 17]. The frailty index was 
developed and validated in the Canadian Study of Health and Aging, by Rockwood and 
Mitnitski [14]. In contrast to the frailty phenotype, the frailty index does not consist of a 
fixed set of variables, has a continuous nature (no strict categorization), identifies frailty 
using different health domains, and has meaningful results in disabled and non-disabled 
individuals [16]. Frailty indices have been calculated for large older populations from 
different countries. Although these frailty indices were constructed using different da-
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 1tasets, different deficits, and different numbers of deficits (20-130), all predicted adverse 
health outcome [18-20]. Since the frailty index does not require a fixed set of variables, 
it is possible to compose a frailty index from an existing health data set [21]. In addition 
to the frailty phenotype and the frailty index, there are many more instruments [22]. 
Several frailty instruments use self-report questionnaires addressing multiple health 
domains, e.g. in the Netherlands, the Tilburg Frailty Indicator [23] and the Groningen 
Frailty Indicator [24].
Frailty in PeoPle with iD
People with Down syndrome have an increased risk for age-related disorders such as 
thyroid dysfunction, Alzheimer disease, musculoskeletal disorders, hearing loss, and 
visual impairment [25, 26]. Consequently, although the life expectancy of people with 
Down syndrome has increased, there seems to be an early onset of functional decline 
that can be considered as early aging on a genetic basis. With the exception of Down 
syndrome, there are no clear indications for ‘early aging’ in people with other causes of 
ID. Even so, it has long been a common understanding that people with ID are old from 
the age of 50 years onwards [27, 28]. This understanding may influence support and 
intervention. For example, a 60 year-old lady with mobility limitations might be offered 
a wheelchair because she is already ‘old’, whereas with adequate treatment this could 
have been postponed. We wondered whether, the observed early aging or functional 
decline might be an early onset of frailty. If so, this would offer possibilities for preven-
tion or delay of functional deterioration. Indeed, studies in the general population show 
that frailty is a dynamic process that is reversible by interventions [3, 29-32]. Information 
about the frequency, determinants and consequences of frailty can help to understand 
and influence the observed early aging in people with ID.
As stated before, there are many different operationalizations of frailty. It was unknown 
whether they are applicable and valid in people with ID. Brehmer and Weber were 
the first to investigate frailty in this population. They developed an experience-based 
questionnaire that classified over a quarter (27%) of 50 included adults aged 50 years 
and over as frail [33]. This scale has not yet been validated in terms of predictive value 
for adverse health outcomes, and the uniqueness of the questionnaire makes direct 
comparison with the general population impossible. Evenhuis et al. applied the frailty 
phenotype to people with ID aged 50 years and over (n = 848) [34]. They showed that 
frailty is more common in people with ID than in the general population. Also, they 
found a high correlation between mobility impairment and frailty. Since mobility im-
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pairment in this population can be lifelong or develop early in life, this could limit the 
validity of this frailty operationalization.
For several reasons we have chosen to measure frailty with a frailty index. First of all, it 
can cover a broad range of domains considered important for health and dependence 
(e.g. nutritional status, physical activity, energy, cognition) [22, 35]. Second, as a frailty 
index does not require the use of a pre-defined set of variables, we were able to include 
problems that are often prevalent in people with ID (e.g. dysphagia, chronic obstipation, 
epilepsy), as well as use diagnostic questionnaires that have been validated in people 
with ID. Third, a frailty index is designed using a well-evaluated standardized procedure, 
which enables comparison with other groups [21]. Fourth, self-report, which would be 
problematic for those with limited understanding or communication problems, can 
be avoided. Last, a frailty index can be composed from a (pre-existing) comprehensive 
assessment. The Dutch Healthy Ageing and Intellectual Disability study provided an 
opportunity to design a frailty index.
the healthy ageing anD intellectual Disability stuDy
There are very few large epidemiological studies on the health of people with an ID. 
Therefore, the Healthy Aging and Intellectual Disability study (HA-ID) was initiated in 
2007 to gain more knowledge about the health of older people with ID. Three large 
Dutch care organizations (Abrona, Ipse de Bruggen and Amarant) and two university 
departments (the department of Intellectual Disability Medicine of Erasmus Medical 
Center Rotterdam and Movement Sciences of Groningen University) participated in 
this study. The aims of the HA-ID study were to perform baseline assessments of health 
conditions relevant to prevention, to identify risk groups and to select and evaluate 
diagnostic tools. The HA-ID study was based on of three sub-themes: physical activity 
and fitness, nutrition and nutritional state, and depression and anxiety.
Participants were recruited from the three care organizations, that provided a broad 
spectrum of care, ranging from ambulatory support to intensive residential care. At 
the start of the study, in 2008 the three care provider services together offered care 
to 2322 people with ID aged 50 years and over, which was 10% of the total Dutch 
population with ID receiving formal care. Eventually 1050 participants were included 
who constituted a near-representative sample of people with ID who use formal care 
in the Netherlands. Within the three subthemes of the HA-ID study, a comprehensive 
set of measurements was selected, including physical assessments, a fitness test bat-
tery, actigraphy, pedometer measurements, mealtime observations of swallowing, 
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 1nutritional diaries, screening questionnaires and standardized psychiatric interviews for 
depression and anxiety, questionnaires on life events, quality of life, IADL, ADL, mobility, 
dementia, social circumstances, somatic complaints, and laboratory tests as well as the 
collection of data from the medical and location files. We wondered whether the frailty 
index would show the same predictive value as observed in the general population. The 
lifelong impairments (e.g. neurological problems, musculoskeletal problems, visual and 
hearing impairments), observed in people with ID, could have led to early rehabilitation 
and, possibly, to habituation. For example, people with cerebral palsy are likely to use 
walking aids or a wheelchair. It was unknown how such early limitations might influ-
ence frailty. In the general population, disabilities in daily living (e.g. going to the toilet, 
meal preparation, grooming) are considered a consequence of frailty [36-38]. On the 
contrary, in people with ID, limitations in activities of daily living can be life-long and 
might contribute to frailty rather than the other way around. Therefore, to study the 
relation between frailty and adverse health outcomes, a longitudinal follow-up study of 
the HA-ID population was established, evaluating aspects of health, dependence and 
mobility of the participants three years after the baseline measurements.
The extensive dataset of the HA-ID study was used to answer the main research ques-
tions in this thesis: how is frailty distributed in the ID population, what are its correlates 
and to what extent does it predict adverse health outcomes? This general research ques-
tion was broken down in the sub-studies outlined in the next section. 
aims anD outlines
Chapter 2 provides an overview of the different frailty measurements and their potential 
applicability to the ID population. Chapter 3 describes the design of a frailty index for 
people with ID using data from the HA-ID study. The distribution of frailty in this sample 
is presented. Furthermore, differences between subgroups (age, level of ID, gender and 
Down syndrome) are described. These results were compared to results from the general 
population. In chapter 4, the characteristics are examined of participants with the low-
est frailty index score named the ‘least frail’. The least frail participants give insight into 
possible intervention strategies. To understand why people with ID show signs of early 
frailty, we had a closer look at possible physiological pathways towards frailty. Therefore 
we examined the association between inflammation, renal functioning, micronutrient 
status and metabolic factors, and frailty, as described in chapter 5. Using follow-up 
data from the HA-ID study, we examined whether high frailty index scores at baseline 
predicted negative health outcomes three years later. First, the relation was studied 
between frailty and the risk to develop (more severe) disabilities in daily functioning 
and mobility (chapter 6). To further study the consequences of frailty we evaluated its 
14 Chapter 1
relation with falls, fractures, hospital admission, medication use, and chronic diseases 
(chapter 7). If frailty leads to a deterioration of health and dependence it will eventually 
also influence health care costs. To approach this, we studied the relation between frailty 
and (increased) care intensity (chapter 8). In chapter 9, we show the relation between 
frailty and all-cause mortality. As previously mentioned, we hypothesized that the frailty 
index would be a more suitable measure for an early-handicapped population than the 
frailty phenotype. To test this hypothesis we compared the applicability and the relation 
with adverse health outcomes of the frailty index with those from the frailty pheno-
type (chapter 10). The general discussion (chapter 11) reflects on the main results and 
findings of this thesis and provides recommendations for the implications for clinical 
practice and future research. 
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Frailty and intellectual disability: a 
different operationalization?
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abstract
Frailty is increasingly being recognized as a relevant health measure in older populations, 
associated with an increased risk of adverse health outcomes and care dependency. 
Because it is generally received that people with intellectual disabilities are “old” from 
age 50 onwards, frailty research in this group might lead to an understanding of factors, 
contributing to this perception. The development since the 1990s of conceptual and 
operational definitions of frailty has resulted in different approaches: biological (pheno-
type), multidimensional, and non-specific deficit accumulation. All approaches consider 
disability a consequence rather than a cause of frailty. This may be different for long-
disabled populations, which would have consequences for validity of frailty measures. 
First research shows that the different approaches are applicable to study populations 
with intellectual disabilities as well. Frailty as defined by both the phenotypic and deficit 
accumulation approach appears to develop considerably earlier and is more severe in 
people with intellectual disabilities than in the general older population, supporting the 
notion of early aging. Before any clinical implications can be outlined, health outcomes 
(validity), causes, and prevention of frailty should be investigated.
Key words: Intellectual disability, frailty, frailty phenotype, frailty index
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introDuction
In public health research as well as geriatric clinical practice, frailty is increasingly being 
recognized as a relevant health measure in older people, associated with an increased 
risk of adverse health outcomes (falls, acute and chronic disease, complicated hospital 
stay), functional decline and care dependency, declining quality of life, and early death 
[1-6]. As in the general population, the proportion of aging individuals is steadily in-
creasing in the population with intellectual disabilities. However until recently, frailty 
in this population has not been investigated. Insight into its frequency, distribution, 
determinants, and consequences would be of paramount importance for prevention 
and treatment policies, as well as for healthcare policy in general for this vulnerable and 
high cost population group. We will give an overview of the most relevant conceptual 
definitions of frailty and their operationalizations in the general population, and pres-
ent outcomes of first application of the different approaches to adults with intellectual 
disabilities.
concePtual DeFinitions
Buchner and Wagner (1992) were the first to formulate a conceptual definition of frailty: 
“A state of reduced physiological reserve associated with increased susceptibility to 
disability.” This and following definitions [7, 8] were exclusively based on biological 
functions. Other researchers support an integral, multidimensional concept of frailty, 
addressing, apart from biological functions, also cognitive, psychological, social, and 
environmental aspects [9-12]. Since 2008, several international expert consensus meet-
ings have addressed the definition and assessment of frailty [13-15], showing that the 
multidimensional nature of frailty was increasingly accepted, as was the necessity to 
include multiple domains in its assessment. These different conceptual definitions of 
frailty have resulted in a range of operationalizations for clinical and scientific use.
Physically orienteD oPerationalization
The theoretical model developed by Fried and co-authors for the American Cardiovas-
cular Health Study (CHS) [1] is an example of a physically oriented operationalization, 
designed around conditions that were considered markers of frailty in the scientific 
literature (Figure 1). It has resulted in a “frailty phenotype” which includes measures of 
decreased muscle function and endurance (Table 1). This frailty phenotype has been 
validated against adverse health outcomes at a population level [1, 16]. Although its 
22 Chapter 2
sensitivity and specificity as a diagnostic measure have not been evaluated, it is now 
widely used in geriatric clinical care. Table 1 shows, that muscle function and mobil-
ity play a central role in this approach, and it has been argued that phenotypic frailty 
represents in fact disability. There is now a growing consensus in the general geriatric 
literature that, although there is an overlap of frailty with disability, these are distinct 
clinical entities that are causally related [1, 17]. In late life, physical disability, resulting 
in mobility loss, or impaired (instrumental) activities of daily life [(i)ADL], is considered 
an outcome of diseases and physiologic alterations with aging. It may develop progres-
sively or acutely, e.g., after a fracture or stroke [18]. So for the general older population, 
disability is considered a consequence rather than a cause of frailty [13, 18].
This may be completely different for long-disabled populations, such as the population 
with intellectual disabilities addressed in this article. No experimental research of frailty in 
long-disabled groups had been published, but it was to be expected that in such groups, 
disability can be a consequence of, but also, a contributing factor to frailty. Therefore, we 
have assessed phenotypic frailty in older people with intellectual disabilities, using data 
collected during 2009 and 2010 in the Dutch study “Healthy Ageing and Intellectual 
Disabilities” (HA-ID) [19]. The study cohort of 1050 clients of formal service providers 
for people with intellectual disabilities, aged 50 years and over, is nearly representative 
Figure 1. Cycle of frailty hypothesized as consistent with demonstrated pairwise associations and clinical 
signs and symptoms of frailty [1].
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for all clients of Dutch formal specialized care, consisting of people with borderline to 
profound disabilities whom are provided sheltered living in more or less centralized 
settings, community-based living in group homes, daycare only, or independent living 
with specific outreaching support. We hypothesized that frailty would strongly overlap 
with and might even be identical to motor and severe cognitive disability. It was estab-
lished that in the age group 50–64 years, prevalence of phenotypic frailty (11%) [20] 
was as high as in the general population aged 65 years and over (7–9%) [1, 21-24], with 
a further increase after the age of 65. Age, Down syndrome, dementia, motor disability, 
and severe or profound intellectual disability were significantly associated with frailty, 
but in a multivariate analysis, only motor disability had a unique association with frailty. 
Indeed, people using walking aids or a wheelchair were 10 times more likely to be frail 
as those who walked independently. In a regression model with the above variables, 
25% of the variance of frailty was explained, implying that motor or severe intellectual 
disability only partially explain frailty. We were critical towards application of the narrow 
frailty phenotype to people with intellectual disabilities, because apart from longstand-
ing disability, this group is subject to multiple comorbidity and medication use, negative 
life events and other damaging psychological and environmental factors during their 
whole life, which all might contribute to higher frailty in old age. Therefore, we were 
more interested in the broader operationalizations of frailty.
tabel 1.
A Characteristics of frailty
1 Shrinking: weight loss; sarcopenia (loss of muscle mass)
2 Weakness
3 Poor endurance; exhaustion
4 Slowness
5 Low activity
B Cardiovascular Health Study measure
1 Baseline: > 10 lbs loss unintentionally in prior year
2 Grip strength: lowest 20% (by gender, body mass index)
3 “Exhaustion” (self-report)
4 Walking time/15 feet: slowest 20% (by gender, height)
5 Kcals/week: lowest 20%: males: < 383 Kcals/week; females: < 270 kcal/week
C Presence of frailty
Positive for frailty phenotype: ≥3 criteria
Intermediate or pre-frail: 1 or 2 criteria present
24 Chapter 2
multiDimensional oPerational DeFinitions
The multidimensional approach has resulted in a range of operationalizations that are in 
fact clusters of items, considered relevant on a basis of shared experience of gerontolo-
gists, and not always supported by explicit theory. In a systematic review, Levers et al 
[25]. identified physical, cognitive/psychological, nutritional, and social factors, as well 
as the variables “aging” and “disease,” in both the theoretical and experimental literature. 
The authors concluded that confusion existed about the relational direction between 
frailty and such factors. More recently, Gobbens et al. [12] have published an integral 
model of frailty, based on hypothesized relations between variables in time (Figure 2). A 
pathway is shown from possible determinants of frailty (life course, disease, age-related 
decline in physiologic reserve) to frailty (presenting with markers of physical, psycho-
logical, and social decline) to adverse outcomes. Each stage may offer opportunities for 
interventions. It appeared that the predictive validity of a multidimensional self-report 
questionnaire, based on the model (Tilburg Frailty Indicator, TFI), appeared moderate 
to good for disability, most aspects of healthcare utilization, and quality of life after 
1 and 2 years [4]. Addition of the Timed Up and Go test improved predictive validity 
for disability [26]. We have judged applicability of the TFI items to the population with 
intellectual disabilities, concluding that 17 out of 25 items can be answered by people 
with borderline and mild intellectual disabilities, of which one by independently living 
persons only. However, four of these items should be objectively assessed for a reliable 
result (questions on sensory impairments, memory problems, and weight loss). For per-
sons with moderate or severe intellectual disabilities, only 10 items can be completed 
by their caregivers. Some of the items are insufficiently discriminative in subgroups (e.g., 
being married, highest education level, two or more chronic conditions). Therefore, the 
TFI might be applied to and evaluated in adults with borderline or mild disabilities. The 
multidimensional model has been applied by Brehmer and Weber to Austrian adults 
with intellectual disabilities [27]. The authors developed a multidimensional self-report 
and observation-based questionnaire, based on published determinants in the general 
population as well as consensus of experts, in this case in intellectual disability care. 
A first evaluation was performed in a group of 190 adults (18–76 years) of whom 60% 
lived in a residential setting and the others lived alone or with family. The outcomes 
showed a satisfying internal consistency for the total questionnaire, but not for all 
individual items. With provisional frailty criteria, 17 participants (9%) were identified as 
frail, of which a majority had mild or moderate intellectual disabilities and lived in an 
institutional setting. The authors are planning further evaluation of the reliability and 
validity of the instrument.
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accumulation oF DeFicits
A different approach was taken by Rockwood and Mitnitski [3], who abandoned the 
search for specific determinants or markers of frailty, based on theoretical models and 
empirical accounts, after realizing that “combining traditional foci of gerontologists 
left much variance unexplained and did not consider relative fitness.” They aimed for 
a model that was “conceptually simple, could evaluate impairments in many systems, 
accommodate change, and grade severity of frailty.” An approach was proposed in 
which health- and age-related deficits present in individuals are simply counted, and 
relative frailty is inferred on that basis, without specifying deficits or combinations of 
deficits. Deficits are included that are readily available in survey or clinical data, includ-
ing symptoms, signs, disabilities, diseases, and laboratory measurements. If a sufficiently 
large number (at least 30) of variables are considered, the variables can be selected at 
random and still yield comparable results of the risks of adverse outcomes, as long as 
they adhere to a number of basic principles [28, 29]. A frailty index score is calculated 
as the proportion of potential deficits that are present in an individual, resulting in a 
value between 0 (no deficits present) and 1 (all deficits present) [29]. The validity of this 
approach has been demonstrated in 65+ and 70+ population studies, examining aver-
age accumulation of deficits between countries, relationship with mortality, and differ-
ences between population-based and institutional or clinical cohorts [3, 30]. In different 
community-based populations, the distribution of index scores is always as shown in 
Figure 3, independent of specific deficits included in the index, with most scores around 
0.15, a skewed distribution to the right with a limited prevalence of score 0 (zero state), 
and maximal scores around 0.7 [29]. Recently, the distribution in a large 50+ European 
Figure 2. An integral conceptual model of frailty [17].
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population sample has been published, showing a different picture with a majority of 
scores below 0.2 (Figure 4) [5].
We were specifically interested in the frailty index approach, because the conceptual 
model of frailty, published by Gobbens et al. [14], may apply to aging persons with in-
tellectual disabilities as well, but its operationalization is problematic. People with 
intellectual disabilities often experience early multimorbidity and may, apart from a 
cognitive disability, have motor and/or sensory problems from a young age onwards 
[31-33]. Further, their living conditions often differ from those of other people. In addi-
tion, we feared that focusing too much on published and consensus data for the general 
population might lead to a failure to identify variables that are specifically relevant to 
development of frailty in this population. Therefore, we decided to test the applicabil-
ity and outcomes of the deficit accumulation approach, too. The collection of over 400 
variables in the HA-ID study enabled us, in a collaboration with Rockwood and Mitnitski, 
to develop a frailty index consisting of 51 health- and age-related physical, mental, and 
social items, and to perform a cross-sectional evaluation of the distribution of frailty 
index scores in this population, as well as of their relationship with age. It appeared that 
the distribution of frailty index scores in the 50+ population with intellectual disabilities 
is more similar to that in general 70+ populations than to that in the general 50+ Euro-
Figure 3. Frailty index distribution. Gamma distribution fit (lines) of the observed distribution of the frailty 
index (bar) in the baseline (gray) and 18 month follow-up (black) sample [29].
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pean population. The group aged 50–59 years had a mean frailty index score similar to 
that of individuals aged 80–89 years in the general European population [5], after which 
the scores increase in further age groups. No participants had zero deficits.
conclusion anD next stePs
We conclude that the phenotypic, multidimensional, and deficit accumulation ap-
proaches of frailty principally can all be applied to people with intellectual disabilities. 
Frailty seems to be more prevalent and more severe in relatively young individuals, as 
compared to the general population. This may explain the notion of “early aging” in this 
group. However, an outline of clinical implications for prevention and treatment cannot 
yet be made as long as health outcomes (validity), causes, and prevention of frailty have 
not been evaluated in this population. Therefore, our research group is now collecting 
3-year follow-up data in the above HA-ID cohort. Our aims are to evaluate predictive 
validity of the phenotypic and frailty index outcomes for adverse health outcomes and 
daily functioning, and to analyze the relative contribution of positive and negative 
determinants, leading to a valid operational definition of frailty for this group.
Figure 4. Distribution of the frailty index in a 50+ European study population [5].
28 Chapter 2
reFerences
 1. Fried, L.P., C.M. Tangen, J. Walston, A.B. Newman, C. Hirsch, J. Gottdiener, et al., Frailty in older 
adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001. 56(3): p. M146-56.
 2. Morley, J.E., H.M. Perry, 3rd and D.K. Miller, Editorial: Something about frailty. J Gerontol A Biol Sci 
Med Sci, 2002. 57(11): p. M698-704.
 3. Rockwood, K. and A. Mitnitski, Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci 
Med Sci, 2007. 62(7): p. 722-7.
 4. Gobbens, R.J., M.A. van Assen, K.G. Luijkx and J.M. Schols, The Predictive Validity of the Tilburg 
Frailty Indicator: Disability, Health Care Utilization, and Quality of Life in a Population at Risk. Geron-
tologist, 2012. 52(5): p. 619-31.
 5. Romero-Ortuno, R. and R.A. Kenny, The frailty index in Europeans: association with age and mortal-
ity. Age Ageing, 2012. 41(5). P. 684-9
 6. Shamliyan, T., K.M. Talley, R. Ramakrishnan and R.L. Kane, Association of frailty with survival: A 
systematic literature review. Ageing Res Rev, 2013. 12(2):p. 719-36
 7. Campbell, A.J. and D.M. Buchner, Unstable disability and the fluctuations of frailty. Age Ageing, 
1997. 26(4): p. 315-8.
 8. Walston, J. and L.P. Fried, Frailty and the older man. Med Clin North Am, 1999. 83(5): p. 1173-94.
 9. Rockwood, K., R.A. Fox, P. Stolee, D. Robertson and B.L. Beattie, Frailty in elderly people: an evolving 
concept. CMAJ, 1994. 150(4): p. 489-95.
 10. Strawbridge, W.J., S.J. Shema, J.L. Balfour, H.R. Higby and G.A. Kaplan, Antecedents of frailty over 
three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci, 1998. 53(1): p. S9-16.
 11. Schuurmans, H., N. Steverink, S. Lindenberg, N. Frieswijk and J.P. Slaets, Old or frail: what tells us 
more? J Gerontol A Biol Sci Med Sci, 2004. 59(9): p. M962-5.
 12. Gobbens, R.J., M.A. van Assen, K.G. Luijkx, M.T. Wijnen-Sponselee and J.M. Schols, Determinants of 
frailty. J Am Med Dir Assoc, 2010. 11(5): p. 356-64.
 13. Abellan van Kan, G., Y. Rolland, H. Bergman, J.E. Morley, S.B. Kritchevsky and B. Vellas, The I.A.N.A 
Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging, 2008. 12(1): 
p. 29-37.
 14. Gobbens, R.J., K.G. Luijkx, M.T. Wijnen-Sponselee and J.M. Schols, In search of an integral concep-
tual definition of frailty: opinions of experts. J Am Med Dir Assoc, 2010. 11(5): p. 338-43.
 15. Rodriguez-Manas, L., C. Feart, G. Mann, J. Vina, S. Chatterji, W. Chodzko-Zajko, et al., Searching for 
an operational definition of frailty: a Delphi method based consensus statement: the frailty operative 
definition-consensus conference project. J Gerontol A Biol Sci Med Sci, 2013. 68(1): p. 62-7.
 16. Rothman, M.D., L. Leo-Summers and T.M. Gill, Prognostic significance of potential frailty criteria. J 
Am Geriatr Soc, 2008. 56(12): p. 2211-116.
 17. Gobbens, R.J., K.G. Luijkx, M.T. Wijnen-Sponselee and J.M. Schols, Towards an integral conceptual 
model of frailty. J Nutr Health Aging, 2010. 14(3): p. 175-81.
 18. Fried, L.P., L. Ferrucci, J. Darer, J.D. Williamson and G. Anderson, Untangling the concepts of dis-
ability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci 
Med Sci, 2004. 59(3): p. 255-63.
 19. Hilgenkamp, T.I., L.P. Bastiaanse, H. Hermans, C. Penning, R. van Wijck and H.M. Evenhuis, Study 
healthy ageing and intellectual disabilities: recruitment and design. Res Dev Disabil, 2011. 32(3): p. 
1097-106.
Frailty in people with ID 29
C
ha
pt
er
 2
 20. Evenhuis, H.M., H. Hermans, T.I. Hilgenkamp, L.P. Bastiaanse and M.A. Echteld, Frailty and disability 
in the older population with intellectual disabilities: Results from the Healthy Aging and Intellectual 
Disabilty Study (HA-ID). J Am Geriatri Soc, 2012. 60(5): p. 934-938.
 21. Hirsch, C., M.L. Anderson, A. Newman, W. Kop, S. Jackson, J. Gottdiener, et al., The association of 
race with frailty: the cardiovascular health study. Ann Epidemiol, 2006. 16(7): p. 545-53.
 22. Kulminski, A.M., S.V. Ukraintseva, I.V. Culminskaya, K.G. Arbeev, K.C. Land, L. Akushevich, et al., 
Cumulative deficits and physiological indices as predictors of mortality and long life. J Gerontol A Biol 
Sci Med Sci, 2008. 63(10): p. 1053-9.
 23. Syddall, H., H.C. Roberts, M. Evandrou, C. Cooper, H. Bergman and A. Aihie Sayer, Prevalence and 
correlates of frailty among community-dwelling older men and women: findings from the Hertford-
shire Cohort Study. Age Ageing, 2010. 39(2): p. 197-203.
 24. Hubbard, R.E., I.A. Lang, D.J. Llewellyn and K. Rockwood, Frailty, body mass index, and abdominal 
obesity in older people. J Gerontol A Biol Sci Med Sci, 2010. 65(4): p. 377-81.
 25. Levers, M.J., C.A. Estabrooks and J.C. Ross Kerr, Factors contributing to frailty: literature review. J Adv 
Nurs, 2006. 56(3): p. 282-91.
 26. Gobbens, R.J. and M.A. van Assen, Frailty and its prediction of disability and health care utilization: 
the added value of interviews and physical measures following a self-report questionnaire. Arch 
Gerontol Geriatr, 2012. 55(2): p. 369-79.
 27. Brehmer, B. and G. Weber, Frailty vs. Disability Distinctions in People With Intellectual Disabilities. 
JPPID, 2010. 7(1): p. 49-58.
 28. Rockwood, K., A. Mitnitski, X. Song, B. Steen and I. Skoog, Long-term risks of death and institution-
alization of elderly people in relation to deficit accumulation at age 70. J Am Geriatr Soc, 2006. 54(6): 
p. 975-9.
 29. Searle, S.D., A. Mitnitski, E.A. Gahbauer, T.M. Gill and K. Rockwood, A standard procedure for creat-
ing a frailty index. BMC Geriatr, 2008. 8(24).
 30. Mitnitski, A., X. Song, I. Skoog, G.A. Broe, J.L. Cox, E. Grunfeld, et al., Relative fitness and frailty of 
elderly men and women in developed countries and their relationship with mortality. J Am Geriatr 
Soc, 2005. 53(12): p. 2184-9.
 31. Meuwese-Jongejeugd, A., M. Vink, B. Zanten van, H. Verschuure, R. Bernsen and H.M. Evenhuis, 
Prevalence of hearing impairment in adults with an intellectual disability: cross-sectional population 
study. International J Audiology, 2006. 45(11): p. 9.
 32. van Splunder, J., J.S. Stilma, R.M. Bernsen and H.M. Evenhuis, Prevalence of visual impairment in 
adults with intellectual disabilities in the Netherlands: cross-sectional study. Eye (Lond), 2006. 20(9): 
p. 1004-10.
 33. Cleaver, S., D. Hunter and H. Ouellette-Kuntz, Physical mobility limitations in adults with intellectual 
disabilities: a systematic review. J Intellect Disabil Res, 2009. 53(2): p. 93-105.

Chapter 3
Development of a frailty index 
for older people with intellectual 
disabilities: results from the HA-
ID study
Josje D. Schoufour, Arnold Mitnitski, Kenneth Rockwood, Heleen M. Evenhuis, 
Michael A. Echteld
Research in Developmental Disabilities, 2013. 34(5): p. 1541-1555
32 Chapter 3
abstract
background: Although there is no strict definition of frailty, it is generally accepted 
as a state of high vulnerability for adverse health outcomes at older age. Associations 
between frailty and mortality, dependence, and hospitalization have been shown. We 
measured the frailty level of older people with intellectual disabilities (ID). Furthermore 
variation in gender, age, and level of ID were identified. Results were compared to a 
frailty study in the general European population. methods: This research elaborates on 
a large cross-sectional study: Healthy Ageing with Intellectual Disability (HA-ID). Nine 
hundred-eighty-two men and women (≥50yr) with ID were included. Based on the col-
lected data, we developed a frailty index with 51 health-related deficits, and calculated a 
frailty index score between 0 and 1 for each individual. Deficits included physical, social 
and psychological problems. results: The mean frailty index score was 0.27 (standard 
deviation.13). Frailty was positively correlated with age (r = .297, p < .001). More severe ID 
was associated with higher frailty scores (β = .044, p < .001). The upper limit of the frailty 
index was 0.69, which was consistent for all age categories. conclusion: As people with 
ID are getting older, the question whether additional years are spent in good health be-
comes salient. Here, people with ID over age 50 had frailty scores similar to most elderly 
people over 75y. Future research is needed to confirm if frail elderly people with ID have 
an increased risk of adverse health outcomes.
Key words: Older people, intellectual disability, health, frailty, frailty index, aging
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introDuction
Although frailty, a state in which older persons are more vulnerable to negative health 
outcomes, has been extensively studied in the general population, little is known about 
frailty in people with intellectual disabilities (ID). Frailty in this population might be of 
major importance, given that people with ID have, in addition to general aging prob-
lems, an increased risk of motor and sensory disabilities, chronic diseases (e.g. epilepsy), 
and mental health problems [1-3]. It is therefore plausible that there is an early onset of 
frailty in this population compared to the general population. Furthermore, life expec-
tancy of people with ID is approaching the general public’s life expectancy [4, 5]. To be 
able to prevent or delay frailty in this population, research on frailty in this population 
is urgently required. 
The underlying mechanisms behind frailty are not yet fully understood. While it is well 
accepted that frailty is a useful construct, there is yet no consensus on how it should be 
operationalized, nor is there complete consensus on the definition, or on how it should 
be diagnosed [6]. The essential feature is that it is a state of increased risk for adverse 
health outcomes [7]. Gobbens et al described frailty as “a dynamic state affecting an indi-
vidual who experiences losses in one or more domains of human functioning (physical, 
psychological, social), which is caused by the influence of a range of variables and which 
increases the risk of adverse outcomes” [8] which is in line with prior conceptualizations 
[9, 10]. Associations between frailty and mortality, institutionalization, and dependence 
have been shown [11]. Since frailty is a highly age-associated phenomenon [11, 12] and 
the number of older adults increases across the globe [13], frailty becomes one of the 
major challenges for health care professionals [14].
Despite lacking complete consensus, two approaches are broadly accepted in the op-
erational definition of frailty. The first defines frailty as a syndrome, with specific features; 
the second defines frailty from a multidimensional perspective. The frailty phenotype 
[11] proposes five features, using elements operationalized in the Cardiovascular Health 
Study (CHS). It classifies people as frail if 3 or more of the following features are present: 
slow walking speed, impaired grip strength, low activity levels, unintended weight loss, 
or exhaustion. The phenotypic approach has shown to correlate with adverse health 
outcomes in wide range of studies in different settings [15]. Our research group investi-
gated frailty status of 848 clients of formal ID care, aged 50 years and over, according to 
these criteria and found that 13% was frail. Among the subgroup aged 50-64 years, the 
prevalence of frailty (11%) is comparable to that in the general population aged 65 years 
and over. Frailty in the subgroup aged 65 years and over was 18%, compared to 7-9% in 
the general population [16]. It has been suggested that frailty measured according to the 
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CHS criteria is highly influenced by low mobility [17], which was also found in our study 
group with ID. Due to the exclusively physical orientation of the criteria, longstanding 
motor disability may be misclassified as frailty. It could be that the second perspective 
to measure frailty, the multidimensional one, is more suitable for this population. This 
broader concept includes in addition to physiological health also social circumstances 
and mental health. There are several methods using such a multidimensional perspec-
tive, e.g. in the Netherlands, the Tilburg Frailty Indicator [18] and the Groningen Frailty 
Indicator [19]. However such methods based on self-report may be difficult to apply in 
this population because of limited understanding and communication problems, as well 
as unidentified health problems [20].
Another multidimensional measure for frailty is the frailty index which is explicit in 
characterizing frailty not as a syndrome, but as a state. A frailty index is a quantitative 
measure based on a concept of non-specific accumulation of a broad spectrum of 
age-related impairments (deficits), including symptoms, signs, diseases, disabilities or 
laboratory measurements [12, 21]. A main advantage of the frailty index is the wide 
range of deficits which are not merely focused on physical health but also include 
social circumstances and mental health [22]. A systematic review taking into account 
20 different frailty instruments concluded that the only instrument taking all frailty 
factors (nutritional status, physical activity, energy, strength, cognition, mood, social 
relations/social support) into account is the frailty index [23]. Frailty indices have been 
calculated for large older populations in Canada, Australia, Sweden [24], China [25, 26], 
Wales [27], Mexico [28], United Kingdom [29, 30], Europe [31], and the United States [32, 
33]. Although these frailty indices were constructed using different datasets, different 
deficits, and different numbers of deficits (20-130), all were highly associated with early 
mortality [24, 34, 35]. High frailty index scores are related to institutionalization [36, 37] 
and to cognitive decline [38]. Frailty indices, designed for different countries, show the 
same characteristics: a skewed distribution concentrated to the right, a high correlation 
with age, and a consistent upper limit of the frailty index Score. Furthermore, Rockwood 
et al., showed that a random selection of deficits, within any given frailty index, yields 
comparable frailty estimates [37]. Several researchers showed that frailty index-defined 
frailty predicts adverse health outcomes more precisely than phenotypic-defined frailty 
[38-40]. These results indicate a robust relation between deficit accumulation and frailty 
[34].
For us, an advantage of this method is the relatively free choice of deficits, so a frailty in-
dex can be specified for older adults with ID. Furthermore, the broader approach might 
be a more valid perspective for this population. Constructing a frailty index for older 
people with ID may therefore help to provide insight into the onset and character of 
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frailty and its associated factors in this group. The main aim of this study was to provide 
first insight into the accumulation of deficits among older persons with ID. To achieve 
this objective the following questions needed to be answered. 
• Is it feasible to create a frailty index for older people with ID from an existing set of 
health data?
• What are the properties of the frailty index (distribution, correlation with age and 
the slope of the 99th percentile score of each age group, minimum and maximum 
score)?
• What are the differences in mean frailty index scores in subgroups (according to 
gender, age, and level of ID)?
• What are the differences in mean frailty index score per age decade in older people 
with ID compared to the general population?
methoDs
Design
Data from the HA-ID study, a cross-sectional observational study in 1050 clients of ID 
care provider services, were employed for these analyses. The main goal of the HA-ID 
study was to establish the health status of older persons with ID using formal care for 
people with ID in the Netherlands. Inclusion criteria and data collection have been 
described elsewhere [41]. In short, participants were recruited through three Dutch care 
provider services offering a broad spectrum of care, ranging from ambulatory support 
to residential care. The three care organizations are located in different parts of the 
Netherlands. The Medical Ethics Committee of the Erasmus Medical Center Rotterdam 
(MEC- 2008-234) and the ethics committees of the participating care organizations ap-
proved this study. This study adheres to the Declaration of Helsinki for research involving 
human subjects.
Participants
All 2322 clients of 50 years and older receiving care or support by one of the partici-
pating care organisations were invited to participate in the study. The total number of 
clients who participated in the study was 1050. Those capable of understanding the 
available information signed the consent form themselves. Legal representatives were 
approached for those not able to make this decision. The level of intellectual disability 
ranged from borderline to profound. The HA-ID population is nearly representative for 
all Dutch older people with ID using formal services. There is a slight underrepresenta-
tion of men X2(1, N = 2322) = 0.53, p = .028, people aged 80 and above X2(8, N = 2322) = 
27.41, p = .001, and people living independently X2(3, N = 2237) = 50.55, p < .001.
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Data collection
The HA-ID study consisted of three main themes: (1) physical activity and fitness, (2) 
nutrition and nutritional state, and (3) mood and anxiety. Within these themes a broad 
diagnostic assessment was performed in addition to the collection of file data. These as-
sessments included: physical assessments, a fitness test battery, actigraphy, pedometer 
measurements, mealtime observations of swallowing, nutritional questionnaires (gas-
troesophageal reflux and undernutrition), screening questionnaires and standardized 
psychiatric interviews for depression and anxiety, questionnaires on life events, quality 
of life, (instrumental) activities of daily living, mobility, dementia, social circumstances, 
somatic complaints, as well as laboratory tests. All used instruments were carefully 
selected for this study and population and if necessary and applicable, psychometric 
properties were tested and reported [41-43]. The physical fitness assessments were 
performed by physiotherapists, physical activity instructors or occupational therapists, 
who were all experienced with people with ID and trained during a two-day course. 
Questionnaires were completed by self-report or if not applicable, through observation-
based reports completed by professional caregivers. All test administrators were trained 
by the researchers themselves or external experts; their test assessments and scoring 
were tested regularly during the entire duration of the study. Level of ID was obtained 
from the scores of psychologists or test assistants, who determined level of ID from 
available IQ tests, Vineland scores and social emotional development. Data were col-
lected between February 2009 and July 2010.
inclusion criteria for health deficits into the frailty index
During the HA-ID study, 409 different variables (including single items from question-
naires) were collected. The frailty index employed here was based on a selection of these 
variables. An overview of criteria for selecting a variable for inclusion is shown in Table 
1. We used the selection criteria published by Searle at al. [44]: 1) The deficit must be 
associated with health status, 2) The prevalence of the deficit must generally increase 
with age, 3) Only deficits that do not ‘saturate too early’ should be selected, which means 
that ceiling effects should not occur within the sample population, 4) The deficits should 
cover all basic dimensions of health. To meet these requirements, all deficits without a 
significant correlation with age within this study population (p > .1) were excluded (e.g. 
communication problems, sadness, trying to eat inedible things, dealing with money, 
severe behavioural problems, and hyperthyroidism). To exclude deficits that saturate 
too early, deficits with prevalences over 80% were excluded (not doing laundry and 
ironing). To cover a broad variety of health aspects, variables about mental wellbeing, 
blood values, chronic diseases, fitness, nutritional status, level of independence ((in-
strumental) activities of daily living), physical and mental risk factors, and social aspects 
were included. Additional inclusion criteria were developed for this specific population 
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by consensus of our research group. Deficits were excluded if outcome values were miss-
ing in over 30% of the participants (e.g. experiencing dizziness, sit and reach test, 30 
seconds chair test, and information about dental health). Furthermore, single items of 
questionnaires were used as individual deficits rather than using subscale or total scores 
of the questionnaire, in order to increase the number of deficits. However, several items 
of questionnaires may refer to the same topic and will therefore be highly correlated (r 
> .7). To limit the influence of specific topics in such cases, only the item with the high-
est correlation with age was included. For example from the variables ‘fatigue’ & ‘lack 
of energy’ and ‘dressing’ & ‘grooming’ only two of the four (fatigue and dressing) were 
chosen. Similarly, if multiple items were designed to measure the same concept, the 
item with the most objective measure or with the highest correlation with age was cho-
sen. For this reason variables such as ‘able to walk 50 meters’, and metabolic syndrome 
were excluded, while general mobility and the individual factors of metabolic syndrome 
were included. Last, deficits with prevalences below 5% were not included (for example 
sleep apnea and Parkinson’s disease). If possible, related variables with low prevalences 
were combined to multi-item deficits (including: chronic obstructive pulmonary disease 
& asthma, diabetes mellitus type 1 & 2 and/or high serum glucose levels, coronary heart 
disease & heart failure & cardiac dysrhythmia & having a pacemaker). Only variables 
fulfilling all inclusion criteria were included as a deficit. The list of excluded variables 
was screened for variables that were excluded beyond expectations. Questions regard-
ing dementia showed no relation with age, which was surprising. Further research 
revealed Down syndrome as a confounder. It is a well-known fact that people with Down 
syndrome are more likely to develop early Alzheimer dementia and other dementia 
problems [45, 46] and have a decreased life expectancy [33]. When adjusted for Down 
syndrome four dementia variables did correlate with age (β = .059-0.09, p < .1) and were 
therefore included in the frailty index as well.
table 1. criteria that need to be fulfilled before a variable was included into the frailty index
A maximum of 30% of the cases is missing
The deficit should be present in > 5% of the participants
If items are designed to measure the same concept, the item that best fits the criteria is chosen. 
If questionnaires are used, single items of that questionnaire can be used as deficits as long as they fulfil all 
criteria and do not correlate too strong with each other (r > 0.7). 
The deficit is associated with health status. 
The deficit is positively associated with age (p-value < 0.1). 
The deficit does not saturate too early (in over 80% of the participants the deficit was present). 
The deficits together must cover different health aspects. 
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scoring of deficits 
All deficits were scored between ‘0’ and ‘1’, ‘0’ indicating the absence of the deficit 
and ‘1’ the complete presence of the deficit. Pragmatic cut-off values were used that 
are congruent with previous publications. If available, valid cut-off values for people 
with ID were used, and otherwise cut-off values for the general older population were 
applied. Diseases were scored dichotomously: 1 = disease present, 0 = disease absent. 
For variables with intermediate response, values between 0 and 1 were used. Variable 
scores derived from blood samples were scored according to cut-off values as stated 
in the laboratory guide of the Erasmus Medical Center, Rotterdam. Cut-off values for 
fitness tests were derived from literature (general older population), with the exception 
of the Box and block test. Reference values [47] for this test were not suitable for the ID 
population and therefore quartiles obtained in the HA-ID population were used for score 
calculations. Diabetes mellitus was scored 1 for participants with the diagnosis diabe-
tes mellitus according to their medical record, participants taking drugs for diabetes 
(ATC-code A10), or participants with serum glucose levels above 7 mmol/l. If applicable, 
scores were stratified for gender (walking speed, grip strength, high-density lipoprotein, 
haemoglobin), for body mass index (grip strength), or height (walking speed). If, due 
to physical problems, participants were unable to perform the walking speed test, grip 
strength test or box and block test, a score of 1 was given. The cut-off values were not 
stratified for age categories. No weighting of individual variables was applied, conse-
quently all chosen deficits contributed equally to the final frailty score.
calculation of the frailty index
A frailty index score was calculated for each individual by dividing his/her sum of deficit 
scores by the total number of deficits measured, resulting in a score between 0 (no defi-
cits present) and 1 (all deficits present). If for example an individual scored twelve points 
out of 51, the frailty index score was 12/51 = 0.24. In general, the frailty index becomes 
more precise if more variables are included [44], but it has been shown that with an 
index of 30-40 deficits it is possible to predict adverse health outcomes [24]. Therefore 
participants with less than 30 deficits measured were excluded from further analyses. 
Missing deficits were coded as missing values and were not included in the frailty index 
score calculation. Therefore, a difference in total deficit count between participants was 
possible, but no one with fewer than 30 deficits in the denominator was included.
analyses
Frequencies for all possible variables were calculated to identify floor effects (deficit 
present in < 5% of the participants), ceiling effects (deficit present in > 80% of the 
participants), and missing values (unknown in > 30% of the participants). To assess the 
association between age and potential deficits, a scatter plot was generated for each 
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deficit and the correlation coefficient and p-value were calculated. A p < .1 was required 
in order to be included.
Pearson Chi-square tests were used to compare the group of clients for whom a frailty 
index could not be calculated, because less than 30 variables were known, with the 
group with a frailty index score on baseline characteristics: age, gender, level of ID, and 
presence of Down syndrome. If the criteria for the expected cell frequency were not 
met (maximum of 20% of the cells with an expected count less than five) variables were 
recoded into combined variables. If dichotomous variables did not meet the criteria, the 
Fisher’s exact test was used as an alternative.
Properties of the frailty index were analysed. First, mean and standard deviation of 
the frailty score were calculated for the total study population. A histogram was plot-
ted to examine the distribution of the frailty index. The regression coefficient B was 
calculated to estimate the increase in mean frailty index score per year. The minimum 
and maximum score of the frailty index was calculated. Age-specific trajectories of the 
frailty index were calculated as the mean frailty index score across 10-year age groups. 
To obtain insight into a potential relationship of maximum frailty index scores with age, 
we calculated 99th percentile scores per 10-year age group, and subsequently calculated 
the slope of these 99th percentile scores.
The extent to which the frailty index was sensitive for individual included deficits 
was evaluated using a random re-sampling procedure. Fifty subsets of 75% of the total 
number of included deficits were repetitively used to calculate frailty indices and the 
best fit regression line with age.
Mean and standard deviation of the frailty score were calculated for different sub-
groups: gender, age group (per 10 year), level of ID (borderline, mild, moderate, severe, 
profound), and the presence of Down syndrome. Differences in frailty score between 
subgroups were tested with an independent samples t-test (presence of Down syn-
drome and gender), or univariate regression analysis (level of ID and age). All tests were 
two-sided and a p-value of less than .05 was considered to be statistically significant. In 
order to compare our results with the general population, data from a European 50+ 
study were used to plot the mean frailty index score of the general population against 
age.
The random re-sampling procedure was performed using Matlab (version 7.9). All 
other statistical analyses were performed using SPSS statistics 17.0 for Windows (SPSS, 
Inc, Chicago, IL, USA). 
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results
Deficits included in a frailty index for older people with intellectual disabilities
Data from the HA-ID study included 409 variables for evaluation to construct a frailty index 
for older people with ID. Of the 409, 162 were excluded due to insufficient responses or 
were a duplicate of similar variables (Figure 1). An additional 204 variables did not meet the 
pre-specified criteria. After which 11 variables were combined to 4 deficits. After adjusting 
for Down syndrome four questions about short-term memory did correlate with age and 
were retained. Finally, 51 variables were included in the frailty index (Figure 1). Detailed 
information about included deficits and cut-off values is shown in Table 2. 
Participant selection
Only participants with at least 30 known deficits were included, consequently all par-
ticipants with 21 or more missing values were excluded from further analyses. Of the 
1050 participants, 68 had too many missing values and were not included in further 
calculations. Main reasons for many missing values were incomplete questionnaires or 
missing file information for community-dwelling participants who received medical 
care from general practitioners. No significant differences were found between the 982 
participants with a calculated frailty index and the 68 excluded participants with respect 
to gender X2(1, N = 1050) = 0.532, p = .466, level of ID X2(4, N = 923) = 3.92, p = .417, age 
All measured variables in 
the HA-ID study (n = 409)
First selection (n = 247)
Second selection (n = 43)
Final selection (n = 51)
Variables that did not fulfil 
the additional inclusion 
criteria (n = 162)
· < 70% response
· Duplicate
· Correlation between 
similar questions r < .7
Variables that did not fulfil the inclusion 
criteria of Searle et al. (n = 204)
· Not associated with health 
· Prevalence does not increases with 
age
· Saturation (> 80%), low prevalence 
(< 5%)
11 variables were combined 
to 4 deficits
Exception dementia (n = 4)
 
Figure 1. Flow chart of deficit selection.
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table 2. Overview of deficits included in the frailty index
# Deficit Additional information Cut-off values and FI scores Ref
1 Bladder control ADL, Completed by professional 
caregivers of the participants
Incontinent = 1
Sometimes continent = 0.5
Continent = 0
[59]
2 Dressing ADL, Completed by professional 
caregivers of the participants
Needs help = 1
Partly with help = 0.5
No help = 0
[59]
3 Walking stairs ADL, Completed by professional 
caregivers of the participants
Needs help = 1
Partly with help = 0.5
No help = 0
[59]
4 Bathing ADL, Completed by professional 
caregivers of the participants
With help = 1
No help = 0
[59]
5 Transfer bed to chair ADL, Completed by professional 
caregivers of the participants
Unable, no sitting balance = 1
Major help = 0.66
Minor help = 0.33
No help = 0
[59]
6 Groceries IADL, completed by professional 
caregivers of the participants
Not independently = 1
With help = 0.5
Can do groceries = 0
[60]
7 Housekeeping IADL, completed by professional 
caregivers of the participants
Not independently = 1
With help = 0.5
Can do housekeeping = 0
[60]
8 Falling Number of falls in the last three 
months. Information gathered via the 
professional care giver
 > 11 falls = 1
6-10 falls = 0.75 
3-5 falls = 0.5
1-2 falls = 0.25
0 falls = 0
9 Present at the care 
centre (max 10 shifts 
per week)
Information gathered via the 
professional care giver
≥3 visits a week = 0
 < 3 visits a week = 1
10 Fatigued ADESS (Dutch translation of the 
Anxiety, Depression And Mood Scale) 
over the past six months. Completed 
by professional caregivers
Very often = 1
Often = 0.66
Sometimes = 0.33
Never = 0
[42, 61]
11 Listless ADESS (Dutch translation of the 
Anxiety, Depression And Mood Scale) 
over the past six months. Completed 
by professional caregivers 
Very often = 1
Often = 0.66
Sometimes = 0.33
Never = 0
[42, 61]
12 Panic attacks ADESS (Dutch translation of the 
Anxiety, Depression And Mood Scale) 
over the past six months. Completed 
by professional caregivers
Very often = 1
Often = 0.66
Sometimes = 0.33
Never = 0
[42, 61]
13 Decreased food 
intake, due to loss of 
appetite, digestive 
problems, chewing of 
swallowing difficulties
Mini Nutritional Assessment 
(MNA) over the past three months. 
Completed by professional caregivers.
Severe decrease in food intake = 1
Moderate decrease in food intake = 
0.5
No decrease in food intake = 0
[62]
14 Weight loss Mini Nutritional Assessment 
(MNA) over the past three months. 
Completed by professional caregivers.
Weight loss greater than 3kg = 1
Does not know = 0.5
Weight loss 1-3kg = 0.5
No weight loss = 0
[62]
15 Fluid intake per day 
(water, juice, coffee, 
tea, milk)
Mini Nutritional Assessment 
(MNA) over the past three months. 
Completed by professional caregivers.
Less than 3 cups = 1
1 to 5 cups = 0.5
 > 5 cups = 0
[62]
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table 2. Overview of deficits included in the frailty index (Continued)
# Deficit Additional information Cut-off values and FI scores Ref
16 Calf circumference 
(CC) in cm
Mini Nutritional Assessment (MNA) 
Completed by professional caregivers.
CC < 31 = 1
CC ≥ 31 = 0
[62]
17 Only eats selected 
types of food (e.g. 
pudding, rice)
Screening Tool of Eating Problems 
(STEP) over the last month. 
Completed by professional caregivers
 > 10 times = 1
Between 1-10 times = 0.5
Not at all/not a problem = 0
[63]
18 Only eats small 
amounts of the 
presented food
Screening Tool of Eating Problems 
(STEP) over the last month. 
Completed by professional caregivers
 > 10 times = 1
Between 1-10 times = 0.5
Not at all/not a problem = 0
[63]
19 Only eats foods of 
certain textures. 
Screening Tool of Eating Problems 
(STEP) over the last month. 
Completed by professional caregivers
 > 10 times = 1
Between 1-10 times = 0.5
Not at all/not a problem = 0
[63]
20 Mobility Provided by professional caregivers Wheelchair = 1
Walks with support = 0.5
Walks independently = 0
21 CVA Medical file, last 24 months Yes = 1
No = 0 
22 Coronary heart 
diseases/ heart 
failure/cardiac 
dysrhythmia/
pacemaker
Medical file, last 24 months Yes = 1
No = 0 
23 Cancer Medical file, entire life Yes = 1
No = 0 
24 Asthma/COPD Medical file, last 24 months, 
mediation
Yes = 1
No = 0 
25 GERD Medical file, last 24 months Yes = 1
No = 0 
26 Obstipation Medical file, last 24 months, 
medication 
Yes = 1
No = 0 
27 Risk for Diabetes 
Mellitus (DM) or 
known DM
Medical file, blood glucose levels, 
medication
DM according to medical file or taking 
drugs for DM and/or serum glucose ≥7 
mmol/l = 1
No DM according to medial file, no DM 
drugs and blood glucose 6.1-6.9 = 0.5
No DM according to medial file, no DM 
drugs and blood glucose < 6.1 = 0
[64]
28 Scoliosis Medical file Yes = 1
No = 0 
29 Visual /Hearing 
impairments 
(V/H impairment)
Medical file At least one severe V/H impairment = 
1 
Two moderate V/H impairment = 1
One moderate V/H impairment = 0.5
No V/H impairment = 0 
30 Medication use 
(polypharmacy)
Medical file ≥ 7 drugs = 1
4-6 drugs = 0.5
0-3 drugs = 0
[65, 66]
31 Over or under weight Medical examination BMI < 18.5 OR > 30 = 1
BMI 18.5-20 OR 25-30 = 0.5
BMI 20-25 = 0
[67, 68]
32 High blood pressure Medical file Yes = 1
No = 0 
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table 2. Overview of deficits included in the frailty index (Continued)
# Deficit Additional information Cut-off values and FI scores Ref
33 Peripheral 
atherosclerosis
Medical examination Ankle Arm index 
 > 0.9 = 0
0.8-0.9 = 0.5
 < 0.8 = 1
[69, 70]
34 Osteoporosis (t-score) Medical examination  < 2.5 = 1
-1 till -2.5 = 0.5
 > -1 = 0
[71]
35 Manual Dexterity 
(BBT)
Fitness assessment
The participants were asked to move 
as many coloured blocks as possible 
in one minute. The blocks were 
2.5cm3 and needed to be moved 
from one side of a wooden box to the 
other side. 
lowest quartile = 1
second quartile = 0.66
third quartile = 0.33
Highest quartile = 0
36 Walking speed Fitness assessment
Comfortable walking speed was 
measured by the average of three 
records of the time needed to 
complete 5 meters after 3 meters for 
acceleration. 
Slow walking speed was Stratified for 
height and gender. 
Male height ≤173cm ≥7 sec = 1
Male height > 173cm ≥6 sec = 1
Females height ≤ 159cm ≥7 sec = 1 
Females > 159 cm ≥6 sec = 1
Faster = 0 
Participant who were not able to 
succeed the walking speed assess-
ment due to physical limitations were 
scored positive (score 1) as well.
[11] 
37 Grip strength Fitness assessment
Measured with a Jamar Hand 
Dynamometer (#5030J1, Sammons 
Preston Rolyan, USA) 
Grip strength was stratified for gender 
and BMI. 
Male
BMI ≤ 24: ≥29kg = 0
BMI 24.1–26: ≥30 kg = 0
BMI 26.1–28: ≥30 kg = 0
BMI > 28: ≥32 kg = 0
Female
BMI ≤ 23: ≥17 kg = 0
BMI 23.1–26: ≥17.3 kg = 0
BMI 26.1–29: ≥18 kg = 0
BMI > 29: ≥21 kg = 0
Below cut-off values = 1
Participant who were not able to suc-
ceed the grip strength assessment due 
to physical limitations were scored 
positive (score 1) as well.
[11] 
38 Hypercholesterolemia Medical dossier Yes = 1
No = 0 
39 HDL Blood examination HDL was stratified for gender
Male 
0-0.9 mmol/l = 1
0.9-1.55 mmol/L = 0.5
 > 1.55 mmol/L = 0 
Female
0-1.1 mmol/l = 1
1.1-1.55 mmol/L = 0.5
 > 1.55 mmol/L = 0 
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table 2. Overview of deficits included in the frailty index (Continued)
# Deficit Additional information Cut-off values and FI scores Ref
40 Haemoglobin Blood examination Stratified for gender
Male
8.6-10.5 mmol/L = 0 
 < 8.6 OR > 10.5 mmol/L = 1
Female
 7.5-9.5 mmol/L = 0 
 < 7.5 OR > 9.5 mmol/L = 1
[64]
41 Dysphagia Diagnosis via DDS questionnaire Severe dysphagia = 1
Moderate dysphagia = 0.5
No Dysphagia = 0
[72]
42 Hospitalization Asked in informed consent form. 
Hospitalization is the past 12 months
 > 2 = 1
1-2 = 0.5
No = 0
43 Makes a sad/
depressing 
impression
SDZ, completed by professional 
caregivers
Last three months
Often = 1
Several times = 0.66
Sometimes = 0.33
Never/very rare = 0
[73]
44 Has fun and interest 
in daily activities
SDZ, completed by professional 
caregivers
Last three months
Never/very rare = 1
Sometimes = 0.66
Several times = 0.33
Often = 0
[73]
45 Sleeps more than 
regularly (trouble 
getting out of bed, 
falls asleep during 
the day)
SDZ, completed by professional 
caregivers
Last three months
Often = 1
Several times = 0.66
Sometimes = 0.33
Never/very rare = 0
[73]
46 Fast fatigue easily 
fatigued/listless
SDZ, completed by professional 
caregivers
Last three months
Often = 1
Several times = 0.66
Sometimes = 0.33
Never/very rare = 0
[73]
47 Is slow or passive in 
his/her movements
SDZ, completed by professional 
caregivers
Last three months
Never/very rare = 0
Sometimes = 0.33
Several times = 0.66
Often = 1
[73]
48 Knows which year it is The Dementia Questionnaire for 
Mentally Retarded Persons (DMR) 
Normally No = 1
Sometimes = 0.5
Normally Yes = 0
[74]
49 Knows the way to 
familiar places
The Dementia Questionnaire for 
Mentally Retarded Persons (DMR) 
Normally No = 1
Sometimes = 0.5
Normally Yes = 0
[74]
50 Is seeing group mates The Dementia Questionnaire for 
Mentally Retarded Persons (DMR) 
Normally No = 1
Sometimes = 0.5
Normally Yes = 0
[74]
51 Knows that today is 
a weekend or a week 
day
The Dementia Questionnaire for 
Mentally Retarded Persons (DMR) 
Normally No = 1
Sometimes = 0.5
Normally Yes = 0
[74] 
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(Mexcluded = 60.19, SDexcluded = 6.78 Mincluded = 61.64, SDincluded = 8.09), t(1047) = 1.43, p = .098 
(two-tailed) and the presence of Down syndrome X2(1, N = 920) = 0.034, p = .853.
Properties of the frailty index and differences in subgroups
The mean score of the frailty index was 0.27 with a standard deviation of 0.13 (Table 
3). The range of frailty index scores was between 0.02 and 0.69. The distribution of the 
frailty index was slightly skewed (skewness value = 0.53, SD = 0.08) to the right (Figure 
2). The average frailty index score showed a .005 (.018 taking the natural log of the frailty 
index) per year increase with age r = .297, t (980) = 9.74, p < .001 (Figure 3). There was no 
significant slope of the 99th percentile slope, showing the same maximum frailty index 
score among all age groups. When a frailty index based on a random selection of 75% of 
the used deficits is plotted against age 50 times, the intercept changes, while the slopes 
of the regression lines are virtually the same (Figure 4). Table 3 shows that there were no 
significant differences in frailty index scores by gender (Mmale = 0.27, SDmale = 0.13 Mfemale 
= 0.28, SDfemale = 0.13), t(980) = 1.41, p = .159 (two-tailed). However, if the difference 
between genders is adjusted for severity of ID, women show significantly higher frailty 
index scores compared to men β = .088, t(878) = 2.91, p = .004. Frailty increased sig-
nificantly with more severe ID β = .440, t(879) = 14.54, p < .001. Participants with Down 
syndrome show significantly higher frailty scores compared to those with ID by other 
table 3. Participant characteristics and associations with the frailty index
Characteristic n Mean FI SD p-value
Total 982 0.27 0.13 -
Gender .159a
Male 507 0.27 0.13
Female 475 0.28 0.13
Level of ID  < .001b
Borderline 29 0.19 0.11
Mild 191 0.21 0.12
Moderate 432 0.26 0.12
Severe 147 0.33 0.12
Profound 82 0.41 0.10
Age categories  < .001b
50-59 years 458 0.25 0.12
60-69 years 344 0.28 0.12
70-79 years 156 0.34 0.12
80-89 years 21 0.41 0.14
90 years and above 3 0.42 0.03
Down syndrome .007a
No 732 0.27 0.13
Yes 142 0.31 0.13
aDifferences between groups calculated with independent sample t-test
bDifferences between groups calculated with univariate linear regression analysis
Note, FI = frailty index
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Figure 2. Frailty index 
distribution: Observed 
distribution of the Frailty 
index for older persons 
with intellectual dis-
abilities.
Figure 3. Frailty index and age. Upper lines represent the average frailty index per age category and the 
corresponding trend line with a slope of .005 for older people with ID. The lower lines represent the aver-
age frailty index per age category and the corresponding trend line from a large 50+ general European 
population [31].
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causes (Mno Down syndrome = 0.27, SDno Down syndrome = 0.13 MDown syndrome = 0.31, SDDown syndrome = 
0.13), t(872) = 2.72, p = .007 (two-tailed). At each age increment older people with ID 
showed higher mean frailty index scores than the general population (Figure 3). 
Discussion
For the first time, a frailty index was successfully constructed for older people with intel-
lectual disabilities receiving formal care. We showed that it is possible to construct a 
frailty index for this specific population and provided a list of all included deficits, their 
diagnostic method, and applied cut-off values. The frailty index calculated for this study 
includes social, physical, and psychological aspects of health. For 982 people with intel-
lectual disabilities aged 50 years and over, a frailty index score was calculated based on 
51 deficits. The mean score was 0.27. Per year increase in age, the frailty index increased 
on average with .005 points (or .018 taking the natural log of the frailty index). The upper 
limit of the frailty index was 0.69 and this limit was consistent over all age categories. As 
was to be expected, more severe levels of ID were clearly associated with higher frailty 
index scores (p < .001). Comparing our results to previous studies among non-disabled 
populations, it appears that the mean frailty index score is higher and that frailty in our 
population, on average, starts at a much younger age compared to the general public 
(Figure 3).
Figure 4. Robustness of the frailty index in respect to the composition of variables. 50 times 75% of the 
deficits were randomly selected to create and plot a frailty index against age. Each line represents the best 
fit regression line of the average frailty index score. While the intercept changes, the slopes of the regres-
sion lines are virtually the same.
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The large number of the included deficits, the objective measurement of most deficits, 
and the critical selection of the deficits provide a robust measure of frailty. Other strong 
points of this study are the large and near-representative study population, providing 
results applicable to all Dutch older people (50+) with ID receiving specialized care. Note, 
however, that older people with borderline or mild intellectual disabilities, not using for-
mal ID care, were not included in the study. Nevertheless, our data must be interpreted 
with caution. Although the population was near-representative, older people with ID 
living independently or with relatives using formal care were slightly underrepresented 
in the HA-ID study. Because of the high correlation between the frailty index score and 
more severe ID this underrepresentation might have caused a slightly higher mean 
frailty index. The applicability of a number of cut-off values across a sample that covers 
many ages is problematic (e.g. osteoporosis and grip strength). In addition, most cut-off 
points have not been validated for this specific population.
Weighting of deficits can improve the area under the curve of a receiver operating 
characteristic curve analysis [48], which is often interpreted as improving the predictive 
ability of the index. Weighting is commonly done in index variables in other epidemio-
logical studies because some items might have more influence on the frailty status of 
an individual than other items. However, here we did not weight the deficits, because 
the arguments against weighting appear to be stronger, which is likely why none of the 
published frailty indices weighted their variables. First, although weighting improves 
prediction, this is only narrowly construed, “retrospective prediction” – i.e. it improves 
the fit in an existing database, but limits generalizability to other databases. Second, 
most importantly, statistical techniques to weight variables rely on the assumption of 
independence between the items, which typically does not hold in complex biological 
systems in which the components interact. Indeed, it is this reason – the redundancy of 
information of items – which means that the items in a frailty index are “auto-weighted”. 
In other words, items that are more important to frailty status in a given individual will 
be seen in the presence of other deficits. For example, consider two individuals each of 
whom reports a skin condition. Many skin conditions are benign – an individual with 
such a skin condition would show little impact on frailty status. In a 51 item frailty index, 
for example, such a skin condition would contribute only one deficit (a score of about 
0.02). But if in the second individual the skin condition would reflect a disabling disorder 
(an autoimmune disease, for example) it would be associated with disability items, with 
feelings of fatigue, with slowing and with other immune disorders – easily contributing 
10 other deficits, or an increase in score by about 0.2. In this way, indirectly, serious 
conditions put more weight on the frailty score; in this sense, it is “auto-weighted”. Last, 
this approach also allows the cumulative impact of small items, which might individually 
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not be associated with an adverse outcome to be considered jointly, which sometimes 
will demonstrate a strong effect [49].
Little research has been conducted on frailty in people with ID. Brehmer and Weber were 
the first to investigate frailty in people with ID, showing that, according to their frailty 
questionnaire, over a quarter of adults aged 50 years and over with ID was frail [50]. 
However the small sample size (n = 50) and different format make it impossible to com-
pare the results with studies conducted in the general population and with our study. 
According to the phenotypic approach, frailty was more often seen in older people with 
ID than in the general population [16]. However as mentioned before, frailty measured 
according to the phenotypic approach might be influenced by longstanding motor 
disability, often seen in this population. Therefore we measured frailty from a multi-
dimensional perspective, according to a standardized method and with a large study 
population, which means that our results could be compared to the general population.
Frailty indices constructed and calculated for non-disabled older populations usually 
show a mean score between 0.08 and 0.17 with a skewed gamma distribution, a deficit 
accumulation rate of .03 (log scale) per year, and a maximum score around 0.70 [12, 
39, 51]. Recently, a European frailty index study was published showing properties 
consistent with earlier results [31]. In this study among 29,905 non-institutionalized 
older people aged 50 years and above, a frailty index was established of 40 items, mostly 
overlapping with deficits used by us [31]. From these results we can conclude that older 
people with ID have much more deficits compared to the general non-disabled (50+) 
population, but accumulate fewer deficits per increased year of age (β = .297). Further-
more, studies conducted among older populations (65 or 70 years and over) showed 
a frailty index score distribution similar to ours, indicating that older people with ID 
accumulate as many deficits as seen in the general population 20 years later. This raises 
the question what the frailty levels are in younger age groups. Lifelong comorbidity in 
many persons with ID might cause an early onset of frailty. In the general population 
(15-79 years old), there are already some deficits present in the earliest age categories, 
exponentially increasing with age [52]. This indicates an ongoing decline of health, start-
ing at relatively young age, eventually leading to frailty. It could be that in older people 
with ID, lifelong cognitive, sensory, motor disabilities and chronic comorbidity cause 
a very early onset of deficit accumulation, leading to early frailty. However, our frailty 
index should be validated against decreasing health and independence before further 
conclusions can be drawn.
The distribution of the frailty index in our study is similar to frailty indices in other 
populations with impairments. Mitnitski et al. showed that the frailty index in people 
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without ID but with cognitive impairments caused by Alzheimer, Parkinson, or other 
forms of dementia has a rather normal distribution and a much higher mean compared 
to the non-disabled population [12]. Institutionalized elderly people without ID also 
show higher means compared to community-dwelling people without ID. However, as 
opposed to the population with ID, the correlation between the frailty index and age 
is close to 0 among these impaired groups [24, 27]. In fact, the distribution and mean 
frailty score in older people with ID are comparable to frailty indices seen in the general 
population in those with a mild form of dementia, with much lower mean scores than 
in those with severe dementia, but clearly higher than in people without cognitive 
impairments [12]. It has been shown that frail elderly people have an increased risk of 
subsequent cognitive decline [38, 53] whereas conversely, low cognition might lead to 
frailty [54]. Such relationships can be explained by low cognition resulting from begin-
ning dementia. Although as opposed to dementia, intellectual disability is usually not a 
progressive condition, we found an association between frailty and more severe ID. This 
might be explained by measurement conditions: items from the (instrumental) activities 
of daily living ((I)ADL) questionnaire and the DMR are related to cognition [55, 56]. Older 
people with more severe levels of ID are therefore more likely to have high frailty scores 
compared to those with borderline or mild levels of ID. 
Most frailty indices show that on average women have more deficits than men. However, 
women seem to tolerate the deficits better, as evidenced in a lower correlation with 
mortality [34]. If adjusted for level of ID, we also found a significant higher mean frailty 
index score for woman compared to men. A remarkable result of our study was the lack 
of the so-called ‘zero state’, i.e., participants with no deficits. Previous studies show that 
roughly 3% (70 years and above) [44] and 9% (50 years and above) [31] of the older 
people without disabilities have no deficits. Although the population in this study was 
on average younger, none of the participants scored “0” deficits. This, again, can partly 
be explained by (I)ADL and DMR items in the frailty index, which are influenced by cog-
nition. However, other problems such as chronic comorbidity, low physical activity and 
nutritional deficiencies might also cause the lack of a zero state. 
More research is necessary to investigate which deficits mostly contribute to the frailty 
status of older people with ID. The cross-sectional nature of the data makes it impossible 
to examine the predictive value of the used frailty index, with regard to deteriorating 
health, independence, and mortality. Longitudinal research is necessary to validate the 
frailty index. Since no gold standard is available, predictive validation should be used to 
investigate whether our frailty index is able to predict adverse health outcomes such as 
falls, hospital admission, decrease of (I)ADL, the onset of diseases and mortality. Although 
the complete frailty index would be too time consuming, burdensome and expensive to 
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use for clinicians and caregivers in routine practise, there are several applications of the 
frailty index in clinical settings. For example, a shorter version of the frailty index can 
be used as a screening tool to identify individuals at risk [57]. Furthermore, in research 
settings the frailty index can be used as a tool to evaluate the effect of interventions [58].
This study shows that older people with ID aged 50 years and over already accumulate 
as much deficits as older people without ID aged 70 and above. In the field of ID care, 
persons with ID are already classified as “old” at the age of 50. It could be possible that 
this phenomenon of “early aging” is partly explained by the early onset of frailty. If older 
people with ID are indeed frail at an earlier age and “biologically old”, in spite of an in-
creased life expectancy, one can question the quality of life in the later years. In order to 
prevent early aging and loss of quality of life it is essential to study possible explanations 
for the high mean frailty index score and early onset of frailty. 
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abstract
The current study focuses on the characteristics of older people with intellectual disabili-
ties with the lowest frailty levels. Frailty is an increased risk of adverse health outcomes 
and dependency. Older adults with intellectual disabilities (ID) show more signs of early 
frailty than the general population. Knowledge of the least frail group characteristics 
may provide insight into possibilities to prevent early frailty in older people with intel-
lectual disabilities. This study was part of the Healthy Aging and Intellectual Disability 
study (HA-ID) which incorporated 1050 adults aged 50 years and over with all levels of 
ID. Frailty was measured with a frailty index. The least frail group was selected based on 
a frailty index score ≤ 0.10. Odds ratios were used to compare the occurrence of health 
deficits in the least frail group to the remaining group. The least frail group consisted of 
65 participants, corresponding with 6.6% of the study population. The least frail group 
was significantly younger, had less severe levels of ID, and less often Down syndrome 
than the remaining group. The lack of mobility and physical fitness limitations, depen-
dence, no signs of depression/dementia, and little medical problems characterized the 
least frail group. The percentage of 50+ adults with intellectual disabilities within the 
least frail group is very low compared to that in the general aging population ( > 43%). 
Interventions to prevent or delay frailty in this population are highly recommended and 
can focus on health characteristics of the least frail group. 
Key words: Frailty index, Healthy aging, Intellectual disabilities, Older adults
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introDuction 
Most of today’s medical research is concentrated on the question: “What causes pathol-
ogy?” Focusing on the understanding of disease causes and the invention of new thera-
pies is considered the so-called ‘negative biology’. Controversially, ‘positive biology’ aims 
at understanding why some people age without the diseases and problems that many 
others suffer from. This perspective receives far less attention, although it could offer 
more insight in successful aging and generate a greater health benefit for the older 
adults than would eliminating one specific disease [1]. A useful method for understand-
ing the process of aging and healthy aging is frailty. Frailty is a state of increased risk 
of adverse health outcomes, which reflects multisystem physiological changes and is 
highly associated with age [2]. A recent study showed that very high levels of frailty 
(deficit accumulation) were present in older people with intellectual disabilities (ID) [3]. 
The current paper adopts a positive biology perspective by analysing the characteristics 
of older people with ID with the lowest frailty levels. There are several methods for mea-
suring frailty. One widely used approach is the frailty index [4].The frailty index is based 
on a non-specific accumulation of deficits in several health domains. Deficits are defined 
as diseases, symptoms, disabilities, laboratory results or health related questionnaires 
and must cover a range of systems. A frailty index score is calculated by dividing the 
sum of deficits present by the total number of deficits measured, resulting in a score 
between 0 and 1 [5]. The frailty index score is highly associated with the risk of deteriora-
tion of health, dependence, and hospital admission, and frail people have decreased life 
expectancies [6]. 
Recently, we developed a frailty index for older adults with ID based on data collected in 
the Healthy Ageing and Intellectual Disability study (HA-ID), a cross-sectional study per-
formed in 1050 participants aged 50 years and over in The Netherlands [3, 7]. In addition 
to general aging problems adults with ID have an increased risk of motor and sensory 
disabilities, chronic diseases (e.g. epilepsy), and mental health problems [8-10]. These 
factors could lead to increased frailty across the lifespan, and in this way to early frailty 
in older adults with ID. Although the frailty index developed for older adults with ID has 
not yet shown to be related to negative health outcomes, preliminary data show that 
average frailty levels are high, and that frailty levels in older adults with ID aged 50 are 
comparable to frailty levels of older people without ID aged 70 and above. Furthermore 
it was shown that more severe ID and higher age were associated with an increased 
frailty score. Frailty in this population is of growing interest, since life expectancy of 
adults with ID is approaching the general public’s life expectancy [11, 12]. The increased 
life expectancy and the high number of frail people make interventions to prevent or 
delay frailty urgently required.
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In the perspective of positive biology, it would be interesting to know why some adults 
maintain very low frailty levels at high ages and remain in the so called zero-state -hav-
ing no measured deficits- for a long time. Previous studies show that roughly 3% (70 
years and above) [5] and 9% (50 years and above) [13] of the general population can be 
classified in the zero state. Across the lifespan, these “fit” adults are far less likely to die 
within 12 years and stay relatively fit over time [14]. Positive biology would promote the 
use of health information of these fit older people for the prevention of future frailty 
[1]. Among participants of the HA-ID study no one was classified in the zero state [3]. 
However, there are older adults with ID who are relatively fit compared to others in the 
population. Therefore, in this study we investigated characteristics of the adults scoring 
lowest on the frailty index. More specifically: Which deficits are found significantly less 
often in older adults with ID with low frailty index scores than in the remaining group?
methoD
Design and setting
In 2008, three Dutch care organizations and two academic departments (Intellectual 
Disability Medicine, Erasmus MC Rotterdam; Center for Human Movement Sciences, 
UMCG Groningen) started a large cross-sectional study titled ‘Healthy Ageing and Intel-
lectual Disability’ (HA-ID), to establish the general health status in older adults (50 years 
and over) with ID in the Netherlands. Three themes were chosen: physical activity and 
fitness, nutrition and nutritional state, and mood and anxiety. Within these themes a 
broad diagnostic assessment was conducted including physical fitness tests which were 
performed by physiotherapists, physical activity instructors or occupational therapists 
who were trained during a two-day course and all experienced in working with people 
with ID, and questionnaires, which were completed by the professional care givers or if 
applicable by self-report. IQ scores, Vineland scores and social emotional development 
was used to determine the level of ID by psychologists or test assistants. Data were col-
lected between February 2009 and July 2010. Detailed information has been published 
elsewhere [7]. The Medical Ethics Committee of the Erasmus Medical Center Rotterdam 
(MEC- 2008-234) and the ethics committees of the participating care organizations ap-
proved this study. 
Participants
The participating care organisations are located in the middle, southern and western 
part of the Netherlands. The three care organizations together had 2322 clients with 
borderline to profound ID aged 50 years and over, who were all invited to participate. 
The total number of people that actually participated was 1050. The study population 
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is nearly representative for the Dutch population using formal care for adults with ID 
aged 50 and above, with a slight underrepresentation of men (X2(1, N = 2322) = 0.53, p 
= .03), people aged 80 and above (X2(8, N = 2322) = 27.41, p = .001), and people living 
independently (X2(3, N = 2237) = 50.55, p < .001) [7]. 
Frailty index
A frailty index was created according to the procedure described by Searle et al. [5]. 
The deficits were defined as symptoms, laboratory results, health status, disabilities, and 
diseases. Deficits were included in the frailty index if they met all the following criteria: 
(1) the deficit is associated with health status, (2) the deficits’ prevalence increases with 
age, (3) the deficit must not saturate too early, (4) the frailty index must cover a range 
of domains. Four additional criteria were applied: (1) a maximum of 30% of the cases is 
missing, (2) if items are designed to measure the same concept, the item that best fits 
the other criteria is chosen, (3) single items of a questionnaire can be used as deficits as 
long as they fulfil all criteria and do not correlate too strongly (r > 0.7) with each other, 
(4) the deficit should be present in > 5% of the participants. In total, 51 variables fulfilled 
all criteria and were used to construct a frailty index. All variables were recoded into 
values between 0 (deficit not present) and 1 (deficit completely present). Cut-off values 
were derived from the literature or the laboratory guide from Erasmus Medical Center 
Rotterdam (2009). An overview of deficits included in the frailty index together with 
their cut-off values is described in elsewhere [3]. Missing values remained unscored. 
No weighting of variables was applied, so each deficit contributed equally to the frailty 
index score. The frailty index score was calculated by the sum of all deficit-scores divided 
by the total amount of deficits. Previous studies showed that at least 30 deficits are 
necessary to reliably predict adverse health outcomes [15]. Therefore all participants 
with less than 30 deficits assessed were excluded from further analyses. The excluded 
participants (n = 68) were not significantly different from the included participants (n 
= 982) regarding to gender (X2(1, N = 1050) = 0.532, p = .47), level of ID (X2(4, N = 923) 
= 3.92, p = .42), age (Mexcluded = 60.19, SDexcluded = 6.78, Mincluded = 61.64, SDincluded = 8.09), 
(t(1047) = 1.43, p = .10) and the presence of Down syndrome (X2(1, N = 920) = 0.034, p = 
.85 [3]. 
Definition of the least frail group
Investigating the characteristics of zero-state participants was not possible, because 
none of the participants had a frailty index score of zero. Rockwood et al. designed 
subgroups for different frailty scores: the relatively fit (frailty index score ≤0.03), less fit 
(0.03 < frailty index score ≤ 0.10), least fit (0.10 < frailty index score ≤ 0.21), and frail 
(frailty index score > 0.21) [14]. The fittest group of our study was selected by combining 
the “relatively fit” and “less fit” groups. Consequently all older adults with a frailty index 
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score of 0.10 or below were selected and will be further referred to as “the least frail”. The 
least frail group was compared to the participants with a frailty index score above 0.10, 
referred to as the remaining group. 
statistical procedure
All statistical analyses were performed using SPSS statistics 20.0 for Windows (SPSS, 
Inc, Chicago, IL, USA). Independent samples t-tests and Pearson Chi-Square tests were 
used to calculate the differences of the basic characteristics (age, gender, level of ID, and 
Down syndrome) between the least frail group and the remaining participants. 
In order to make all outcomes comparable, all deficits were dichotomised as follows, 
0 if the deficit was absent and 1 if the deficit was partly or completely present. Per-
centages of the presence of the deficits were calculated for the least frail group and 
the remaining participants. Pearson Chi-Square tests were used to assess differences 
in frequencies between the groups. Univariate logistic regression analysis was used to 
calculate the chance that the absence of a deficit predicts classification to the least frail 
group. Multivariate logistic regression models were used to determine the magnitude 
of the independent contributions (in terms of odds ratios) of deficits for classification 
into the least frail group. Significant differences at baseline characteristics (p < .05) 
between the two groups and characteristics known from literature were included in the 
multivariate model. Per definition, each deficit and the index are correlated, because 
1/51 of the dependent variable corresponds with the independent variable. To eliminate 
this correlation the index was recomposed without the item of interest for each deficit. 
All tests were two-sided and a p-value of less than .05 was considered to be statistically 
significant. For the calculated Pearson Chi-Square tests and ORs Bonferroni correction 
was applied and a p-value < .05/51 = .001 was considered to be significant. ORs for 
deficits that significantly influenced the outcome (belonging to the least frail group) or 
deficits that were completely absent in the least frail group were combined to clusters. 
These clusters were made by grouping deficits from the same overall domains together. 
results
basic characteristics
The distribution of frailty index scores, with a mean frailty index score of 0.27 (SD = 0.13) 
was slightly skewed with a longer right tail (skewness = .53, SE = 0.08; Figure 1). Sixty-five 
participants had a frailty index score ≤ 0.10 and were classified as the least frail group, 
corresponding with 6.6% of the study population, so 918 participants were classified 
as the remaining group. The average frailty index score of the least frail group was 0.08 
versus 0.29 in the remaining group. Significant differences were found for age, level 
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of ID, and Down syndrome (Table 1). Although the least frail group was significantly 
younger than the remaining participants, older participants were included as well, 
15.4% was 65 years or over (Figure 2). No significant difference for gender was found. 
However, because previous results showed a significant influence of gender on frailty 
when adjusted for level of ID, gender was included in the multivariate model as well [3].
table 1. Basic characteristics of the least frail group compared to the remaining participants
Least frail
FI ≤ 10
Remaining group
FI > 0.10 
p-value
N (%) 65 (6.6%) 917 (93.4%)
Mean FI score (sd) 0.08 (0.02) 0.29 (0.12) < .001a
Age in years 58 (5.4) 62 (8.2) < .001a
Gender: n female (%) 25 (38%) 450 (49%) .098b
Level of ID n (%) < .001b
borderline 6 (11%) 23 (2.8%)
mild 31 (54%) 160 (19%)
moderate 20 (35%) 412 (50%)
severe 0 (0.0%) 147 (18%)
profound 0 (0.0%) 82 (10%)
Down syndrome n (%) 3 (5.6%) 139 (17%) .028b 
a Differences between groups calculated with independent sample t-test
b Differences between groups calculated with Pearson Chi-Square test
Note, FI = frailty index
Figure 1. Distribution of frailty index scores (n = 982). The dotted line marks the cut-off value (frailty index 
score ≤ 0.10) for the least frail group, corresponding with 6.6% of the study population.
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Prevalence of the deficits
A significant difference in prevalence between the least frail and the remaining group 
was found for 39 of the 51 deficits. After Bonferroni correction (.05/51), 24 deficits re-
mained significantly less prevalent in the least frail group (Table 2). Nine deficits were 
completely absent (dressing impairment, only eats food of certain textures, mobility 
limitations, coronary heart disease/heart failure/cardiac dysrhythmia/pacemaker, gas-
troesophageal reflux disease, hypercholesterolemia, sleeps more than regularly, does 
not know the way to familiar places, and does not know that today is a weekend or a 
week day). For these deficits no OR could be calculated. The unadjusted ORs ranged 
between 65.8 (walking stairs) and 0.85 (fluid intake per day). The ORs, adjusted for age, 
gender, level of ID, and Down syndrome, ranged between 21.9 (walking stairs) and 0.68 
(fluid intake; Table 2). Deficits with significant or no calculated OR could be clustered in 
five groups: mobility and physical fitness, independence, signs of depression/dementia, 
medical, and other (Figure 3). 
Discussion 
This study identified the characteristics of the least frail older adults with ID, based on 
a frailty index. There were no participants with a frailty index score of zero. Sixty-five 
participants had a frailty index score of 0.10 or lower and were classified as the least frail 
group, corresponding with only 6.6% of the study population. As was to be expected, 
the least frail participants were younger, had less severe ID, and less often Down syn-
Figure 2. Distribution of age for the least frail (frailty index score ≤0.10; left figure) and the remaining group 
(frailty index score > 0.10; right figure). 
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drome than the remaining group. This group also included participants above the age 
of 65 (Figure 2). Nine deficits were completely absent in the least frail group. Twenty-four 
deficits were less commonly found in the least frail group than in the remaining group 
after Bonferroni correction. After adjustments for baseline characteristics, the least frail 
were characterized by the absence of mobility and physical fitness limitations, relative 
independence, less signs of depression/dementia and less specific medical problems 
(heart problems, gastroesophageal reflux disease, chronic constipation, polypharmacy, 
high blood pressure, and hypercholesterolemia). 
There are only a few published studies addressing the zero-state or least frail in the gen-
eral population. A Canadian study showed that 76% of 40-69-year-old Canadians would 
have been classified as least frail (frailty index score ≤ 0.10), and 53% of the Canadians 
aged 70 years and over [14]. In a European study, the frailty index score distribution 
showed that around 43% of female and 60% of male participants aged 50 years and over 
had a frailty index score ≤ 0.10 [13]. So, the 6.6% of the ID population classified as least 
frail is very small compared to the general population. In the general population it has 
been shown that relatively fit individuals stay fit over time (follow-up period of 12 years), 
whereas individuals who are frail are less likely to become fit. Similarly, as age increases 
it becomes less likely to improve frailty scores [14]. This emphasizes the importance of 
early identification and prevention of frailty. 
Our results show a wide range of deficits that are associated with classification in the 
least frail group. Variables with the most significant values were ability to bath indepen-
dently, do groceries and housekeeping independently, not being fatigued, absence of 
polypharmacy and a normal blood pressure. Older adults who scored well on these vari-
ables were more likely to belong to the least frail group. Because of the cross-sectional 
design of the study, no causal inference can be made between deficits and being in the 
least frail group. Nevertheless, knowing which deficits are present in the least frail may 
be helpful for the design of interventions for the prevention of early frailty. Deficits with 
the highest value could be clustered into the following groups:
1. Mobility and physical fitness. In the general population, frailty is associated with low 
mobility, low grip strength, low balance, and low physical activity [16-19]. Likewise, the 
higher the frailty index, the more likely it will include mobility disability [20]. That is likely 
because mobility is an integrative variable, which means that many health problems will 
affect mobility [21]. These results from the general population show a very important 
correlation between frailty and physical activity and mobility. Since it has been shown 
that physical limitations are very common in older adults with ID [22] and predicts clas-
sification towards the least frail group, interventions aiming to increase physical activity 
and maintaining mobility seem very important for the prevention of frailty in older 
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adults with ID. However, this might not always be possible due to childhood mobility 
impairments (e.g. cerebral palsy).
2. Independence. In our study, items from the IADL and ADL scales [23, 24] were shown 
to be good predictors for classification into the least frail group. In the general popula-
tion, physical frailty predicts ADL limitations [25]. In addition, the higher the level of 
deficit accumulation, the more likely that there will be future disability [26]. In older 
adults with ID it is important to know the underlying mechanism whereby decreased 
dependence is related to frailty before preventive measures can be started. For example 
it has been shown that ADL and IADL limitations are mainly caused by severe ID and 
mobility limitations [27]. Maintaining or improving mobility might therefore be a better 
intervention than improving specific ADL or IADL activities.
3. Signs of depression/dementia. Several signs of dementia and depression had very 
low prevalence in the least frail group. In the general population, elderly people who are 
frail are more likely to report signs of depression and anxiety than non-frail people [28]. 
Hermans, Beekman, & Evenhuis found that in older adults with ID, depressive symptoms 
are often unknown to the participants’ behavioural therapist or psychologist [29]. They 
argued that pro-active detection by use of screening instruments and interventions 
are recommended in this population. Prospective studies should show whether such 
interventions contribute to the prevention of frailty in older adults with ID. 
4. Medical problems. Most medical conditions, included in the frailty index, are rare 
or completely absent in the least frail group. This result was expected since conditions 
such as hypercholesterolemia, heart problems and gastroesophageal reflux disease are 
related to other health problems, that are also included in the index, making it very 
unlikely for people with serious medical conditions to have a frailty index score ≤ 0.10. 
Since frailty and the presence of diseases are correlated it is important to integrate 
proactive diagnostics to detect subjective signs. It has been shown, for example, that 
early detection of hearing impairment [30] and cardiovascular risk factors [31, 32] are 
very important in adults with ID. 
In addition to possible options and ideas to delay frailty in older adults with ID the out-
comes of adults with the lowest level of frailty can also be used as a mean of understand-
ing the outcomes for the group as a whole [33]. Particularly, the outcomes of the least 
frail group can offer an estimate of the background or ambient risk for the whole group. 
The risk of a negative health outcome in a person with N deficits at baseline is the sum 
of the risk associated with N, plus the risks associated with the least frail group [34]. With 
these results the additional risk for a negative health outcome (e.g. death and hospital 
admission) can be calculated for a person or group. 
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Our study has two main strengths. First, our large and near-representative study 
population provided results that are applicable to all older Dutch adults (50+) with ID 
receiving specialized care or support. Second, frailty was measured from a multifacto-
rial perspective with a method that is robust and widely used [5]. The frailty index has 
been used frequently in the general population and has proven to be a valid instrument 
that is highly predictive of deterioration of health, including hospital admission, falls, 
diseases, reduced independence, and early death [21, 35, 36]. Furthermore, most of 
the frailty indices developed for the general population include all eight frailty factors 
(nutritional status, physical activity, mobility, strength and energy, cognition and mood, 
lack of social contacts and social support) that Vries de et al. identified as important 
to the concept of frailty after careful consideration of multiple frailty concepts [37]. 
An additional advantage of this method for this new population is the relatively free 
choice of deficits, which enabled us to specify an index applicable to older adults with 
ID. Although our frailty index needs to be validated against negative health outcomes, 
we confirmed the robustness of our frailty index in the older ID population by randomly 
selecting 75% of the deficits to create and plot a frailty index against age. This showed 
that the index’s relationship with age was not influenced by the deficits in the index [3]. 
An alternative method to measure frailty is the frailty phenotype [38]. But because this 
exclusively physically oriented measure may misclassify longstanding motor disability 
as frailty in this population, the multidimensional perspective seems more appropriate 
[39]. Existing frailty questionnaires using a multidimensional approach are often based 
on self-report but are difficult to apply in this population due to problems of limited 
understanding and communication [40]. 
Our results nevertheless need to be interpreted with caution. First of all, older adults 
with borderline or mild ID who did not use formal care were not included in the study. 
Secondly, the frailty index developed for older adults with ID has not yet demonstrated 
relationship with adverse health outcomes. Due to the cross-sectional nature of the 
study design, causal inferences cannot be made. Future research will demonstrate 
whether the least frail do indeed have a lower risk of negative health outcomes. Thirdly, 
cut-off values were used to classify the least frail group. Although the frailty index was 
designed to be used as a continuous scale, different groups can, if required, be created 
for the sake of comparing different health states [14, 41-43]. Even though little research 
has been conducted with different frailty groups, the cut-off values used in this study 
have been shown to discriminate between different health states in the general popula-
tion [14]. A fourth limitation of this study is that an OR could not be calculated for nine 
deficits due to the absence of this deficit in the least frail group. Although the complete 
absence of these deficits characterises the least frail group, results for these variables 
could not be adjusted for age, gender, level of ID and the presence of Down syndrome. 
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Finally, the Bonferroni correction and low number of participants in the least frail group 
made it hard to detect significant results. This explains our addition in Figure 3, which, in 
addition to the Bonferroni corrected significant p-values, shows ORs with a p-value < .05 
and variables for which no OR could be calculated.
In conclusion, it has been shown that frailty is a dynamic process and that individuals can 
change from a frail stage to a non-frail stage and vice versa [14, 44]. However, because it 
is difficult to recover from frailty at a high age, it is very important to focus on prevention 
rather than intervention. The limited percentage of older adults with ID found in the 
least frail group is of concern, and emphasizes the importance to prevent and monitor 
early frailty in this population. In line with positive biology, our results provide health 
information on the least frail for the prevention of future frailty in older adults with ID. 
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abstract 
People with intellectual disabilities (ID) are earlier frail than people in the general popu-
lation. Although this may be explained by lifelong unfavorable social, psychological and 
clinical causes, underlying physiological pathways might be considered too. Biological 
measures can help identify pathophysiological pathways. Therefore, we examined the 
association between frailty and a range of serum markers on inflammation, anemia, the 
metabolic system, micronutrients and renal functioning. Participants (n = 757) with bor-
derline to severe ID (50+) were recruited from three Dutch ID care and support services. 
Frailty was measured with a frailty index, a measure based on the accumulation of defi-
cits. Linear regression analyses were performed to identify associations between frailty 
and biochemical measures independent of age, gender, level of ID, and the presence of 
Down syndrome. Frailty appears associated with inflammation (IL-6 and CRP), anemia, 
metabolic markers (glucose, cholesterol and albumin) and renal functioning (cystatin-C 
and creatinine). These results are in line with results observed in the general population. 
Future research needs to investigate the causal relation between biochemical measures 
and frailty, with a special focus on inflammation and nutrition. Furthermore, the pos-
sibility to screen for frailty using biochemical measures needs to be employed.
Key words: Frailty, people with intellectual disability, physiological measures, inflamma-
tion, nutritional status
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introDuction 
Although people with Down syndrome and people with severe intellectual disabilities 
(ID) have shorter life expectancies than the general population, the average life expec-
tancy of people with ID is increasing [1]. As a result, frailty, a state in which older people 
are prone to negative health outcomes including disability, hospitalization, institu-
tionalization and premature death [2], can become a major problem. In people with 
ID, early onset and high levels of frailty were observed by us [3, 4] and others [5]. The 
underlying pathways leading to the early onset of frailty in this population have not yet 
been investigated. 
Frailty is a complex cascade that involves several physiological alterations, eventually 
leading to loss of function and failure to respond to stressor events [2]. The physiological 
mechanisms underlying the onset and development of frailty remain complicated and 
poorly understood. Even so, frailty has been associated with dysregulation in several 
physiological systems including the inflammatory system, the endocrine system, mus-
culoskeletal functioning, metabolism and specific diseases including cardiovascular 
diseases and renal failure [2]. Biomarkers involved in these mechanisms have been asso-
ciated with the prevalence [6] and incidence of frailty [7-9]. Although several biochemi-
cal measures show strong associations with frailty, there is not yet one biomarker that 
can adequately identify frailty [10]. Nevertheless, information on biochemical measures 
can provide useful information on underlying physiological processes leading to frailty. 
For example nutritional deficiencies could reflect insufficient (micro)nutrient intake, 
problems with the gastrointestinal tract, or an increased utilization. Knowledge about 
the relation between (micro)nutrient status and frailty could promote interventions to 
limit (micro)nutrient deficiencies. In addition, eventually biochemical measures can help 
to screen and identify those at high risk to develop frailty (figure 1) [11].
Knowledge about dysregulation in physiological systems and its association with frailty 
has not yet been investigated in people with ID. Information from the general population 
might not be applicable to the ID population because the development of frailty and its 
relation with biochemical processes may be different in this population because of life-
long unfavorable chronic conditions, environmental factors, life style and genetic factors 
(figure 1). Previously, Carmeli et al. found high inflammatory markers in healthy adults with 
unspecified ID compared to those without ID [12], but it has not yet been studied whether 
these high inflammatory markers are associated with overall health status. Therefore, in 
the present, explorative study we aimed at assessing the association between frailty (in 
terms of deficit accumulation) and physiological processes (inflammation, anemia, micro-
nutrients, metabolic markers, renal functioning) in older people with ID. 
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materials anD methoDs
subjects and study design
This study was part of the ‘Healthy aging and intellectual disabilities’ study (HA-ID)[13]. 
In this observational study, information was collected on the general health status of 
older people with ID using formal care in the Netherlands. Two university departments 
and three Dutch care provider services for people with ID off ering a broad spectrum of 
care, ranging from ambulatory support to residential care, collaborated in this study. 
The three care organizations together provided care to 2322 clients with borderline to 
profound ID aged 50 years and over, who were all invited to participate. Eventually 1050 
clients participated in the HA-ID study, forming a study population nearly representa-
tive for the Dutch population of adults aged 50 and above with ID who receive formal 
care. Those capable of understanding the available information signed the consent form 
themselves. Legal representatives were approached for those not able to make this deci-
sion. Details about recruitment, design, inclusion criteria, and representativeness have 
been published elsewhere [13]. The Medical Ethics Committee of the Erasmus Medical 
Center Rotterdam (MEC-2008-234) and the ethics committees of the participating care 
organizations approved this study. Measurements were conducted within three main 
themes (1) physical activity and fi tness, (2) nutrition and nutritional state, and (3) mood 
and anxiety. The data collection included body measurements, physical fi tness tests, 
questionnaires, and laboratory tests in addition to fi le records. Data on age, gender and 
residential status were retrieved from the administrative systems. Residential status was 
categorised as centralized setting, community-based setting and living independently 
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Figure 1. Schematic representation of the pathway of frailty and the role of biochemical measures. 
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or with relatives with ambulatory support. Level of ID was obtained from the scores 
of psychologists or test assistants, who determined level of ID from available IQ tests, 
Vineland scores and social emotional development. The presence of Down syndrome 
was retrieved from the medical files. Medical files were used to determine the used 
medication. The following ATC-codes were used to classify drugs that could interfere 
with the included biochemical values: A10 for glucose lowering drugs, B03A for hemo-
globin related drugs, C10 for lipid lowering drugs, A12A for calcium supplements, and 
A11CC and A11CB for vitamin-D supplements. 
blood samples
Blood sample were drawn in Becton Dickinson collection tubes by a trained medical 
assistant in the morning following an 8 h overnight fast (November 2008- July 2010). The 
samples were centrifuged and serum was stored at -80 °C until the measurements. CRP, 
hemoglobin, and all metabolic marker were analyzed at the laboratory of the Erasmus 
Medical Center, which is a reference laboratory. Calcium was determined on a Beckman 
Coulter DxC analyser. Vitamin-D3 (25-OH vitamin-D) measurements were performed us-
ing an electrochemiluminescence immunoassay with polyclonal antibodies on a Cobas-
E module (Roche Diagnostics®, 128 Penzberg, Germany). Creatinine and cystatin-C were 
measured using the Cobas 8000 Modular Analyzer from Roche Diagnostics AG (Rotkreuz, 
Swiss). IL-6 was analyzed for this study specifically. The level of IL-6 was quantified using 
a sensitive enzyme-linked immunosorbent assay (ELISA; Human IL6 Elisa Ready-SET-Go!, 
cat#.88-7066). The lower detection limit for IL-6 was 19.5 pg/ml. 
constructing the frailty index
Frailty was measured with a frailty index, an operationalization of frailty that focuses 
on the quantity, rather than on the nature of health problems. In other words, the more 
health problems an individual has, the frailer he or she is [14]. It captures physical, 
psychological and social health and has been shown to predict negative health out-
comes in several clinical and community-dwelling populations [2, 14, 15]. Following a 
standardized procedure [16], we developed a frailty with data collected in the HA-ID 
study. The index consisted of 51 deficits that were all (1) related to health, (2) positively 
associated with age, (3) frequently but not too often present in the population (> 5%, < 
80%), and (4) successfully in at least 70% of the participants. Furthermore, the deficits 
did not correlate too strongly with each other (r < 0.7), and together they covered differ-
ent health aspects. All deficits were re-coded to a score between 0 (deficit absent) and 
1 (deficit present). A frailty index score was calculated by the number of present deficits 
divided by the total number of measurements, resulting in a score ranging from zero 
(lowest level of frailty) to one (highest level of frailty). No weighting of variables was 
applied, so each deficit contributed equally to the Frailty index score. Missing values 
82 Chapter 5
remained unscored. Information on at least 30 deficits was required before a frailty index 
score could be calculated. A complete list of the deficits, used measurements and cut-off 
values has been presented elsewhere [3]. Cholesterol, glucose (diabetes mellitus) and 
haemoglobin were originally included in the frailty index. Therefore, per definition these 
measures are somewhat correlated with the frailty index. To eliminate this correlation in 
the analyses, the index was recomposed without the item of interest for each biochemi-
cal measure. 
statistical analysis
First, participants for whom blood samples were available were compared with non-
participants using Pearson-chi-square tests for categorical variables and t-tests for 
continuous variables. Second, regression analyses were performed with the biochemical 
measures as dependent variables and the frailty index as independent variable. We could 
not assume a linear association between all biochemical measures and frailty since for 
several of the markers it could be expected that either an increased or a decreased level 
would negatively influence the frailty status. Therefore a curve estimation procedure 
was used to find the best fit of the model for each biochemical measure. If required, 
a polynomial effect was added into the regression model. The physiological measures 
were incorporated into the models on a continuous scale, with an exception for IL-6, 
which was dichotomized at the detection limit (19.5 pg/ml). Three different linear re-
gression models were created. The first model analyzed the unadjusted association be-
tween the biochemical measures and the frailty index (to aid interpretation, multiplied 
by 100). Participant’s characteristics (gender, age, level of ID, and Down syndrome) were 
entered into a second model. Dummy variables were composed for Down syndrome 
(the presence of Down syndrome or unknown status versus no Down syndrome) and 
for the level of ID (moderate or severe/profound versus borderline/mild). Furthermore, 
potential confounders were entered per biochemical measure: vitamin-D was adjusted 
for vitamin-D suppletion and the period (summer/winter) of blood collection (sun 
exposure), calcium was adjusted for calcium suppletion, anemia was adjusted for iron 
suppletion, glucose was adjusted for glucose lowering drugs, and cholesterol/HDL/
triglycerides were adjusted for lipid lowering drugs. The third model incorporated all 
biochemical measures from the same functional category to study their association with 
frailty, adjusted for each other and the baseline characteristics. The following functional 
categories were defined: Inflammation (CRP and IL-6), anemia (hemoglobin), micronu-
trients (vitamin-D and calcium), metabolic markers (glucose, triglycerides, cholesterol, 
and albumin), and renal functioning (creatinine and cystatin-C). SPSS version 21.0 (SPSS, 
Inc., Chicago, IL) was used for statistical analyses. Results were considered statistically 
significant if the p-value was less than 0.05. 
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table 1. Baseline descriptive characteristics of the HA-ID Study
included excluded all Statistics
Test p-value
n 757 293 1050
Age (mean [SD] 61.7 (8.0) 61.6 (8.3) 61.6 (8.0) 0.43 .93
Gender (%) 0.55 .46
Male 394 145 539
Female 363 148 511
Level of ID (%) 4.86 .30
Borderline 19 12 31
Mild 154 69 223
Moderate 373 133 506
Severe 128 44 172
Profound 70 21 91
Unknown 13 14 27
Down Syndrome (%) 0.03 .87
Yes 111 38 149
No 544 180 724
Unknown 202 75 177
FI-score (mean [SD] 0.28 (0.12) 0.26 (0.14) 0.27 (0.13) 2.10 .036
Residential Status 33.5  < .001
Central setting 430 127 557
Community based 296 137 433
Ambulatory support 30 20 50
Unknown 1 9 10
Biochemical measures n mean (SD)/number of abnormal values (%)
CRP (mg/L) 723 6.84 (18.0)
IL-6 (% > pg/ml19.5) 622 63 (10%)
Hemoglobin (mmol Fe/L) 735 8.74 (0.83)
Vitamin-D (nmol/L) 618 63.3 (33.4)
Calcium (mmol/L) 585 2.22 (0.12)
Glucose (mmol/L) 724 5.01 (2.6)
HDL (mmol/L) 724 1.25 (0.38)
Triglycerides (mmol/L) 724 1.43 (0.76)
Cholesterol (mmol/L) 723 5.29 (1.04)
Albumin (g/L) 724 42.2 (3.83)
Creatinine (µmol/L) 634 75.2 (19.9)
Cystatin-C (mg/L) 634 1.05 (0.26)
Note, SD = standard deviation, ID = intellectual disability, FI = frailty index, the total number of included 
biochemical measurements depended on the availability and successfulness of the laboratory measure-
ments
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results
baseline characteristics 
For 757 out of 1050 of the HA-ID participants at least one biochemical measure was 
available. The included participants did not show significant differences with regard to 
gender, level of ID, age and the presence of Down syndrome (Table 1). Those who were 
excluded showed slightly lower mean frailty index scores compared to the included 
participants. People who lived in the community were more often excluded from the 
analyses. 
association between frailty and available biochemical measures
Unadjusted and adjusted for age, gender, level of ID and Down syndrome, higher 
frailty index scores were associated with higher levels of IL-6, CRP and cystatin-C and 
with lower levels of hemoglobin, cholesterol, glucose and albumin (Table 2;model 1 & 
2), although the associations between cholesterol and IL-6 weakened after adjusting 
for other biochemical measures from the same system (Table 2;model 3). Calcium and 
creatinine showed a non-linear association with the frailty index score; either a high or a 
low calcium/creatinine level was associated with higher frailty index scores. 
Discussion
For the first time, we showed associations between frailty and biochemical measures 
in a large, nearly representative, population of older people with ID (50 years and over) 
receiving specialized support or care. Frailty was associated with inflammation (CRP and 
IL-6), anemia, metabolic markers (glucose, cholesterol and albumin) and renal function-
ing (cystatin-C). 
Chronic inflammation can result in organ damage, muscle waste and chronic diseases, 
which all contribute to frailty [2]. The other way around, inflammation arises as a con-
sequence of chronic diseases such as atherosclerosis, Alzheimer dementia and type 2 
diabetes [17, 18]. An association between inflammatory markers and frailty is therefore 
expected. For years, IL-6 has been called the cytokine for gerontologists [19], and IL-6, 
CRP and other inflammatory markers have frequently been associated with both aging 
and frailty [20-23]. In line with these results, we found that elevated levels of IL-6 and 
CRP were associated with higher frailty index scores. 
The consequences of low levels of hemoglobin (e.g. exhaustion, fatigue, low muscle 
strength, cognitive decline and mortality) are frequently observed in frail individuals 
[24], which could explain the association we found. The scarce amount of literature on 
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the association between frailty and hemoglobin shows inconsistent results [25-27]. In 
contrast to most results observed in the general population [6, 8, 9], we were unable 
to find an inverse association between vitamin-D and frailty. Even though we adjusted 
for supplements prescribed by the physician, we were unable to adjust for over-the-
counter-drugs that may have included vitamin-D suppletion. This could have interfered 
with our results. Serum albumin is the most abundant blood protein in human beings 
and low levels are associated with malnutrition, disease and inflammation [28]. There-
fore, alteration in serum albumin can reflect complications in multiple systems. Not 
surprisingly, frailty—related to failure in several organs and systems, was found to have 
a strong inverse association with serum albumin in the general population [6, 20]. In ac-
cordance with these studies, we found that low albumin concentrations were associated 
with higher frailty index scores. We found an association between low levels of glucose 
and cholesterol and frailty, but this association disappeared if adjusted for albumin. Nev-
ertheless, these results suggest that a poor nutritional status is associated with higher 
frailty. Last, we found a rather strong association between creatinine, cystatin-C and 
frailty. In the general population, a higher prevalence and incidence of frailty was ob-
served for participants with lower levels of kidney functioning measured with cystatin-C 
[29]. The consequences of kidney failure could result in a higher prevalence of frailty 
[30]. In addition to its relation with renal functioning, cystatin-C has frequently shown 
to predict cardiovascular outcomes [31, 32]. Alternatively, cystatin-C may be associated 
with a chronic inflammatory state in frail individuals [33]. 
These results provide an important basis for future research into both the understand-
ing of frailty in people with ID and the possibility to the identification of frail individuals. 
Special focus should be given to inflammation. Aging is characterized by a low-grade 
chronic inflammatory status, termed ‘inflammaging. Inflammaging is associated with 
and predictive for several chronic diseases and adverse health outcomes [34]. Although 
the exact etiology needs to be further investigated, we showed, in line with others, an 
association between inflammation and frailty. Carmeli et al. showed that overall, people 
with unspecified ID (n = 15), have an increased inflammatory state [12]. These results 
imply that a chronic inflammatory state in people with ID could partly explain the early 
onset of frailty. We included only 12 biochemical measures, but many more are known 
to be associated with frailty, for example TNF and oxidative stress [23, 35]. Similarly, be-
cause frailty is characterized by abnormalities across different systems, a combination of 
biochemical measures rather than a single biomarker is likely to be required to measure 
frailty [11, 23, 26, 27, 36, 37]. 
Our study has several limitations and results need to be interpreted with caution. First 
and most important, the cross-sectional design is not suited to study causal effects. It 
is therefore unknown whether alterations in the studied biochemical measures contrib-
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uted to the incidence of frailty, or that being frail affects physical processes leading to 
deviated biochemical measures. Second, people of whom no blood sample was avail-
able had slightly lower frailty index scores and were more often living in the community, 
leading to an overrepresentation of people living at central settings. Last, contrary to 
most studies, we used a frailty index to measure frailty instead of the clinical frailty 
phenotype, in which frailty is defined as the presence of three or more of the following 
characteristics: weight loss, exhaustion, weakness, slow walking speed, and low physical 
activity [38]. Even so, Hubbard et al. showed that the associations between biochemical 
markers and frailty are consistent across the two frailty measures [21]. In addition, the 
frailty index seems to be a more suitable measure for people with ID (Schoufour et al., 
submitted) and has shown predictive validity in this group [39-41]. 
In conclusion, we showed, for the first time, associations between frailty and biochemical 
measures in people with ID. In line with the literature, we found associations between 
frailty and inflammation, metabolic markers, hemoglobin and kidney functioning. We 
suggest that future research focuses on the possible effect of inflammaging on frailty in 
people with ID, using prospective study designs. In addition, the effect of a poor nutri-
tional status and frailty needs further examination. This knowledge may not only lead 
to interventions but also to a possible (combination of ) biomarkers that may be used to 
screen for frailty in a population that has difficulties with the general frailty screening 
measures (e.g. self-report questionnaires or physical performance tests). 
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abstract
Frailty is a state of increased vulnerability to adverse health outcomes compared to 
others of the same age. People with intellectual disabilities (ID) are more frequently and 
earlier frail compared to the general population. Frailty challenges much of health care, 
which will likely further increase due to the aging of the population. Before effective 
interventions can start, more information is necessary about the consequences of frailty 
in this, already disabled, population. Here we report whether frailty predicts disabilities 
in daily functioning. Frailty was measured with a frailty index. At baseline and follow-up 
activities of daily living (ADL), instrumental activities of daily living (IADL) and mobility 
were collected by informant report. For 703 older people with ID (≥50yr) baseline and 
follow-up measures were known. Multivariate linear regression models were used to 
predict ADL, IADL and mobility at follow-up. The frailty index was significantly associ-
ated with disabilities in daily functioning independent of baseline characteristics (age, 
gender, level of ID, Down syndrome) and baseline ADL, IADL or mobility. The frailty index 
showed to be most predictive for those with relative high independence at baseline. 
These results stress the importance for interventions that limit the progression of frailty 
and, thereby, help to limit further disability.
Key words: People with ID, frailty, limitations, disability, mobility
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introDuction
Frailty is a state of increased vulnerability to adverse health outcomes compared to 
others of the same age. The prevalence increases with age, even recognizing that older 
people in general are more vulnerable to adverse health outcomes as a result of decline 
in many physiological systems [1]. Frailty challenges much of health care, which has 
a single problem or single system focus [1, 2]. People with intellectual disabilities (ID) 
typically are at greater risk to develop frailty than others of the same age. Because they 
have, in addition to general aging problems, an increased risk of motor and sensory 
disabilities, co-morbidities, mental health problems, and syndrome specific aging prob-
lems (for example Down syndrome) [3-7]. The construct of frailty has been developed [8] 
and validated in relation to the risk of death in older people with ID [9]. Here we report 
on whether frailty also predicts for disabilities in daily functioning. This information 
provides insight into the consequences of frailty in this specific population, which is 
necessary to design effective interventions. 
Which method captures frailty the best is still a matter of discussion. Several frailty 
instruments have emerged in recent years [10]. One broadly used method is the frailty 
index which is a multifactorial measure for frailty. The frailty index is based on accumula-
tion of a broad spectrum of non-specific age-related impairments (deficits), including 
symptoms, signs, diseases, disabilities or laboratory measurements [11, 12]. Inasmuch 
as the administration of the frailty index does not necessarily involve self-report and 
the measure is multifactorial, which means that it is not focused on specific problems, 
this approach appears to offer a suitable measure for people with ID [13]. Therefore, 
we developed a frailty index for older (≥50 year) people with ID [8] according to a stan-
dardized procedure [14]. This frailty index showed the same characteristics (frequency 
distribution, correlation with age) but frailty seemed to start at a younger age compared 
to the general population [8, 12, 15, 16]. The frailty index showed a clear relationship 
with 3-year mortality. Those classified as frail were at least 8 times (95%CI 7.7-17.3) more 
likely to die compared to those classified as non-frail [9]. 
The relationship between the frailty index and survival underlined the problem of 
frailty in people with ID. It is however not yet clear whether frailty also has an impact 
on disability in this already disabled population. In the general population it has been 
shown that frail individuals have a higher risk for disabilities in activities of daily living 
(ADL), instrumental activities of daily living (IADL) and mobility compared to non-frail 
individuals [17-24]. In people with ID, activities of daily living were found, in addition 
to aging, to be related to cognitive functioning and mobility limitations [25-27]. As a 
result, people with ID often experience lifelong dependence. The relationship between 
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frailty and increasing dependence can therefore not be assumed to be the same as that 
observed in the general population. If frailty is a risk factor, frailty instruments that can 
identify those at risk can help selecting those who benefit from intervention programs 
aiming at maintaining independence and mobility. Maintaining as much independence 
as possible can increase the quality of life and diminish the burden for individuals, fam-
ily, caregivers, and health care facilities [28, 29]. Therefore, the primary objective of this 
study was to analyze the association between the frailty index score and deterioration of 
ADL, IADL and mobility over a 3-year follow-up period in older people with ID. 
methoDs
Design and participants
This study was part of the ‘Healthy Ageing and Intellectual Disability’ (HA-ID) study. The 
observational HA-ID study collected information on the general health status of older 
people with ID. The HA-ID study focused on (1) physical activity and fitness, (2) nutrition 
and nutritional state, and (3) mood and anxiety. The study was conducted in three care 
organizations throughout The Netherlands [30]. The Medical Ethics Committee of the 
Erasmus Medical Center Rotterdam (MEC- 2008-234) and the ethics committees of the par-
ticipating care organizations approved this study. The three care organizations together 
provided care to 2322 clients with borderline to profound ID aged 50 years and over, who 
were all invited to participate. Those capable of understanding the available information 
signed the consent form themselves. Legal representatives were approached for those 
not able to make this decision. Written informed consent was provided for 1050 clients. 
They formed a nearly representative study population for the Dutch population of older 
adults (aged 50 and above) with ID who receive formal care, albeit with a slight under-
representation of men (X2[1, N = 2322] = 0.53, p = .03), people aged 80 and over (X2[8, N = 
2322] = 27.41, p = .001), and people living independently (X2[3, N = 2237] = 50.55, p < .001). 
Three years after the baseline measurements a follow-up study evaluated health, depen-
dence, and mobility. The follow-up study was approved by the Medical Ethics Committee 
of the Erasmus Medical Center Rotterdam (MEC-2011-309) and the ethics committees of 
the participating care organizations. All participants, or their legal representatives, who 
still received care from one of the care organisations were asked again to provide written 
informed consent for the follow-up study. 
Data collection
Baseline data collection has been described in detail elsewhere [30]. The broad spec-
trum of data collected included physical assessments, a fitness test battery, actigraphy, 
pedometer measurements, mealtime observations of swallowing, nutritional question-
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naires, screening questionnaires and standardized psychiatric interviews for depression 
and anxiety, questionnaires on life events, quality of life, IADL, ADL, mobility, dementia, 
social circumstances, somatic complaints, and laboratory tests. Level of ID was obtained 
from the scores of psychologists or test assistants. They determined the level of ID from 
available IQ tests, Vineland scores and social emotional development. The presence 
of Down syndrome was retrieved from the medical files. Baseline data were collected 
between February 2009 and July 2010.Three years after baseline, follow-up data were 
collected by informant report to limit the burden for the clients. Questionnaires on 
IADL, ADL, and mobility were completed by professional caregivers, as in the baseline 
measurement. ADL was assessed with the Barthel Index [31]. The Barthel index has been 
shown to be reliable and sensitive when completed by proxy [32-34]. It consisted of 10 
items (feeding, bathing, grooming, dressing, bowels, bladder, toilet use, transfers [bed 
to chair and back], mobility on level surfaces, and mobility on stairs) with two to four 
answer categories. The total ADL score ranged from 0 (completely dependent) to 20 
(completely independent). The Lawton scale was used to measure IADL [35]. The Lawton 
scale has been previously used in hospitalized older patients and is valid to be filled in 
by clinicians [36, 37]. The Lawton scale consisted of eight items (telephone use, grocer-
ies, food preparation, housekeeping, laundry, transportation, medication and finances) 
with three answer categories (not able, able with support, independent). The total score 
ranged from 8 (completely dependent) to 24 (completely independent). 
Mobility was assessed with five questions based on the Hauser Ambulation Index and 
the characteristics of the Gross Motor Function Classification Scale (ability to walk: at 
home, work/school, less than 50 meters in a safe environment, over 50 meters in a safe 
environment, outside the safe environment) [38]. For each question 8 different answers 
were possible: 1) no help, 2) furniture or railing, 3) cane or crutch, 4) walker, 5) wheelchair, 
but able to move using his/her feet, 6) wheelchair, but able to move using his/her arms, 
7) pushed in a wheelchair, 8) electric wheelchair, 9) bedridden. Mobility scores ranged 
between 0 (walking independent on all items) and 40 (bedridden). For ADL, IADL and 
mobility questionnaires, differences between baseline and follow-up were considered 
as outliers if the change exceeded 3 SD. Questionnaires from these participants were 
checked with the professional caregivers to ensure correctness. If the large difference 
could not be explained, the participant was excluded from the analysis. 
Frailty index
A frailty index was created with 51-items from the baseline measures of the HA-ID study. 
Following a standard procedure, all deficits were (1) related to health, (2) positively as-
sociated with age, (3) frequently but not too often present in the population ( > 5%, < 
80%), and (4) measured in at least 70% of the participants. Furthermore, the items did 
98 Chapter 6
not correlate too strongly with each other (r < 0.7), and together they covered different 
health aspects [14]. All items were recoded to a score ranging from 0 to 1 of which 0 indi-
cated the complete absence of a deficit and 1 the complete presence of a deficit. A frailty 
index score was calculated taking the proportion of deficits present, resulting in a score 
between 0 and 1. For each individual participant the deficits that were missing were 
removed from both the numerator and the denominator. For example if an individual 
had missing values on two items, the frailty index was calculated with a denominator 
of 49. A frailty index score could not be calculated for participants with less than 30 
known deficits. The design of the frailty index and details on the used deficits has been 
described elsewhere [8]. To examine the association of frailty with daily functioning the 
index was rescored to exclude the mobility and disability items. Specifically, compared 
with the original frailty index used in this study, five ADL deficits (bladder control, 
dressing, walking stairs, bathing, transfer bed to chair), two IADL deficits (groceries and 
housekeeping) and one mobility deficit were each excluded. The intraclass correlation 
coefficients between the original frailty index and the frailty index without ADL, IADL or 
mobility items was .97, .98 and .99 respectively (p < .001).
statistical analysis
For the ADL, IADL and mobility questionnaires, missing items were imputed using 
the mean of each respondent’s answers to other ADL, IADL or mobility questions. For 
example, if a participant had 1 missing response on the ADL scale the missing value 
was substituted with the average of the remaining nine questions. No more than 30% 
missing values were accepted for each individual. The level of ID was classified in three 
categories (borderline/mild, moderate, severe/profound) and dummy variables were 
created to compare the ID groups with borderline/mild. Dummy variables were also 
created to compare the participants without Down syndrome with those with Down 
syndrome and those without information on Down syndrome. Characteristics of the 
study population were first assessed with a non-response analysis, in which those in-
cluded in the follow-up study were compared to those who dropped out of the study. 
Pearson-chi-square tests for categorical variables and t-tests for continuous variables 
were used. Percentages of participants able to perform ADL, IADL and mobility items 
independently were provided for baseline and follow-up and changes over time were 
tested for significance with the McNemar test. Overall differences between the baseline 
score and follow-up score were assessed with paired-samples t-tests.
To analyze the univariate correlation between the frailty index score and ADL, IADL 
and mobility measurements the Pearson correlation coefficient was used. Multivariable 
linear regression with two or three steps was used to predict ADL, IADL and mobility 
three years after baseline. In step 1, the baseline characteristics (age, gender, level of 
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ID, Down syndrome) and the baseline ADL, IADL, or mobility scores were included. In 
step 2, the frailty index score was included (to aid interpretation, the frailty index score 
was multiplied by 100). It was expected that the influence of the frailty index depended 
on the baseline score of the ADL, IADL or mobility measurement, since those with high 
scores at baseline could decrease more than those with low scores at baseline and vice 
versa. Therefore, interactions between the frailty index score and the baseline scores 
of the instruments were tested and an interaction term was applied into a third step if 
applicable (p < .05). A graph was plotted to show the effect of the interaction term. This 
graph showed the frailty index in relation to the estimated limitations in daily function-
ing 3 years after baseline, standardized for a male individual with a moderate ID, aged 
55 years and without Down syndrome, using the regression coefficients of step 3. For 
all independent variables, multicollinearity was checked with the variance inflation fac-
tor (VIF) of linear regression analysis. VIF values above 10 indicated multicollinearity, 
provided that variables were no interaction terms or dummy variables. A p-value < .05 
was considered statistically significant.
results
characteristics of the study population
At baseline, 989 out of 1050 (94%) respondents had completed ADL and IADL question-
naires. After 3 years of follow-up, excluding those who died (n = 120), moved (n = 19), 
or did not sign a consent form for follow-up measurements (n = 148), 737 of the ques-
tionnaires were returned. For 30 participants no questionnaires had been completed at 
baseline, and for four participants questionnaires were incorrectly filled out, leaving 703 
participants (Figure 1). As shown in Table 1, those who dropped out were significantly 
older, had more often Down syndrome, were less mobile, had lower ADL scores, and had 
higher frailty index scores. 
Differences between baseline and follow-up
Table 2 shows that, on average, almost all ADL, IADL and mobility items declined signifi-
cantly over the 3 years. ADL at baseline and ADL at follow-up were highly correlated (r = 
0.82); the mean decrease in the ADL score was 1.23 (SD = 3.35) ([Mbaseline = 14.3, SDbaseline = 
5.3, Mfollow-up = 13.1, SDfollow-up = 5.8], t(702) = 9.7, p < .001). The correlation between baseline 
and follow-up IADL score was 0.85 with a mean decrease of 0.70 (SD = 2.49) points after 
three years ([Mbaseline = 12.0, SDbaseline = 4.7, Mfollow-up = 11.3, SDfollow-up = 4.3], t(702) = 7.5, p < 
.001). On average mobility limitations increased with 3.2 (SD = 6.14) points ([Mbaseline = 
6.8, SDbaseline = 9.9, Mfollow-up = 10.0, SDfollow-up = 11.4], t(697) = 13.6, p < .001). Baseline and 
follow-up mobility score showed a correlation of 0.84 (p < .001). 
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Predicting disability with the frailty index
All VIF values, not being interaction term or dummy variables were below 10. Data for 
people without information on Down syndrome were not shown. 
Activities of daily living
Frailty and ADL were highly correlated, with a Pearson correlation coefficient of .70 at 
baseline, and .68 at follow-up (p < .001). A linear regression model predicting ADL at 
follow-up, including the baseline characteristics (gender, age, Down syndrome, and 
level of ID) and baseline ADL, explained 72% of the variance (Table 3A). The full model 
Invited to the HA-ID 
study
N = 2322
Baseline sample 
n = 1050
Moved n = 19
Deceased n = 120
Invited for 
follow-up 
t = 3yr
n = 911
Included 
in follow-up
n = 763
No responds n = 82
Not willing to 
participate n = 66
Questionnaires 
returned
n = 737 
No questionnaire at 
baseline n = 30
Incorrect 
questionnaire n = 4
Included in the 
analysis
n = 703
No questionnaire 
returned n = 26 
 Figure 1. Flow chart of the participant inclusion throughout the study 
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(step 2) explained 73% of the variance, of which 1.1% was explained by the frailty index. 
ADL at follow-up was independently correlated with age, Down syndrome, level of ID, 
ADL at baseline, and the frailty index score (Table 3A). Change in the frailty index score 
was important: each 0.01 increase in frailty index score predicted a 0.09 lower ADL score 
at follow-up, independent of the baseline ADL score and baseline characteristics. In 
other words, an individual with a frailty index score of 0.50 would have an ADL score at 
follow-up being 3.6 points lower compared to an individual with a frailty index score of 
0.10. There was no additional effect of the frailty index with the addition of an interac-
tion term (data not shown). 
table 1. Baseline characteristics at baseline and 3 years follow-up
Characteristics n (%) X2 p-valuea
Baseline n = 1050 Follow-up
Included n = 703 Dropped out n = 347
Gender Male 539 (51%) 355 (50%) 184 (53%) 0.59 .441
Female 511 (49%) 348 (50%) 163 (47%)
Age (years) 50-59 493 (47%) 352 (50%) 141 (41%) 11.7 .020
60-69 370 (35%) 239 (34%) 131 (38%)
70-79 162 (15%) 100 (14%) 62 (18%)
80+ 25 (2.4%) 12 (1.7%) 13 (3.8%)
Level of ID Borderline 31 (3.0%) 19 (2.7%) 12 (3.5%) 8.35 .138
Mild 223 (21%) 137 (20%) 86 (25%)
Moderate 506 (48%) 344 (49%) 162 (47%)
Severe 172 (16%) 128 (18%) 44 (13%)
Profound 91 (8.7%) 59 (8.4%) 32 (9.2%)
Unknown 27 (2.6%) 16 (2.3%) 11 (3.2%)
Down syndrome No Down syndrome 724 (62%) 511 (73%) 213 (61%) 4.52 .034
Down syndrome 149 (14%) 92 (13%) 57 (16%)
Unknown 177 (24%) 100 (14%) 77 (22%)
Test scores Mean (SD) t p-valueb
n Baseline Follow-up
n Included n Dropped out
Barthel index (0-20) ↑ 989 13.9 (5.77) 703 14.3 (5.29) 286 12.7 (6.66) -4.10  < .001
Lawton IADL scale (8-24) ↑ 989 11.9 (4.69) 703 12.0 (4.71) 286 11.7 (4.64) -0.81 .420
Mobility score (0-35) ↓ 989 7.80 (10.5) 703 6.82 (9.93) 286 10.2 (11.49) 4.66  < .001
Frailty index (0-1) ↓ 982 0.27 (0.13) 700 0.26 (0.12) 282 0.32 (0.14) 6.46  < .001
a p-Value calculated for the difference between included and dropout participants with chi-square.
b p-Value calculated for the difference between included and dropout participants with an independent 
sample t-test.
↑↓ indicates the direction of the best score. 
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Instrumental activities of daily living
At baseline, 35% of the participants were unable to perform any of the IADL items (IADL 
score: 8). The frailty index score and IADL showed a Pearson correlation coefficient of 
.58 at baseline, and .56 at follow-up (p < .001). IADL at follow-up was independently 
correlated with age, level of ID, IADL at baseline, and the frailty index score (Table 3B). 
As shown in Table 3, most of the variance was explained by baseline IADL score. The 
interaction term between the frailty index score and baseline IADL score was significant 
table 2. Percentage of participants able to perform ADL and IADL tasks independently and the percentage 
of participants able to move without help, walking aid or wheelchair in different situations
Barthel Index (n = 703) Baseline Follow-up X2a p-value
All 13.8 11.5 2.62 .106
1. Bowel 61.7 59.2 1.59 .208
2. Bladder 54.6 51.9 1.96 .161
3. Grooming 30.7 23.0 18.7  < .001
4. Toilet use 57.0 51.1 9.77 .002
5. Feeding 61.3 52.5 27.8  < .001
6. Transfer 78.2 70.6 22.7  < .001
7. Mobility 80.2 68.4 44.5  < .001
8. Dressing 57.3 46.5 42.0  < .001
9. Stairs 54.8 44.0 42.0  < .001
10. Bathing 36.4 29.6 17.8  < .001
Lawton IADL Scale (n = 702) Baseline Follow-up X2a p-value
All 2.6 1.4 NAb NAb
1. Telephone use 25.3 22.8 4.01 .05
2. Groceries 29.4 22.9 19.5  < .001
3. Food preparation 12.7 9.7 5.33 .02
4. Housekeeping 10.8 6.0 16.0  < .001
5. Laundry 10.8 9.1 2.52 .11
6. Transportation 12.8 10.5 4.02 .05
7. Medication 14.1 9.8 12.7  < .001
8. Finances 22.0 16.5 13.8  < .001
Mobility items (n = 698) Baseline Follow-up X2a p-value
All 60.6 46.2 87.0  < .001
1. Walking in home 75.5 63.3 61.5  < .001
2. Walking at work/school 73.0 60.2 67.6  < .001
3. Walking protected area ( < 50m) 70.7 58.5 67.5  < .001
4. Walking protected area ( > 50m) 64.0 49.6 85.0  < .001
5. Walking unprotected area 62.4 47.4 92.1  < .001
a Chi-Square calculated with the McNemar test.
b Expected cell count less than 5, McNemar test not possible. 
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(β = 0.30; p < .001; Table 3B, step 3). The frailty index score and corresponding interaction 
term explained 1.9% of the variance in addition to the 74% which was already explained 
by the baseline measurements. The slope of the regression line between the frailty 
index score and change in IADL differed per baseline IADL score. As shown in Figure 2, a 
high baseline IADL combined with a high frailty index score predicted a higher decline 
compared to those with low baseline IADL and high frailty index scores. 
Mobility
The Pearson correlation coefficient for the frailty index score and mobility at baseline was 
.60 and with mobility at follow-up .60. Mobility at follow-up was significantly related to 
gender, age, Down syndrome, baseline mobility score and the frailty index score (Table 
3C). The frailty index and the corresponding interaction term explained 1.7% of the vari-
ance in addition to the 74% already explained by the baseline measures. The significant 
interaction term showed that the influence of the frailty index on mobility limitations at 
follow-up depends on baseline mobility score. Figure 3 shows that, for those with low 
mobility scores (little mobility limitation) at baseline, the highest correlation between 
the frailty index score and deterioration in mobility was found.
Discussion
We have shown that frailty is significantly associated with increasing disabilities in daily 
functioning in people with ID. In univariate analysis, the frailty index was highly correlated 
with baseline disabilities and disabilities over a 3-year follow-up period. After adjusting 
for gender, age, level of ID, presence of Down syndrome, and baseline disability, frailty 
table 3a. Multiple linear regression models predicting ADL at follow-up 
n = 684 Step 1 R2 = 0.713* Step 2 R2 = 0.724*
B (SE) β t p-value B (SE) β t p-value
Gender (female) -0.52 (0.24) -0.04 -2.12 .034 -0.44 (0.24) -0.04 -1.82  < .001
Age (years) -0.10 (0.02) -0.13 -6.11  < .001 -0.07 (0.02) -0.10 -4.32 .069
Down syndrome -2.10 (0.37) -0.12 -5.65  < .001 -2.07 (0.37) -0.12 -5.60  < .001
Level of ID
Moderate -1.28 (0.31) -0.11 -4.09  < .001 -1.06 (0.31) -0.09 -3.29 .001
Severe -2.43 (0.39) -0.19 -6.15  < .001 -1.99 (0.40) -0.15 -5.02  < .001
Barthel Index Baseline 0.80 (0.03) 0.74 30.8  < .001 0.70 (0.03) 0.64 21.6  < .001
FI score (0-100)a - - - - -0.09 (0.02) -0.16 -5.27  < .001
Note. Low scores indicate low ADL capacities
* R Square change significant with a p-value < .001
aThe frailty index was recomposed without the ADL items which are included in the original frailty index
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continued to be associated with disabilities in ADL, IADL and mobility three years later. In 
all models, frailty was better able to predict decreased health outcomes than was chrono-
logical age. Overall it was shown that within three years, the percentage of participants 
who were able to independently perform ADL, IADL and mobility tasks decreased. 
In line with previous results, we confirm that the frailty index is a valid indicator to 
predict adverse health outcomes. Most studies found an association between frailty and 
disabilities in daily functioning, although the strength of the associations differs from 
study to study. This was mainly due to the variation regarding the study population, 
follow-up period, used instruments, study size, and confounders. Several studies have 
shown that physical frailty leads to ADL/IADL disability [22]. But multidimensional frailty 
measures are also able to identify those at risk [18, 21, 23]. Woo et al. showed that the 
standardized beta between the frailty index and change of ADL (Barthel index) at 3-year 
follow-up was -0.12 [23]. We found similar results with a somewhat higher standardized 
beta of -0.16. However, comparison remains difficult because the Hong Kong cohort (70 
years and over), used by Woo et al., was on average older, less disabled in ADL func-
tioning, and showed lower (i.e., better) frailty scores at baseline compared to our study 
population. In addition to the frailty index, the level of ID was a significant predictor for 
Figure 2 
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Figure 2. Correlation between the frailty index score at baseline and the estimated IADL difference 3 years 
after baseline. A linear regression model (including gender, age, level of ID, Down syndrome, baseline IADL, 
frailty index score, and interaction term for IADL and frailty index score) was used to estimate the function. 
Lines represent a male with moderate intellectual disability, aged 55 years, no Down syndrome and an IADL 
baseline score of 8 (fully dependent; striped black line), 16 (half dependent; dotted dark grey line), and 24 
(fully independent; straight light grey line).
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disabilities in daily function. The association between the level of ID and disabilities in 
ADL and IADL was previously found in cross-sectional studies [27, 39]. Here we have 
shown that the level of ID is also an predictor for deterioration in ADL and IADL activities 
after a 3-year follow-up period. Participants with moderate or severe levels of ID were 
more likely to develop disabilities compared to participant with low levels of ID.
Our results show that the association between frailty and disability in IADL at follow-up 
depends on the baseline IADL score. More precisely, the index has the most predictive 
value for those who are independent at baseline, whereas in those with low baseline 
independence, the frailty index has little prognostic value. This was also observed for 
mobility. This result can be explained by the floor effects present in the used scales 
of the IADL and mobility questionnaires. In participants with very low baseline IADL 
scores, negative changes could not be observed, although they were likely to have high 
frailty index scores [24]. In contrast, those with better scores had more room for scores 
to decline, which explains the strong association between frailty and reduced IADL and 
mobility. 
Figure 3 
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Figure 3. Correlation between the frailty index score at baseline and the estimated mobility difference 3 
years after baseline (increased score predicts mobility deterioration). A linear regression model (including 
gender, age, level of ID, Down syndrome, baseline mobility, frailty index score, and an interaction term for 
mobility and the frailty index score) was used to estimate the function. Lines represent a male with moder-
ate intellectual disability, aged 55 years, no Down syndrome and a mobility score of 0 (no limitations; black 
striped line), 10 (walking with a cane or crutch; dark grey round dotted line), 20 (walker or wheelchair; grey 
square dotted line), or 30 (wheelchair or electric wheelchair; light grey straight line). 
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The explained variance found for the models predicting deterioration in the health 
outcomes was around 0.75. Most of the variance was explained by baseline functional 
status. Previously, it has been shown that baseline functional status is highly correlated 
with functional status in later life [21, 40]. The extra variance explained by the frailty 
index ranged between 1.1 and 1.9%, which can still be considered rather high, since 
little variance was left unexplained and the standardized regression coefficients showed 
to have a small to medium effect size. In addition, the regression coefficients showed 
clinically important effects. For example, according to the model, an individual with 
a high frailty index score (0.5) would have an ADL score at follow-up 3.6 points lower 
compared to an individual with a low frailty index score (0.1). This difference could mean 
for example that the individual is no longer able to bath independently, needs help 
with feeding, is no longer fully continent, and lost some mobility. Nevertheless, our data 
do not provide evidence that the frailty index can exclusively predict adverse health 
outcomes. The unexplained variance could be contributed to variables not included in 
the model (including protective factors) but also by noise in the data. Frailty itself is a 
dynamic process, and those categorized as frail could no longer be frail at follow-up or 
the other way around [41]. Similarly, as we had only one single follow-up assessment, 
we cannot be sure of the extent to which disability fluctuation might be a phenomenon 
in this group [42], or how trajectories of disability relate to frailty. Budget cuts, changes 
of a personal care giver, relocation from outpatient environment towards an intramural 
environment are all factors that could have caused changes in ADL, IADL, and mobility. 
The strengths of our study are the prospective design, the large study population, and 
the completeness of the follow-up. Additionally, we chose to measure frailty with an 
instrument that includes multiple health aspects and is not solely focused on physi-
cal health. Although it has been shown that physical frailty indicators are important in 
predicting ADL disability [21, 22], multiple health domains also strongly contribute to 
ADL disabilities [43]. Additionally, the frailty index showed good validity across diverse 
clinical and community dwelling populations and is applicable to people with ID [1, 8, 
44]. 
This study has also several limitations. First, dropout between baseline and follow-up 
was associated with more frailty, more ADL limitations, and more mobility limitations. 
Thirty-five percent of the drop-out was caused by the death of the participants. The abil-
ity of the frailty index to predict adverse health may have been underestimated because 
people who dropped out were more likely to have died. Second, some remarks need 
to be made about the questionnaires we employed in relation with the frailty index. 
The major advantages of using the Barthel ADL index and Lawton IADL scale are the 
ability to compare our results with the general population, and their known feasibility 
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in people with ID. Even so, the observed floor effect made negative changes in the low-
est ADL, IADL and mobility categories impossible. A more sensitive instrument could 
have increased the predictive value of the frailty index for those who already have little 
independence. Also, the ADL and IADL questionnaires had been used to compose the 
original frailty index. Overlap between the index and the questionnaires was reduced by 
the development of new frailty indices excluding the ADL/IADL/mobility items. This has 
led to slightly modified indices. Nevertheless, Theou et al. (2012) showed that regardless 
of whether ADL items are included in the index, the predictive value remains, although 
the ADL items do contribute to the risk of developing adverse health outcomes. Ad-
ditionally, we found very high correlations between the original and adjusted frailty 
indices and we performed all analyses also with the original frailty index and found no 
major differences (Appendix A). Although the VIF indicated that there was no multicol-
linearity, it could be that the high correlation between frailty and the disabilities in daily 
function caused some bias in the predictive accuracy of the frailty index. 
In spite of these limitations, we demonstrated that frailty predicted declined disability 
and mobility in an already disabled population. The frailty index showed most predictive 
value for those with high baseline mobility or IADL independence. Although prefer-
ably the index would be sensitive for all subgroups within this population, those with 
relative high independence may benefit the most from interventions. Future research 
should focus on possible disability fluctuations in this group. In addition, a more sensi-
tive ADL and IADL questionnaire can help to detect deterioration in those with very 
low dependence at the start of the study. Caregivers should be able to recognize frail 
and vulnerable people at an early stage to avoid further health decline. Interventions 
that limit the progression of frailty potentially also limit further disability and thereby 
diminish the burden for individuals and caregivers and limit health costs in this, already 
expensive, population.
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appendix a.i Multiple linear regression models predicting ADL at follow-up with the original frailty index 
n = 684 Step 1 R2 = 0.716* Step 2 R2 = 0.730*
B (SE) β t p-value B (SE) β t p-value
Gender (female) -0.52 (0.24) -0.04 -2.12 .034 -0.40 (0.24) -0.03 -1.65 .099
Age (years) -0.10 (0.02) -0.13 -6.11  < .001 -0.07 (0.02) -0.09 -4.02  < .001
Down syndrome -2.10 (0.37) -0.12 -5.65  < .001 -2.01 (0.36) -0.12 -5.52  < .001
Level of ID
Moderate -1.28 (0.31) -0.11 -4.09  < .001 -0.98 (0.31) -0.08 -3.17 .002
Severe -2.43 (0.39) -0.19 -6.15  < .001 -1.92 (0.40) -0.15 -4.87  < .001
Barthel Index 
Baseline
0.81 (0.03) 0.74 30.8  < .001 0.64 (0.04) 0.58 16.28  < .001
FI score (0-100) - - - - -0.11 (0.02) -0.22 -5.79  < .001
Note. Low scores indicate low ADL capacities
* R Square change significant with a p-value < .001
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Chapter 7
The use of a frailty index to 
predict adverse health outcomes 
in people with intellectual 
disabilities
Josje D. Schoufour, Michael A. Echteld, Luc P. Bastiaanse, Heleen M. Evenhuis
Research in Developmental Disabilities, 2015. 38: p. 39-47
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abstract
Frailty in older people can be seen as the increased likelihood of future negative health 
outcomes. Lifelong disabilities in people with intellectual disabilities (ID) may not only 
influence their frailty status but also the consequences. Here, we report the relation 
between frailty and adverse health outcomes in older people with ID (50 years and over). 
In a prospective population based study, frailty was measured at baseline with a frailty 
index in 982 older adults with ID (≥50yr). Information on negative health outcomes (falls, 
fractures, hospitalization, increased medication use, and comorbid conditions) was 
collected at baseline and after a three-year follow-up period. Odds ratios for negative 
health outcomes were estimated with the frailty index, adjusted for gender, age, level of 
ID, Down syndrome and baseline adverse health condition. The frailty index was related 
to an increased risk of higher medication use and several comorbid conditions, but not 
to falls, fractures and hospitalization. Frailty at baseline was related to negative health 
outcomes three years later in older people with ID, but to a lesser extent than found in 
the general population. 
Key words: People with ID, frailty, adverse health outcomes, falls, comorbid conditions 
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introDuction
As the life span of people with intellectual disabilities (ID) increases [1, 2], age-related 
frailty will likely become a major problem for individuals, caregivers and health care 
facilities, as has been seen in the general population [3]. Nevertheless, there is no infor-
mation on the causes, development and consequences of frailty in people with ID [4]. 
Frailty has been described as “a dynamic state affecting an individual who experiences 
losses in one or more domains of human functioning (physical, psychological, social), 
which is caused by the influence of a range of variables and which increases the risk of 
adverse outcomes” [5, p. 342]. Frailty can be measured with different instruments, based 
on different operationalizations. Previously, we measured frailty in people with ID using 
a frailty index [6]. A frailty index is a method that focuses on the quantity, rather than on 
the nature of health problems: the more problems are present in an individual, the more 
frail he or she is [7, 8]. It captures physical, psychological and social health and has been 
shown to predict negative health outcomes in several clinical and community-dwelling 
populations [3, 7, 9]. People with ID showed high frailty index scores compared to the 
general population of the same age [6, 10]. 
Frail individuals in the general population are more likely to fall, have fractures, get 
admitted to a hospital, and develop more chronic diseases including osteoarthritis, 
depressive symptoms, coronary heart disease, diabetes mellitus and chronic lower 
respiratory tract disease [11-15]. These consequences may be different for older people 
with ID due to their lifelong disabilities. For example, lifelong mobility limitations and 
low bone quality [16] may influence the relation between frailty and falls and fractures. 
The high levels of comorbidity [17] may lead to an increased risk of hospital admission. 
Contrary, the care and support provided at the care organizations may limit the necessity 
of hospitalization, specifically for those with severe behavioral problems or profound 
levels of ID. Also, gastrointestinal, neurological, sleep, and musculoskeletal problems, 
epilepsy, and visual and hearing impairments can be lifelong, start at a younger age, or 
are more prevalent compared to the general population, leading to early interventions 
and possibly habituation [18-22]. As a result, the relation between frailty and morbid 
conditions may be less strong than found in the general public. To explore how frailty 
is related with health problems, we used prospective data from the Healthy Aging and 
Intellectual Disability study (HA-ID) [23]. The main aim of our study was to analyze the 
ability of the frailty index to predict the occurrence of falls, fractures, hospitalization, 
chronic medication use, and comorbid conditions over three years. 
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methoDs
study design and participants
This study was part of the ‘Healthy aging and intellectual disabilities’ study (HA-ID) [23]. 
This observational study collected information on the general health status of older 
people with ID using formal care in the Netherlands. All clients of the care organiza-
tions aged 50 years and over were invited to participate (N = 2322). Those capable of 
understanding the available information signed the consent form themselves. Legal 
representatives were approached for those who were not able to make this decision. 
Written informed consent was provided for 1050 clients, forming a nearly representative 
study population for the Dutch population of older adults (aged 50 and above) with ID 
who use formal care, albeit with a slight underrepresentation of men, people aged 80 
and over, and people living independently. Baseline data collection took place between 
February 2009 and July 2010. The Medical Ethics Committee of the Erasmus Medical 
Center Rotterdam (MEC-2008-234) and the ethics committees of the participating care 
organizations approved this study. Details about recruitment, design, inclusion criteria, 
and representativeness of the HA-ID study have been published elsewhere [23]. Three 
years after baseline, follow-up data were collected between February 2012 and August 
2013. The participants, or their legal representatives, who still received care of the care 
organisations were asked again to provide written informed consent for the follow-
up study. The follow-up study was approved by the Medical Ethics Committee of the 
Erasmus Medical Center Rotterdam (MEC-2011-309) and the ethics committees of the 
participating care organizations. 
Data collection
Details about the baseline data collection have been described elsewhere [23]. In short, 
baseline characteristics were retrieved from the administrative systems of the care 
organizations. Measurements were conducted within three main themes (1) physical 
activity and fitness, (2) nutrition and nutritional state, and (3) mood and anxiety. The 
broad spectrum of data collection included anthropometric measurements, physical 
fitness tests, psychiatric assessment, and laboratory tests in addition to file records (e.g. 
medical file). Level of ID was obtained from the records of behavioral therapists and 
psychologists. The presence of Down syndrome was obtained from medical files. Mobil-
ity limitations were categorized as no help, walking-aid or wheelchair use. Follow-up 
data were collected three years after baseline without client interference.
Falls and fractures
At baseline and follow-up, professional caregivers provided information on how often 
the participants fell in the past three months (not fallen, 1-2 falls, 3 -5 falls, 6-10 falls, 11 
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falls or more). At baseline, data on fractures having occurred over the last 5 years were 
requested from the physician. For the follow-up measurement, data on fractures having 
occurred over the last three years were requested from both the professional caregiver 
and the physician.
General hospital admission
Occurrences of hospitalization (no, once, twice, three times, more than three times) were 
collected via the personal caregiver at baseline (preceding year) and via physicians at 
follow-up (preceding three years). Hospitalization was defined as an admission of at 
least one day in a general hospital. Procedures in outpatient clinics were not taken into 
account. Clients with severe behavioral problems, or clients who received a high level of 
care from the care organization, were thought to be less likely to be admitted for a hos-
pital stay. Therefore, an adjustment was made for participants who received intensive 
support or intensive support and regulation of behavior. This classification was based 
on long term care indications under the Dutch Act on Exceptional Medical Expenses 
(AWBZ)- a law that finances specialized long-term care. 
Total number of used medicines
Current medication use was requested at baseline and follow-up from the physician 
or pharmacy. Total medication count included the total number of medicines taken at 
the point of measurement. Vitamins, minerals, basic skin creams (e.g Vaseline), or anti-
dandruff shampoo prescribed by the physician, were not counted as medicines, with the 
exception of vitamin D and calcium tablets. 
Comorbid conditions
Information on conditions (cardiovascular, respiratory, gastrointestinal tract, endocrine 
system, neurological, sleep, psychiatric, musculoskeletal, and hearing and vision), were 
requested from the attending physician. Additionally, the anatomical therapeutic chemi-
cal (ATC) classification system [24] was used to identify problems based on medication 
use, according to the organ or system they act on. Both diagnosis and ATC-code were 
used to classify participants as having a problem, disease or condition regarding that 
organ systems (Table 1). Although originally included in the ATC classification, ’antipara-
sitic products, insecticides and repellents’ and ‘antineoplatic and immunomodulating 
agents’ were not included in the analysis because less than 1% of the participants used 
medication in these groups. Removing all morbidity items from the index could result 
in an unbalanced index. Therefore we did not test whether the frailty index was able to 
predict an increase in comorbidity (e.g. all comorbid conditions together).
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the frailty index
We previously developed a frailty index using 51 deficits from the baseline measure-
ments of the HA-ID study. Together, these deficits covered psychological, physical and 
cognitive health aspects. All deficits were carefully selected and fulfilled the criteria 
developed by Searle et al. [25]. Each deficit has to be health-related and increase with 
age, and the deficit should not saturate too early (no ceiling effects). All deficits were 
re-coded to a score between 0 (deficit absent) and 1 (deficit present). A frailty index 
score was calculated by the number of present deficits divided by the total number 
of measurements, resulting in a score ranging from zero (lowest level of frailty) to one 
(highest level of frailty). Detailed information on the selection, diagnostic methods, 
deficits, and used cutoff values have been reported elsewhere [6]. To examine the asso-
ciations of frailty with the different adverse health outcomes, the index was rescored to 
exclude items that concerned that health outcome. For example, if the frailty index was 
correlated to falls, the fall deficit was excluded from the original index, and if the frailty 
index was correlated to the cardiovascular system, all deficits regarding cardiovascular 
conditions were excluded from the original index. 
table 1. Classification comorbid conditions according to the anatomical therapeutic chemical classification 
(ATC) system and diagnosis by the physician
Anatomical main group Diagnosis physician First level of the 
ATC code
Alimentary tract and metabolism gastroesophageal reflux disease, peptic 
ulcer, constipation, dysphagia, diabetes 
mellitus 
A
Blood and blood forming organs - B
Cardiovascular system heart failure, valve abnormalities, coronary 
heart disease, heart rate disorder, 
hypertension, hypercholesterolemia, 
intermittent claudication, stroke
C
Dermatologicals - D
Genitourinary system and sex hormones - G
Systemic hormonal preparations, excl. sex 
hormones and insulins
hypothyroidism, hyperthyroidism H
Anti-infectives for systemic use - J
Musculoskeletal system scoliosis, rheumatism, arthrosis, 
osteoporosis, spasticity
M
Nervous system dementia, epilepsy, Parkinson’s disease, 
sleep disorders, depression, anxiety, 
psychosis
N
Respiratory system asthma, COPD, sleep apnea R
Sensory organs vision or hearing impairment S
Note. The anatomical main groups are reproduced from the WHO collaborating Centre for Drugs Statistics 
Methodology, ATC/DDD Index 2014
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statistical analysis
First, characteristics of the study population were assessed with a non-response analysis. 
Participants who provided informed consent for the follow-up study, and had medical 
information available at both baseline and follow-up were included in the study. Differ-
ences between participants included and excluded in the follow-up study were assessed 
using Pearson-chi-square tests for categorical variables and t-tests for continuous vari-
ables. Second, linear regression (number of medication) or logistic regression analysis 
(falls [one or more], fractures [one or more], hospitalization [one or more], and comorbid 
conditions [as defined in Table 1]) were used to analyze the association between the 
baseline frailty index score and negative health outcomes three years later. To aid 
interpretation, the frailty index score was multiplied by 100. After univariate analysis, 
multivariate analyses were performed, adjusting for gender (male = 0, female = 1), age 
(years), level of ID, and Down syndrome. Level of ID was classified in three categories 
(borderline/mild, moderate, severe/profound). Subsequently, dummy variables were 
created for level of ID and borderline/mild was used as the comparison category. Dummy 
variables were also created to compare the participants with Down syndrome to those 
without Down syndrome and those without information on Down syndrome. In order 
to assess the increased risk for a negative health outcome, all models were adjusted 
for the negative health outcome at baseline. In addition, the model to predict falls was 
adjusted for mobility (no help, walking-aid, wheelchair) and the epilepsy, and the model 
to predict hospitalization was adjusted for participants who received intensive support 
or intensive support and regulation of behavior. The percentage of the explained vari-
ance was represented by the Nagelkerke R2 (logistic regression analysis) or the adjusted 
R2 (linear regression analyses) statistic. A Bonferroni correction was applied to the mor-
bid conditions (0.05/11). All statistical analyses were performed using SPSS version 21.0 
(SPSS, Inc., Chicago, IL).
results
characteristics of the study population
At baseline, 1050 participants had been included in the HA-ID study. After 3 years of 
follow-up, 19 moved and 120 died. The remaining 911 participants were invited for 
participation, of whom 763 provided informed consent. At follow-up, data from the 
medical records were provided for 693 participants, of which 61 did not have baseline 
information available, leaving 632 participants in the final analysis. Those who dropped 
out, more often had a borderline or mild intellectual disability, lived more often in the 
community, had more often been hospitalized in the preceding year, took on average 
more medicines, and showed on average higher frailty index scores at baseline (Table 2). 
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For 689 participants baseline and follow-up data on falls were known. Of these partici-
pants, 170 (25%) reported falls at follow-up. The frailty index at baseline was not related 
with falls three years later (Table 3). Those with reported falls at baseline (OR = 3.5, p 
table 2. Characteristics at baseline 
Characteristics n (%)
Follow-up
Baseline 
n = 1050
Included 
n = 632
Dropped out 
n = 418
X2/t p-value
Gender Male 539 (51%) 316 (50%) 223 (53%) 1.13 .29
Female 511 (49%) 316 (50%) 195 (47%)
Age (years) 50-59 493 (47%) 310 (49%) 183 (44%) 4.88 .30
60-69 370 (35%) 220 (35%) 150 (36%)
70-79 162 (15%) 90 (14%) 72 (17%)
80+ 25 (2.4%) 12 (1.9%) 13 (3.1%)
Level of ID Borderline 31 (3.0%) 14 (2.2%) 17 (4.1%) 24.1  < .001
Mild 223 (21%) 113 (18%) 110 (26%)
Moderate 506 (48%) 312 (49%) 194 (46%)
Severe 172 (16%) 125 (20%) 47(11%)
Profound 91 (8.7%) 60 (9.5%) 31 (7.4%)
Unknown 27 (2.6%) 8 (1.3%) 19 (4.5%)
Down syndrome No Down syndrome 724 (62%) 514 (81%) 210 (50%) 5.7 .02
Down syndrome 149 (14%) 91 (14%) 58 (14%)
Unknown 177 (24%) 27 (4.3%) 150 (64%)
Residential status Central 557 (53%) 385 (61%) 172 (41%) 54.9  < .001
Community 432 (41%) 236 (37%) 196 (47%)
Independent with support 43 (4.1%) 10 (1.6%) 33 (7.9%)
With relatives 7 (0.7%) 1 (0.2%) 6 (1.4%)
Unknown 11 (1.0%) 0 (0%) 11 (2.6%)
Falls ≥1 preceding 3 months1 233 (24%) 137 (23%) 96 (26%) 1.15 .28
Fractures ≥1 preceding 5 years2 78 (8.8%) 58 (9.5%) 20 (7.4%) 1.08 .30
Hospitalization ≥1 preceding year3 99 (11%) 49 (9.0%) 50 (15%) 7.63 .006
Number of medicines (mean [SD]4 4.1 (3.1) 3.9 (2.8) 4.5 (3.6) 3.7 .007
Frailty index (mean [SD]5 0.27 (0.13) 0.26 (0.12) 0.29 (0.14) 3.5  < .001
Note. SD = Standard Deviation
1 Falls at baseline were missing for 69 participants, 26 were included, 43 dropped out
2 Fractures at baseline were missing for 168 participants, 22 were included,146 dropped out
3 Hospitalization was missing for 175 participants, 88 were included, 87 dropped out
4 Number of medicines was missing for 127, zero were included, 127 dropped out
5 Frailty index unknown for 68 participants from the baseline participants, 22 were included, 46 dropped 
out 
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< .001), people with epilepsy (OR = 1.9, p = .013) and people without Down syndrome 
(OR = 2.1, p = .04) were more likely to report falls at follow-up. For 651 participants, frac-
tures at baseline and follow-up were known. Ninety-seven (15%) participants reported 
to have at least one fracture during the follow-up period. The frailty index at baseline 
was not related with fractures during the follow-up period (Table 3). The only variables 
significantly associated with an increased fracture risk were being female (OR = 1.84, 
p = .013) and previous fractures (OR = 4.56, p < .001). For 579 participants, information 
on hospitalization was known at baseline and follow-up. Over three years, 114 (20%) of 
the participants were hospitalized at least once. Participants with a high frailty index at 
baseline had no statistically significant increase in their risk for hospitalization (Table 
3). Higher age predicted hospitalization significantly (OR = 1.03, p = .028). At follow-up, 
participants took on average 1.5 (SD = 2.8) more medicines than at baseline. The frailty 
index was related with the total number of medicines three years later (p < .001). Also, 
participants with high frailty index scores tended to increase their number of medicines 
during the follow-up period (B = 0.07, p < .001; Table 3). 
Overall, there was an increase in comorbid conditions within the follow-up period (Fig-
ure 1). Most were related to the alimentary tract and metabolism group (baseline 73%, 
follow-up 79%), followed by the nervous system (baseline 63%, follow-up 72%) and the 
sensory organs (baseline 55%, follow-up 60%). After adjusting for the baseline charac-
teristics and the comorbid condition at baseline, a high frailty index score was related to 
comorbid conditions in the alimentary tract & metabolism, dermatologicals, systemetic 
hormonal preparations, and nervous system, but after a Bonferroni correction only the 
relation with the alimentary tract & metabolism remained statically significant (Table 4). 
table 3. Three-year outcomes associated with the frailty index
Outcome n (events) model OR/B (95%CI) p-value R2
Falls 597 (148) Unadjusted 1.01 (0.99-1.02) .23 0.004
Adjusted* 1.01 (0.98-1.03) .54 0.152,3,4
Fractures 617 (97) Unadjusted 1.00 (0.98-1.02) .62  < 0.01
Adjusted* 0.99 (0.97-1.02) .32 0.091,3
Hospitalization 540 (114) Unadjusted 1.01 (0.99-1.03) .38  < 0.01
Adjusted* 1.01 (0.99-1.03) .49 0.03
Medication use 601 (NA) Unadjusted 0.14 (0.12-0.16)  < .001 0.21
Adjusted* 0.07 (0.04-0.09)  < .001 0.443
Note. The frailty index was recomposed without the outcome of interest and multiplied by 100. OR = Odds 
Ratio, B = Beta, events = number of events at follow-up. 
*Adjusted for gender, age, level of ID, presence of Down syndrome, outcome at baseline. 
Other factors significantly associated with the health outcome in the adjusted model: 1 being female, 2 
absence of Down syndrome, 3 outcome at baseline, 4 the presence of epilepsy 
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Discussion
We studied the relation between frailty (defined as the accumulation of deficits) and 
negative health outcomes in adults with ID, aged 50 years and over, during a follow-up of 
three years. Those with high frailty index scores at baseline, were more likely to develop 
new comorbid conditions and to get more medication prescriptions. The proportion of 
participants who reported falls, fractures or hospitalization at follow-up, was not related 
to the frailty index. 
Falls, especially if accompanied with a fracture, can be considered negative health out-
comes and are expected to be related to frailty. Nevertheless, in the general population, 
there is still inconsistency about the association between frailty and falls. Some study 
results showed a correlation [26-28], whereas others did not [29, 30]. We did not find 
a relation between high frailty index scores and an increased risk of falls and fractures. 
A possible explanation for this result is that the underlying risk factors related to falls 
could be different in people with ID. Failure in overall health generally starts with the 
highest order functions, including walking [8]. This line of thinking is supported by 
the finding that physical fitness is related to falls in the general population [31, 32]. 
Previous results from the HA-ID study showed however that physical fitness (i.e. gait 
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Figure 1. percentage of morbidities among participants of the HA-ID study at baseline (black bars) and 
after 3-year follow-up (grey bars).
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speed, strength, balance) was not related to falls in people with ID [33]. Furthermore, 
frailty is generally related to an age-related decline in health. Since falls, in the general 
population, increase with age, this contributes to the explanation that age-related frailty 
is associated to increased fall risk. In this study we did not observe an increase in falls 
with age. Also, the explained variance of the model was low (explained variance = 13%) 
and mainly related to previous falls, indicating that other factors, such as epilepsy, visual 
deficits, behavioral problems, and polypharmacy may be more important to predict falls 
in people with ID [34-38]. Nevertheless, our results need to be interpreted with caution 
since the used measurements may have limited the accuracy of the association. We re-
quested falls over the last three months, which is subject to problems in recall that could 
table 4. Logistic regression models to predict comorbidity at follow-up with a frailty index
Anatomical main group n = 602 n (events) model OR (95%CI) p-value R2
Alimentary tract and metabolism 602 (476) unadjusted 1.09 (1.07-1.17)  < .001^ 0.17
adjusted* 1.06 (1.03-1.09)  < .001^ 0.417
Blood and blood forming organs 602 (84) unadjusted 1.05 (1.03-1.07)  < .001^ 0.07
Adjusted* 1.02 (0.99-1.05) .25 0.315,7
Cardiovascular system 602 (277) Unadjusted 1.01 (0.99-1.02) .34 0.00
Adjusted* 1.01 (0.99-1.03) .47 0.546,7
Dermatologicals 602 (127) unadjusted 1.02 (1.01-1.04) .009 0.02
adjusted* 1.03 (1.01-1.05) .011 0.084,7
Genito urinary system and sex 
hormones
602 (51) Unadjusted 1.01 (0.99-1.04) .29 0.00
Adjusted* 1.00 (0.97-1.04) .89 0.447
Systemic hormonal preparations 602 (144) unadjusted 1.03 (1.02-1.05)  < .001^ 0.04
adjusted* 1.04 (1.01-1.07) .017 0.683,7
Anti infectives for systemic use 602 (51) unadjusted 1.02 (1.00-1.05) .045 0.02
Adjusted* 1.02 (0.99-1.05) .20 0.067
Musculo-skeletal system 602 (135) unadjusted 1.04 (1.02-1.06)  < .001^ 0.06
Adjusted* 1.01 (0.99-1.04) .33 0.442
Nervous system 602 (432) unadjusted 1.07 (1.05-1.09)  < .001^ 0.13
adjusted* 1.04 (1.01-1.07) .007 0.477
Respiratory system 602 (128) unadjusted 1.02 (1.00-1.04) .029 0.01
Adjusted* 1.02 (1.00-1.05) .086 0.424,7
Sensory organs 602 (360) unadjusted 1.03 (1.01-1.04)  < .001^ 0.03
Adjusted* 1.00 (0.98-1.02) .86 0.241,3,5,7
Note. The frailty index was recomposed without the mentioned diseases or conditions, which are included 
in the original frailty index, events = number of comorbidities at follow-up. 
*Adjusted for gender, age, level of ID, Down syndrome, and baseline morbid condition.
^Significant after Bonferroni correction (p < .05/11 = .005)
Other factors significantly associated with the health outcome in the adjusted model: 1 increased age, 2 
decreased age, 3 presence of Down syndrome, 4 absence of Down syndrome, 5 more severe level of ID, 6 
less severe levels of ID, 7 baseline morbid condition. 
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have been diminished with prospective data collection (for example falls records) [39]. 
Also, falls were only requested at follow-up, so we do not know the complete occurrence 
of falls between baseline and follow-up. In addition, we were unable to classify recurrent 
fallers ( > 1 falls) in a separate group, due to the structure of the questionnaire used in 
our study. 
Frailty was not associated with hospital admission during the follow-up period. This 
result is different from several studies in the general population showing that frailty is 
associated with hospitalization [12, 28, 40, 41] and with a longer length of hospital stay 
[42]. There are several possible explanations for our results. Conditions that normally 
require specialist services may have been undiagnosed [43, 44]. In addition, family, per-
sonal caregivers or hospital staff may have decided that hospital treatment was not in 
the best interest for the client [45, 46]. Despite the attempt to adjust for this, we did not 
find an increased risk for hospitalizations in frail participants.
Frailty was associated with the number of used medicines and with an increased 
likelihood of increasing medication use, which is in line with results from the general 
population [47, 48]. Multiple drug use can cause severe side effects, drug-drug interac-
tions and drug-nutrient interactions [49, 50]. The high levels of comorbidity [17, 51] and 
frequent prescription errors found in people with ID [52], raises concerns about the high 
medication consumption in frail people. Age-related physiological changes related with 
drug absorption, metabolism, distribution and excretion are possibly more extreme 
in frail individuals [53]. Potentially, this increases the risk of adverse drug reactions, 
and contributes to the frailty-related deterioration in health. Attempts at diminishing 
polypharmacy in people with ID applying systematic medication reviews is therefore 
recommended. 
At follow-up, frailty was associated with most comorbid conditions, which has also been 
found in the general population [3, 14, 15, 54]. Even so, after adjusting for the condition 
at baseline (i.e. new comorbidities), the relation was only slight or non-significant. A lon-
ger follow-up period may be required to monitor the development of new diseases and 
thereby increase the power of the analysis. Because information was obtained through 
the medical files, undiagnosed conditions may have led to an underestimation of this 
association. 
The comprehensive set of outcome measurements, collected via the physicians and per-
sonal caregivers, and the prospective design are the major strengths of our study. Our 
study has also several limitations. First, the results are influenced by specific dropout. 
The 418 participants who were not included in the main analysis were on average frailer, 
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took more medication, and had more often be hospitalized prior to the study. Almost 
30% (n = 120) of the dropout was caused by the death of the participants. Previously we 
showed that survival was associated with higher frailty levels, more profound level of ID, 
higher age and the presence of Down syndrome [55]. Also, prior to death, health condi-
tion may deteriorate, leading to an underestimation of the association between frailty 
and health conditions. Similarly, deterioration in health could have been a reason to 
refuse participation in the follow-up study. Furthermore, participants living in the com-
munity, who received medical care from a general practitioner instead of a specialized 
ID physician, were more likely to drop out. The specific dropout limits generalization of 
the results to the complete older ID population. Second, frailty was only measured once. 
It has been shown that frailty is a dynamic process in which people can either become 
worse or recover from their (pre-)frail state [56, 57]. Life events [58], mood swings, and 
temporary illness may momentarily influence the frailty status. It is unknown how tra-
jectories of frailty may be a phenomenon in this population and how these trajectories 
influence the association between frailty and negative health outcomes. 
In conclusion, we demonstrated that frailty, defined as deficit accumulation, is related 
to negative health outcomes in people with ID, but to a lesser extent than found in the 
general population. The frailty index is not suitable as a tool to predict admission to gen-
eral hospitals and falls in this group. The low explained variance of the models implies 
that specific (individual) problems may be more important risk factors than a measure of 
general health, such as the frailty index. The frailty index did predict an increase in medi-
cation use. This confirms that frailty is related to decreased health status. Previously, we 
demonstrated that frailty is common in this population, starts at a relatively young age 
and is related to mortality, increased care intensity, and deterioration in independence 
and mobility [6, 55, 59, 60]. Together, these results show that frailty has serious conse-
quences in older people with ID, and effective interventions are required to limit this 
burden. In addition, future research should focus on potential for clinical application of 
the frailty index, i.e. on an individual level. A clinically applicable frailty index could be 
used to recognize frail individuals and to evaluate interventions.
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abstract
Frailty appears to develop earlier and is more severe in people with intellectual dis-
abilities compared to the general population. The high prevalence of frailty may lead to 
an increase in care intensity and associated health care costs. Therefore a longitudinal 
observational study was conducted to determine the effect of frailty on care intensity. 
The association between frailty and care intensity at baseline and follow-up (3 years 
later) was assessed. Furthermore, the ability of the frailty index to predict an increase in 
care intensity after three years was evaluated. This study was part of the Dutch ‘Healthy 
ageing and intellectual disabilities’ (HA-ID) study. Frailty was measured at baseline with a 
frailty index that included 51 health-and age-related deficits. For all participants informa-
tion on care intensity in seven steps was available, based on long term care indications 
under the Act on Exceptional Medical Expenses (AWBZ)- a law that finances specialized 
long-term care. 676 participants (50 years and over) with ID were included in the final 
analysis. In 26% of the participants, care intensity had increased during the follow-up 
period. Increased care during the follow-up was related to a high frailty index score at 
baseline, independent of gender, age, level of ID and the presence of Down syndrome 
(p = .003). After exclusion of ADL and IADL items, the frailty index remained significantly 
related with increasing care intensity during follow-up (p = .007). Our results underline 
that screening instruments for early detection of frailty and effective interventions are 
required to limit the burden of frailty for individuals and caregivers, but also to limit 
health care utilization.
Key words: People with ID, frailty, frailty index, care intensity
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introDuction
Improved quality of residential and healthcare has increased the life expectancy of 
people with intellectual disabilities (ID) [1, 2]. Much is still unknown about the effects 
of aging on health and health care needs in this older population. In recent years, the 
Healthy Ageing and Intellectual Disability (HA-ID) study provided information on a 
broad spectrum of health aspects and quality of life in older people with ID [3]. Among 
many results, it was observed that frailty develops earlier and is more severe compared 
to the general population [4, 5]. The high prevalence of frailty may lead to an increase in 
care intensity, which was evaluated in this study. 
The operationalization of frailty remains controversial and various models for measuring 
frailty have been reported [6]. In general, researchers agree that frailty is a state in which 
older people are more vulnerable to negative health outcomes compared to others of 
the same age [7]. One frequently used operationalization is the frailty index, which is 
based on the non-specific accumulation of deficits [8]. Deficits can be symptoms, signs, 
diseases, disabilities or laboratory measurements as long as they fulfill certain criteria 
(e.g. health and age related) [9]. The frailty index is a robust method, showing validity 
across diverse clinical and community dwelling populations, and has been adapted as a 
useful measure to evaluate health status in older people [6, 10]. We have argued that the 
frailty index is a suitable measure for the ID population [5, 11] and we have confirmed its 
ability to predict adverse health outcome in an older ID population [12, 13].
In the general population, it has been shown that frailty predicts the transition to long-
term or higher care facilities [14-16]. In people with ID, this relation has not yet been 
evaluated. Increase of care intensity is associated with care costs, and insight into the 
financial consequences of frailty can help to raise awareness towards policy makers. Our 
main objective was to study the predictive value of frailty for increase of intensity of 
care during a 3-year follow-up period. Furthermore, we provided an overview of the 
characteristics that are associated with intensity of care (e.g. multimorbidity, level of 
dependence, behavioral problems).
methoDs
Study design and participants
The HA-ID study is a longitudinal study of older adults (50 years and over) with ID [3], 
executed in a consortium of three large formal ID service providers in the Netherlands. 
These service providers offered low to high level of care and support to people with 
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ID. The HA-ID aimed to study the health status of people with ID within three themes: 
(1) physical activity and fitness, (2) nutrition and nutritional state, and (3) mood and 
anxiety. Baseline data collection took place between February 2009 and July 2010. 
Ethical clearance was provided by the Medical Ethics Committee of the Erasmus Medical 
Center Rotterdam (MEC 2008-234) and by the ethics committees of the participating 
care organizations. All clients aged 50 years and over who received care from one of 
the participating care organizations were invited (N = 2322) to participate. Eventually 
1050 clients, or their legal representatives, provided informed consent, forming a nearly 
representative study population for the Dutch population of older adults (aged 50 and 
above) with ID who use formal care, albeit with a slight underrepresentation of men, 
people aged 80 and over, and people living independently. A full description of the 
design, recruitment, representativeness, and diagnostic methods has been published 
elsewhere [3]. A second wave of measurements was collected three years after baseline 
(between February 2012 and August 2013). The follow-up study was approved by the 
Medical Ethics Committee of the Erasmus Medical Center Rotterdam (MEC-2011-309) 
and the ethics committees of the participating care organizations. The participants, or 
their legal representatives, who still received care from one of the care organisations, 
were asked again to provide written informed consent for the follow-up study. 
outcome measures
Client characteristics
Information on age, gender and residential status was collected through the care 
provider services. Residential status was categorised as centralized setting, community-
based setting and living independently with ambulatory support. Level of ID was 
obtained from the scores of psychologists or test assistants, who determined level 
of ID from available IQ tests, Vineland scores and social emotional development. The 
presence of Down syndrome was retrieved from the medical files. Care intensity was 
based on a strictly standardized professional estimation of the required level of care 
and support and, if necessary, on behavioral problems (see section 2.2.2). Information 
on care and support related items were therefore also provided. Multimorbidity was 
defined using a list of 20 chronic conditions, assessed through physical assessment or 
obtained from medical files [17]. To enable comparison with other studies, multimorbid-
ity was defined as the presence of ≥2 and ≥4 comorbid conditions. Severe behavioral 
problems were defined as the presence of automutilation and/or aggressive behavior 
(verbal or physical). To determine the levels of dependence, questionnaires on activities 
of daily living (ADL) and instrumental activities of daily living (IADL) were completed by 
professional caregivers. ADL was assessed with the Barthel Index [18]. It consisted of 10 
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items (feeding, bathing, grooming, dressing, bowels, bladder, toilet use, transfers [bed 
to chair and back], mobility on level surfaces, and mobility on stairs) with two to four 
answer categories. The total ADL score ranged from 0 (completely dependent) to 20 
(completely independent). The Lawton scale was used to measure IADL [19]. The Lawton 
scale consisted of eight items (telephone use, groceries, food preparation, housekeep-
ing, laundry, transportation, medication and finances) with three answer categories 
(not able, able with support, independent). The total score ranged from 8 (completely 
dependent) to 24 (completely independent). 
Care intensity
Information on care intensity was available for all participants, based on long term care 
indications under the Dutch Act on Exceptional Medical Expenses (AWBZ)- a law that 
finances specialized long-term care. For the ID population needing chronic care or sup-
port, eight different care intensity packages (in Dutch = Zorg Zwaarte Pakket [ZZP]) exist 
[20]. Each package is based on how many hours of care per week are required and what 
kind of care and support is necessary. Package 1 offers minimal support while package 8 
offers all-day support and nursing. ZZP 1-ZZP 5 and ZZP 8 are ordinally related in terms 
of care and financing. ZZP 6 and ZZP 7 are specific packages for subgroups needing 
specialized care focused on behavioral problems (Table 1). At the time the baseline mea-
surements took place, ZZP 8 did not yet exist. A transition from ZZP 5 to ZZP 8 during the 
follow-up period was therefore not always related to increase of care need that period. 
table 1. ZZP classification in intellectual disability care (College voor Zorgverzekeringen, 2013; Per Saldo 
2012)
ZZP Content ZZP classification Allocated annual
budget (2013)a 
ZZP 1 VG Residence with minimal support € 30768,-
ZZP 2 VG Residence with support € 36671,-
ZZP 3 VG Residence with support and care € 42040,-
ZZP 4 VG Residence with support and intensive care € 46286,-
ZZP 5 VG Residence with intensive support and intensive care € 59415,-
ZZP 6 VG Residence with intensive support, care and regulation of behavior € 55776,-
ZZP 7 VG Residence (if necessary enclosed) with very intensive support, care and 
regulation of behavior
€ 74530,-
ZZP 8 VG Residence with support and full care and nursing € 65509,-
Note. ZZP (in Dutch = Zorg Zwaarte Pakket) are care intensity packages
a Gross personal budget per person per year without transport costs
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Frailty index
At baseline, frailty was measured with a frailty index, which was developed earlier and 
has been described in detail elsewhere [5]. In short, the frailty index consists of 51 items 
from the baseline measurements of the HA-ID study. A standardized procedure was fol-
lowed to develop the frailty index [9]: all items were (1) related to health, (2) positively 
associated with age, (3) frequently but not too often present in the population ( > 5%, 
< 80%), and (4) measured in at least 70% of the participants. Furthermore, the items did 
not correlate too strongly with each other (r < 0.7), and together the items covered a 
range of health problems (physical, psychological and social). All items were recoded 
between 1 (presence of the deficit) and 0 (absence of the deficit). A frailty index score 
was calculated taking the number of deficits present, divided by 51, resulting in a score 
between 0 and 1. In the case of missing data, the deficit was removed from both the 
numerator and the denominator and the frailty index was calculated with the deficits 
present (at least 30). ZZP classification highly depends on the level of independence. 
The level of independence was incorporated in the frailty index via selected questions of 
the ADL and IADL questionnaires. To estimate the effect of frailty without ADL and IADL 
items, the two ADL-and the five IADL items, originally included in the frailty index, were 
excluded for an additional analysis. 
Statistical analysis
First, an overview of client characteristics was provided per baseline ZZP category. 
Descriptives were provided using means and standard deviations or percentages and 
were analyzed using analysis of variance or the chi-square statistic, respectively. Second, 
average frailty index scores were calculated per ZZP category at baseline and follow-up 
with corresponding 95% confidence intervals (CI). The Spearman’s rho correlation coef-
ficient was calculated for the ZZP categories without behavioral regulation. For the two 
ZZP categories with behavioral regulation an independent sample t-test was performed 
to test the differences between frailty index scores. Third, the association between frailty 
and increase of care intensity during the follow-up was evaluated. Increase of care was 
defined as a higher ZZP at follow-up than at baseline. Only participants that could receive 
a higher ZZP package were included in this analysis. Hereby, participants classified in ZZP 
5 or ZZP 7 at baseline were excluded from this analysis, because they were the highest 
ZZPs in their respective categories. Logistic regression analysis was used to estimate the 
risk of increase care after three years. Curve estimation revealed a non-linear association 
between the frailty index score and increase of care. The exponential model was the best 
model to fit the observations. Therefore the exponent of the frailty index was used for 
the logistic regression analysis. In addition to the exponent of the frailty index (to aid 
interpretation, multiplied by 10), gender, age, Down syndrome and level of ID were in-
corporated into the model. The other baseline characteristics (e.g. multimorbidity) were 
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not incorporated because they are part of the frailty index. To illustrate the exponential 
effect of frailty on increased care intensity, effects of different frailty index score were 
calculated. The intercept and the regression coefficients from the logistic regression 
model were used to calculate ORs for different frailty index scores. Last, a second logistic 
regression model was created using the frailty index without ADL and IADL items. Again, 
the exponent of this frailty index was used, together with gender, age, Down syndrome 
and the level of ID. Multicollinearity limited incorporation of ADL, IADL and the original 
frailty index into one model. All statistical analyses were performed using SPSS statistics 
20.0 for Windows (SPSS, Inc., Chicago, IL, USA). All tests were two-sided and a p-value of 
less than .05 was considered to be statistically significant. 
results
Descriptive statistics
From the 1050 participants at baseline, 287 were no longer available after three years 
because of various reasons: participants were deceased (n = 120); no longer associated 
with the service provider (n = 19); or did not provide informed consent for the follow-up 
study (n = 148). Of the remaining 763 participants, another 87 were excluded because 
they only received day care or ambulatory support (no ZZP classification; n = 22) or had 
unknown ZZP classification at baseline or follow-up (n = 65). Eventually, 676 participants 
were included in the analysis. As shown in Table 2, gender, the presence of Down syn-
drome, level of ID, residential status, mobility, multimorbidity, the presence of severe 
behavioral problems, ADL, IADL, and the frailty index were associated with care intensity 
at baseline. 
Frailty and care intensity
Figure 1 shows the frailty index score for each level of care with corresponding 95% 
CI. The packages without behavioral regulation showed a correlation with the frailty 
index of rs = .66 (p < .001) at baseline and rs = .73 at follow-up (p < .001). At baseline, 
no significant different frailty index score was found for ZZP 6 than for ZZP 7, t(168) = 
0.43, p = .67. At follow-up, a slightly higher frailty index score was found for ZZP 7 than 
for ZZP 6 t(177) = 1.99, p = .048. At baseline, 366 participants received care in ZZP 1 to 
ZZP 4 or ZZP 6, this group was included in analyses of increase of care during follow-up. 
Within this group, 96 (26%) participants were indicated for a higher care package during 
the follow-up period, which was associated with frailty at baseline (Table 3). With each 
segment increase (0.1) in the frailty index, the risk for a higher care intensity at follow-up 
increased exponentially (OR = 1.09, p = .003; Table 3). For example, an individual with a 
frailty index of 0.2 had a 1.29 times higher OR than an individual with the same charac-
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teristics but a frailty index of 0.1, whereas an individual with a frailty index of 0.5 had a 
2.13 times higher OR than an individual with a frailty index of 0.4. 
The frailty index without ADL and IADL items was incorporated into a second logistic 
regression model (data not shown). The exponential frailty index remained a significant 
contributor for increased care need (β = 0.09, SE = 0.03, Wald = 7.38, OR = 1.09, p = .007), 
but the Wald statistics showed a slightly lower relation. 
table 3. Logistic regression models to predict increase of care over a 3-year follow-up period in participants 
classified in ZZP 1 to ZZP 4 or ZZP 6 at baseline
n = 346 Increased care
n = 90
Stable care
n = 256
B (SE) Wald OR p-value
Frailty index 0.24 (0.10) 0.20 (0.09) 0.08 (0.03) 8.83 1.09 .003
Gender (female) 42 (47%) 131 (51%) 0.20 (0.26) 0.59 1.22 .44
Age 61 (8.4) 61 (7.1) -0.01 (0.02) 0.21 0.99 .65
Down syndrome 14 (16%) 22 (8.6%) 0.65 (0.40) 2.62 1.92 .11
Level of ID
Moderate 50 (56%) 150 (59%) -0.02 (0.30) 0.00 0.98 .95
Severe 17 (19%) 21 (8.2%) 0.57 (0.44) 1.65 1.77 .20
Notes. The exponent of the frailty index was used in the logistic regression model, ZZP 
(in Dutch = Zorg Zwaarte Pakket) are care intensity packages, SD = Standard Deviation, OR = Odds Ratio, 
20 participants were excluded because they had unknown frailty index scores (n = 15) or unknown level 
of ID (n = 5). 
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Figure 1. Average frailty index score per care intensity package (ZZP) at baseline and follow-up with corre-
sponding 95% confidence interval. Those classified in ZZP 1-5 and ZZP 8 received increasing care and sup-
port (black bars). ZZP 6 and ZZP 7 are specific subgroups, in which support is accompanied by specialized 
care focused on behavioral problems (grey bars). 
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Discussion
In this study we have shown that care intensity is strongly linked to health, as measured 
with public health measures such as multimorbidity, polypharmacy and frailty. Here, we 
mainly focused on frailty—defined as the accumulation of deficits. People who were frail 
tended to increase their care intensity three years onwards, independent of the level of 
ID, age, gender and Down syndrome. This chance increased exponentially with increas-
ing frailty index scores. The frailty index remained a significant contributor for increase 
of care even when ADL and IADL items were excluded from the frailty index. The care 
intensity packages used to classify the intensity of care are directly related to health care 
costs (Table 1). 
Studies in the general population show that frailty predicts increased health care utili-
zation as measured by institutionalization within a 1 and 5-year follow-up period [21, 
22]. The Tilburg Frailty Indicator score (consisting of physical, psychological and social 
domains) was, cross-sectionally, correlated with required personal care and nursing care 
[15]. Frailty has also been related to an increased risk of ‘poor health outcome’, which 
included either death or admission to a residential care facility or transfer to a higher 
level of residential care [21, 23, 24]. Furthermore, a high frailty index score predicted 
long-term care placement in assisted living residents [16]. In line with these studies, we 
showed that the frailty index was associated with care utilization and was able to predict 
an increase in care intensity and associated health care costs in older people with ID. 
The major strengths of our study are the prospective design and the relatively large 
study population. Nevertheless, our results need to be interpreted with caution. First, 
the association between frailty and increase of care could have been influenced by 
selective drop-out. Earlier results from the HA-ID study showed that those who did not 
provide informed consent for the follow-up period, were on average frailer [13]. Over 
30% (n = 120) of the dropout was caused by the death of the participants. Prior to death, 
health support may have increased, leading to an underestimation of the association 
between frailty and increased care. Similarly, deterioration in health could be a reason 
to refuse participation in the follow-up study. Second, we used a specific Dutch system 
to define intensity of care, which makes international comparisons on a level-by-level 
basis impossible. Nevertheless, the ZZP classification has been centrally implemented 
by law, is a strictly standardized and professional estimation, is used for all Dutch citi-
zens in need of long-term care and provides a maximum rate for the care expenses. As 
such, ZZPs provide estimates of care costs. A major disadvantage for this study was the 
introduction of ZZP 8 during the follow-up period. ZZP 8 was introduced for those who 
required all-day care and nursing. An unknown number of participants who were in ZZP 
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5 at baseline, were transferred to ZZP 8 at the time of its introduction, based on their 
current care needs. For that reason, ZZP 5 had to be excluded from the analysis. Similarly, 
those classified in ZZP 7 could not receive a higher care package and were also excluded. 
As a result, those with the highest levels of care had to be excluded, so this analysis was 
not performed in a representative sample of people with ID. Also, we measured care in-
tensity by ZZP classification only. Although the ZZP packages include a certain amount 
of paramedical costs, additional health care costs on for example hospitalization and 
outpatient hospital visits would provide a better overview of the complete effect of 
frailty on health care costs. Third, our results show that frailty is associated with care 
intensity and that it predicts increase of care. Even so, it is known that both ZZP clas-
sification and frailty are associated with activities of daily living [13, 25]. Frailty remained 
associated to increased care without ADL and IADL items, but this effect was less strong. 
Due to multicollinearity, we were unable to estimate the additional effect of frailty on 
top of the ADL and IADL questionnaires. 
In spite of these limitations, we demonstrated that frailty is a burden for the care system. 
The level of ID and Down syndrome are important predictors for ZZP classification, 
but frailty was the only tested predictor related to increased care during the follow-up 
period. The exponential effect of frailty on care need implies that individuals with high 
frailty index scores are the most likely to increase their care needs. This exponential 
effect was also found for the relation between frailty and mortality in this group. It is 
therefore important to limit the progression of frailty in the relatively fit groups [12]. 
This is underlined by the result that recovering from severe frailty is hard, especially at 
higher age [26]. 
Care costs for people with ID are already high [27, 28]. Because of the increased life 
expectancy [1, 2], these costs will keep growing in years to come. Age-related frailty is 
related to a further increase of care intensity and its associated health care costs —even 
though this study does not provide data on direct care costs. It is therefore important 
that caregivers and policy makers are aware of the high prevalence and (financial) con-
sequences of frailty in people with ID. There is an urgent need to develop, validate and 
implement effective interventions to limit the burden of early frailty. For example, in 
the general population, it has been shown that physical activity and fitness can help to 
delay the onset of frailty [29, 30]. The influence of such interventions on frailty should be 
investigated in people with ID. Previously we showed that older people with low frailty 
index scores were more likely to be independent in their daily activities, showed less 
physical disabilities, had less signs of depression and had less medical problems [31]. 
These characteristics may be used as starting points for the development of interven-
tions.
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abstract
objectives: To analyze the relationship between frailty and survival in older people 
with intellectual disabilities (IDs). Design: Population-based longitudinal observational 
study. setting: Three Dutch care provider services. Participants: Individuals with bor-
derline to profound ID aged 50 and older (N = 982). measurements: A frailty index 
including 51 health-related deficits was used to measure frailty. Mean follow-up was 3.3 
years. The Cox proportional hazards model was used to evaluate the independent effect 
of frailty on survival. The discriminative ability of the frailty index was measured using a 
receiver operating characteristic (ROC) curve. results: Greater frailty index values were 
associated with greater risk of death, independent of sex, age, level of ID, and Down 
syndrome. There was a nonlinear increase in risk with increasing frailty index value. For 
example, compared to the relatively fit (frailty index < 0.20) mortality risk for vulnerable 
individuals (frailty index 0.20–0.29) was 2.17 times as great (95% confidence interval [CI] 
= 0.95–4.95) and 19.5 (95% CI = 9.13–41.8) times for moderately frail individuals (frailty 
index 0.40–0.49). The area under the ROC curve for 3-year survival was 0.78. conclusion: 
Although the predictive validity of the frailty index should be further determined, it was 
strongly associated with 3-year mortality. Care providers working with people with ID 
should be able to recognize frail clients and act in an early stage to stop or prevent 
further decline.
Key words: Frailty, older people with ID, survival
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introDuction
Frailty, which is predictive of early mortality, dependence, and institutionalization in the 
general population, will become a major healthcare challenge [1]. It is not clear whether 
these predictions can be extrapolated to people with intellectual disabilities (ID), inas-
much as lifelong mobility and cognitive limitations could influence the consequences 
of frailty in this population [2]. This study focused therefore on whether frailty predicts 
survival in people with ID.
Neither an agreed-upon definition nor a broadly accepted measurement strategy for 
frailty exists [3]. Nevertheless, experts agree that frailty is a condition in which older 
people are more vulnerable to adverse health outcomes as a result of age-related de-
cline in many physiological systems [1]. In people with ID, frailty has been measured 
using the two most commonly cited frailty instruments: the phenotypic approach and 
the frailty index [4-6]. Both approaches show that frailty is more common in older adults 
(≥ 50) with ID than in the general population [7, 8]. Even so, mobility limitations might 
highly influence the phenotype and therefore not be the most-suitable measure for 
this population [2]. In contrast, the frailty index is a multifactorial measure based on 
accumulation of a broad spectrum of nonspecific age-related impairments (deficits), 
including symptoms, signs, diseases, and disabilities [5, 9]. It has shown predictive valid-
ity in diverse clinical and community-dwelling populations [1, 10].
Although characteristics (e.g., correlation with age, maximum score, and distribution) 
of the frailty index for older people with ID were consistent with frailty indices in other 
populations, the predictive value of the frailty index for adverse health outcomes (e.g., 
death) in people with ID is unknown. Therefore, the aim of this study was to determine 
the predictive validity of the frailty index for survival in people with ID aged 50 and older 
for whom a frailty index was previously calculated [7]. More precisely, the objectives 
were to evaluate the relationship between frailty and 3-year all-cause mortality and to 
analyze differences in subgroups (age categories, sex, Down syndrome, level of ID), to 
estimate the differences in survival probability between different frailty levels, and to 
estimate the accuracy of the frailty index in relation to survival in older people with ID.
methoDs
study design and participants
This is a 3-year follow-up to the Healthy Ageing and Intellectual Disability (HA-ID) 
Study, which aimed to establish the health status of older adults using formal care for 
people with ID in the Netherlands. Details about the recruitment and selection pro-
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cess have been previously published [11]. Briefly, participants were recruited through 
three Dutch care provider services offering a broad spectrum of care, ranging from 
ambulatory support to residential care. One thousand fifty participants constituting a 
near-representative sample of people with ID using formal care in the Netherlands were 
included. Competent clients provided informed consent themselves, and otherwise, 
legal representatives were approached. The medical ethics committee of the Erasmus 
Medical Center Rotterdam (MEC-2008-234) and the ethics committees of the participat-
ing care organizations approved this study.
Data collection
Baseline data were collected between February 2009 and July 2010 in three main 
categories: physical activity and fitness, nutrition and nutritional state, and mood and 
anxiety. Within these categories, a broad diagnostic assessment was performed in ad-
dition to the collection of health records data. Details about the measurement have 
been reported elsewhere [11]. Level of ID was obtained from the records of behavioral 
therapists and psychologists and was classified as borderline (intelligence quotient (IQ) 
70–80), mild (IQ 55–70), moderate (IQ 35–55), severe (IQ 25–35), or profound (IQ < 25). 
The mean follow-up period was 3.3 years (range 0–4.7). All-cause mortality data (months 
until death) were collected through the care organizations up to July 2013. If partici-
pants no longer received care from one of the care organizations, the date and reason 
of relocation were requested.
constructing the Frailty index
Based on baseline data from the HA-ID study, a 51-item frailty index was created us-
ing standardized criteria described previously [12]: the deficit is related to health, the 
deficit’s prevalence increases with age, the deficit does not saturate too early, and all 
deficits together cover a broad spectrum of health. In addition, each deficit had greater 
than 5% prevalence and less than 30% missing values. For each individual, the deficits 
were scored between 0 (deficit absent) and 1 (deficit present). Deficits included activity 
of daily living (ADL) items, social circumstances, diseases, biomarkers, and physical mea-
surements. Detailed information on the selection, diagnostic method, and cut-off values 
of the deficits has been reported elsewhere [7]. A frailty index score was calculated for 
each individual by dividing the total deficit score by the number of deficits measured, 
which resulted in a score ranging from 0 to 1. In general, a larger number of deficits mea-
sured results in a more-precise frailty index. If 30 to 40 deficits are included, it is possible 
to predict adverse health outcomes [10, 12], so participants with fewer than 30 known 
deficits were excluded. Using the terms proposed in the 7-point Clinical Frailty Scale 
[13], the sample was divided into five frailty groups: relatively fit (frailty index score < 
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0.20), vulnerable (frailty index score 0.20–0.29), mildly frail (frailty index score 0.30–0.39), 
moderately frail (frailty index score 0.40–0.49), severely frail (frailty index score ≥0.50).
statistical analysis
Participants who were alive at the end of the study were compared with those lost to 
follow-up and those who had using chi-square (Χ2) tests for categorical data and inde-
pendent sample t-tests for continuous data. Baseline characteristics were then calculated 
for the different frailty groups, and the Spearman log-rank test was used to evaluate 
the mean differences. Next, survival analyses were performed. Data on participants who 
were lost to follow-up were censored for the survival analysis. The proportional hazards 
assumption was assessed using the scaled Schoenfeld residuals and by plotting β(t) for 
the variables against time. The risk for informative censoring was evaluated by analyzing 
the characteristics of those lost to follow-up. Survival curves were generated using the 
Kaplan-Meier estimate. The log-rank test was used to evaluate differences in all-cause 
mortality according to baseline characteristics (age, sex, Down syndrome, level of ID, 
frailty groups). The Cox proportional hazards model was used to evaluate the indepen-
dent effect of frailty index score on survival, adjusted for baseline characteristics. Hazard 
ratios (HRs) and corresponding confidence intervals (CIs) for different frailty levels were 
also calculated. Dummy variables were composed for Down syndrome (presence of 
Down syndrome or unknown status vs no Down syndrome) and level of ID (moder-
ate, severe, profound vs borderline, mild). Then, to measure the accuracy of the frailty 
index in relation to all-cause mortality, a receiver operating characteristic (ROC) curve 
was constructed, and the area under the ROC curve (AUC) was calculated. To account 
for censoring, calculations were based on the nearest-neighbor estimator, which uses 
time-dependent sensitivity, specificity, ROC, and AUC [14]. Youden Index cutoff values 
that maximize the sum of sensitivity and specificity were determined for 3-year survival. 
Statistical analyses were performed using SPSS version 20.0 (SPSS, Inc., Chicago, IL) and 
R version 3.0.0 (R Core Team, Vienna, Austria). A two-sided p < .05 was considered statisti-
cally significant.
results
characteristics
Mean age of the participants was 62 ± 8 (range 50−93), and 51% were male. Mean follow-
up was 3.3 years (range 0–4.7 years). Of 1050 participants in the total cohort, 152 died, 
and 25 were relocated. Those who died tended to be older (t = 6.7, p < .001), more likely 
to have Down syndrome (X2 = 20.3, p < .001), more likely to live in the central residential 
setting (e.g. receiving long-term 24h support; X2 = 23.4, p < .001), and have higher frailty 
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index scores (t = 14.8, p < .001). Seven participants were relocated because their health 
was deteriorating, eleven for other reasons, and seven for unknown reasons. Those who 
were relocated were more likely to live in a community-based residential setting (X2 = 
16.5, p = .002) and more often had Down syndrome (X2 = 6.18, p = .01). In 68 participants, 
there were too many missing data to calculate a frailty index. They did not significantly 
differ from the remaining participants with respect to baseline characteristics. The re-
maining analyses were performed on participants with known frailty index scores.
Frailty groups
Using defined cut points, at baseline, 325 (33.1%) participants were classified as rela-
tively fit, 279 (28.4%) as vulnerable, and 315 (38.5%) as frail (frailty index score ≥0.30). 
Frailer people tended to be older, have greater ID, proportionately more often have 
Down syndrome, have more ADL and instrumental ADL (IADL) disabilities, and have 
more multimorbidities (Table 1).
survival analysis
Scaled Schoenfeld residuals showed that the assumption of the proportional hazard was 
met. The log-rank test showed no significant differences in mortality according to sex (X2 
= 2.54, p = .11) or level of ID (X2 = 4.30, p = .12). Participants with Down syndrome had a 
shorter life expectancy than those without (X2 = 25.9, p < .001). Survival probability was 
lower with older age (X2 = 72.6, p < .001; Figure 1A). Mortality was related to frailty (Fig-
ure 1B), with more than 60% of those with frailty index scores greater than 0.50 dying 
within the follow-up period. Overall, mortality increased nonlinearly with level of frailty 
(Figure 2). In a Cox model that incorporated age, sex, level of ID, Down syndrome, and 
frailty index score as a continuous variable (multiplied by 100 to obtain interpretable 
results), the HR for the frailty index score was 1.08 (95% CI = 1.07–1.10, Wald = 136, p < 
.001). In other words, independent of baseline characteristics, each point (0.01) increase 
on the frailty index resulted in an 8% higher HR. The HR for age was 1.05 (95% CI = 
1.03–1.07, Wald = 20.3, p < .001). The regression coefficients and Wald statistics showed 
that the frailty index was more closely related to survival than was age. A second Cox 
model incorporating baseline characteristics and frailty groups (Table 2) showed that 
mildly frail participants were 8.0 times (95% CI = 3.72–17.3), moderate frail participants 
almost 20 times (95% CI = 9.13–41.8), and severely frail participants 33 times (95% CI = 
14.8–73.9) as likely to have died as relatively fit participants. The AUC illustrated that 
the frailty index predicts 3-year survival with acceptable accuracy (0.78) and an optimal 
cutoff point of 0.3.
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Three-year survival is poorer with higher frailty index values, independent of sex, age, 
level of ID, and Down syndrome. At any time during the follow-up period, significantly 
more participants in the frailty groups died than those classified as relatively fit, al-
though the CIs were wide and overlapped between the categories. Frailty had a stronger 
relationship with mortality than age did.
These results are congruent with reported relationships between frailty index score and 
survival in general population studies, although direct comparison with other studies is 
difficult because of differences in follow-up periods, cut-off values, statistical methods, 
table 1. Baseline Characteristics of the Healthy Ageing and Intellectual Disability (HA-ID) Study According 
to Frailty Status (N = 982)
Characteristic Relatively 
Fit 
(FI < 0.20) 
n = 325
Vulnerable 
(FI = 
0.20–0.29)
 n = 279
Mildly Frail 
(FI = 
0.30–0.39) 
n = 192
Moderately 
Frail (FI = 
0.40–0.49) 
n = 130
Severely 
Frail 
(FI≥0.50)
 n = 56
ρ p-valuea
Age, mean±SD 60±6.2 61±7.7 63±9.3 65±9.3 68±10.5 0.23  < .001
Sex, n (%) 0.05 .16
Male 176 (54.2) 151 (54.1) 83 (43.2) 65 (50) 31 (55.4)
Female 149 (45.8) 128 (45.9) 109 (56.8) 65 (50) 25 (44.6)
Level of ID, n (%)b 0.42  < .001
Borderline 18 (5.5) 7 (2.5) 4 (2.1) 0 (0.0) 1 (1.8)
Mild 115 (35.4) 48 (17.2) 24 (12.5) 14 (10.8) 6 (10.7)
Moderate 167 (51.4) 150 (53.8) 84 (43.8) 50 (38.5) 19 (33.9)
Severe 19 (5.8) 54 (19.4) 45 (23.4) 34 (26.2) 13 (23.2)
Profound 1 (0.3) 12 (4.3) 28 (14.6) 31 (23.8) 17 (30.4)
Down syndrome, n (%)c 0.07 .03
Yes 32 (9.8) 46 (16.5) 30 (15.6) 20 (15.4) 14 (25.0)
No 220 (67.7) 195 (69.9) 140 (72.9) 90 (69.2) 40 (71.4)
Frailty index score, mean±SD 0.14±0.04 0.25±0.03 0.34±0.03 0.44±0.03 0.56±0.05 0.97  < .001
Deceased, n (%) 9 (2.8) 19 (6.8) 35 (18.2) 48 (36.9) 35 (63.5) 0.40  < .001
ADL, mean±SDd 18.4±1.9 15.5±2.9 11.6±4.3 6.68±4.7 2.84±3.47 0.80  < .001
IADL, mean±SDe 15.8±4.9 11.1±3.7 9.39±2.4 8.68±1.8 8.20±0.62 0.67  < .001
Multimorbidity, n (%)f 55 (16.9) 124 (44.4) 137 (71.3) 108 (83.1) 55 (98.2) 0.54  < .001
aDifferences between the frailty groups assessed with the Spearman’s Rho
bData on level of intellectual disability (ID) were not available for 21 participants.
cData on presence of Down syndrome were not available for 155 participants.
dAssessed using the Barthel Index; range 0 (completely dependent) to 20 (completely independent) [29]
eAssessed using the Lawton scale; range 8 (completely dependent) to 24 (completely independent) [29]
fAssessed using a list of 20 chronic conditions and defined as presence of ≥4 morbid conditions [30].
SD = standard deviation
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selection of frailty index items, and populations. If frailty is analyzed on a continuous 
scale, studies in the general older population show that, with each deficit increase, the 
risk of death rises by 1% to 8% [15]. The current study found an 8% greater risk of death 
with each 0.01-point increase in frailty index score, although there was a nonlinear rela-
tionship between the HR for mortality and frailty index score. In other words, if the frailty 
index score was high, additional deficits strongly decreased the chances of survival, 
whereas additional deficits had less effect in participants with low frailty index scores. 
The slope between survival time and survival probability was consistently steeper for 
participants with high frailty index scores than for those with low frailty index scores, 
which has also been observed in the general population [16,17]. The nonlinear relation-
ship between frailty and mortality made the frailty subgroup analysis more applicable to 
the current study’s dataset than analyzing continuous frailty index score, although the 
frailty index was designed to be used on a continuous scale, and validated cut-off points 
to classify frail and nonfrail individuals do not exist. Nevertheless, different groups can 
be created to compare different health states, as has been done before [17-20], although 
these values remain arbitrary.
A difference between the current study results and previously reported studies is that 
the current study found greater risk of mortality for those classified as at least mildly 
frail (frailty index score ≥0.30), whereas in the general population, the frailty index 
already discriminates mortality risk in frailty subgroups with scores below 0.30 [15, 
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50-59 years (n = 458) 
60-69 years (n = 344) 
70-79 years (n = 156) 
80+ years (n = 24) 
 
Relatively fit (FI-score < 0.2; n = 325) 
Vulnerable (FI-score 0.2-0.3; n = 279) 
Mildly frail (FI-score 0.3-0.4; n = 192) 
Moderate frail (FI-score 0.4-0.5; n = 130) 
Severely frail (FI-score > 0,5; n = 56) 
Figure 1. Kaplan-Meier survival curves stratified according to age categories (A) and frailty subgroups (B). 
(A) The youngest participants (upper line, solid black; 50–59) had the highest survival, the oldest partici-
pants (lowest line, long hash, light gray; ≥80) had the lowest, and the other age categories were in between. 
(B) Relatively fit participants (upper line, solid black; FI score < 0.20) had the highest survival, severely frail 
(lowest line, long dash light gray, FI score ≥0.50) had the lowest, and vulnerable (FI score 0.20–0.29), mildly 
frail (FI score 0.30–0.39), and moderately frail (FI score 0.40–0.49) were in between.
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21-23]. Similarly, mortality does not seem to increase before the frailty index score is 
0.20 or greater. There seems to be a threshold that limits the frailty index to predict 
mortality at low scores, suggesting that older people with ID can manage a number of 
defi cits before their mortality risk increases. It could be that lifelong disability has lower 
prognostic signifi cance than disabilities acquired in later life. Even so, more than twice 
as many participants in the vulnerable (frailty index score ≥ 0.20–0.29) group died as in 
the relatively fi t (frailty index score < 0.20) group.
These results need to be interpreted with caution. First, although frailty was measured 
in 982 participants, which is the largest frailty study in people with ID, this is fewer than 
in many other studies. Nevertheless, construct validity and characteristics of the frailty 
index were found to be similar to the general public (e.g., maximum frailty index score, 
frequency distribution, relationship with age independent of the items used to construct 
Figure 2. Frailty index score in relation with the log hazard ratio stratifi ed for gender and the presence 
of Down syndrome using centered age and mild level of ID. Dashed lines represent the 95% confi dence 
intervals.
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the frailty index) [7]. Second, it was not possible to study the trajectories of frailty be-
cause it was measured only at baseline, so it remains unknown whether people recover 
or become frailer over time. Third, at least seven participants were lost to follow-up 
because of poor health. It is therefore likely that these participants were lost to follow-
up for reasons related to time of death, so censoring might have been informative. This 
could have led to an underestimation of the predictive value of the frailty index. Even 
so, because major differences were not found between participants who were lost to 
follow-up and the remaining participants, and only a small number of participants were 
involved, it is likely that the influence was limited. Fourth, a very high HR was found 
for the moderately and severely frail compared with the relatively fit. These numbers 
may have been inflated because of the small number of cases in the relatively fit group. 
Last, more-severe intellectual disability was related to lower mortality risk. A possible 
explanation could be that there is a survival effect in the population, that only relatively 
fit people with severe ID reach the age of 50. In addition, those with more-severe ID may 
live in a more-protective environment, with ample care and support.
Trials and longitudinal observational studies have shown that frailty is a dynamic pro-
cess and might be reversible [1, 20, 24-26]. These studies emphasize the importance of 
instruments that can adequately identity frail individuals. The frailty index, as used in 
the current study, might not be applicable in clinical practice because of the extensive 
table 2. Multivariate Survival Analyses of Frailty in Relationship to Survival: Cox Regression Analyses for 
Time Until Death (N = 961)
Covariate B (Standard Error) Wald Statistic p-value Hazard Ratio (95% 
Confidence Interval)
Age 0.05 (0.01) 18.5  < .001 1.05 (1.03–1.07)
Female –0.54 (0.18) 9.25 .002 0.59 (0.41–0.83)
Down syndrome 45.0  < .001
Present 1.53 (0.23) 44.8  < .001 4.61 (2.95–7.22)
Unknown 0.56 (0.26) 4.57 .03 1.75 (1.05–2.92)
Level of ID 13.0 .02
Moderate –0.53 (0.23) 5.32 .021 0.59 (0.37–0.92)
Severe –0.96 (0.27) 12.9  < .001 0.38 (0.23–0.65)
Frailty Index 119.8  < .001
Vulnerable 0.77 (0.42) 3.38 .07 2.17 (0.95–4.95)
Mildly frail 2.08 (0.39) 28.3  < .001 8.02 (3.72–17.3)
Moderate frail 2.97 (0.39) 58.7  < .001 19.5 (9.13–41.8)
Severely frail 3.50 (0.41) 72.5  < .001 33.0 (14.8–73.9)
Of the 982 with known frailty index scores, 21 were excluded from the analyses because their level of 
intellectual disability (ID) was unknown.
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and complex data collection required. Nevertheless, as part of routinely collected data, 
the frailty index, or a modified version, may be clinically applicable, as has been shown 
in the general population [27,28]. Even so, this option needs to be further explored, 
and the validity, reliability, and sensitivity of the adapted version need to be tested. 
Furthermore, it is necessary to study which modifiable factors contribute to frailty or 
can protect people against becoming frail. Some important characteristics (e.g., no 
mobility limitations) of the least-frail older people with ID have previously been shown 
[18]. Eventually, knowledge of these factors and a valid screening instrument can help 
to monitor and prevent or delay frailty in this population. 
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abstract
objectives: To compare the ability of two frequently used frailty approaches, the 
frailty index and the frailty phenotype, to accurately predict 3-year all-cause mortality in 
people with intellectual disabilities (ID). Furthermore, the influence of motor disabilities 
on the predictive ability of the two instruments was established. Design: Three-year 
prospective study. setting: Dutch care provider services offering care and support to 
people with ID. Participants: 1050 elderly people aged 50 years or over with an intellec-
tual disability. measurements: The frailty phenotype and the frailty index were used to 
assess frailty at baseline. The feasibility and mutual agreement (kappa statistics) of the 
approaches were calculated. Furthermore, adjusted risks of three-year all-cause mortal-
ity were estimated (Cox proportional hazard model). results: The frailty index could be 
applied to a larger part of the dataset (94%) than the frailty phenotype (81%). There was 
a slight agreement between the approaches (kappa = 0.3). However defined, frailty was 
related with mortality in people with ID. Nevertheless, the frailty index showed a higher 
discriminative ability and a stronger relation with mortality than the frailty phenotype, 
especially when adjusted for motor disabilities. conclusion: The wide range of factors 
included in the frailty index seems to be more important to predict negative health 
outcomes than physical parameters alone (frailty phenotype).
Key words: Frailty, people with ID, Frailty index, Frailty phenotype, Predictive accuracy, 
Agreement
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introDuction
Frailty is a complex cascade that involves several age-related physiological alterations, 
eventually leading to loss of function and failure to response to a stressor event [1]. Lon-
gitudinal observational studies and trials have shown that frailty is a dynamic process 
and might be reversible by interventions [1-4]. These results emphasize the importance 
of early identification of frail individuals. Several frailty measures emerged in recent 
years. Which one can best be used for people with early disabilities, such as people with 
intellectual disabilities (ID) is however unknown. This paper aims to shed light on this 
void of knowledge. 
The frailty ‘phenotype’ by Fried and colleagues [5], and the frailty index developed by 
Rockwood and Mitnitski [6, 7] are the most evaluated and most frequently used frailty 
instruments [8]. The first is based on five core clinical features that together form the 
frailty phenotype [5]. The second approach is based on a-specific accumulation of 
health problems (deficits). Where the frailty phenotype is based on pre-defined physical 
variables, the frailty index focuses on the total number of deficits in an individual and 
pays less attention to the exact nature of the problems. Both measures have been ap-
plied in several populations and have shown predictive validity in terms of survival and 
health indices [8-10]. A number of studies showed that the frailty index has a somewhat 
stronger relation with negative health outcomes than the phenotype approach [11-15]. 
These results can however not directly be applied to people with ID, because their life-
long disabilities (e.g. motor and sensory disabilities, comorbidities, cognitive limitations) 
can influence both the development and the consequences of frailty [16]. Previously, 
the frailty phenotype and the frailty index approach were applied to a population of 
older people with ID in the Healthy Ageing and Intellectual Disabilities (HA-ID) study. 
Both instruments showed a higher prevalence of frailty in people with ID compared to 
the general population of the same age [17, 18]. The frailty index was able to predict 
mortality, and increased of disabilities over a three-year follow-up period [19-21]. It was 
observed that, according to the frailty phenotype, those with mobility limitations were 
10 times more likely to be frail than those without mobility limitations. Therefore, as 
hypothesized previously, it could be that lifelong motor disabilities in this population 
limit the predictive validity of this approach [16]. However, the predictive validity of the 
frailty phenotype was not previously evaluated in people with ID.
Information on which method can best be applied in the ID population, can help to 
select individuals at risk for negative health outcomes. The purpose of the present study 
was therefore to assess the feasibility of the frailty phenotype and the frailty index and 
168 Chapter 10
to calculate their agreement. Furthermore, the ability of the frailty phenotype and the 
frailty index to predict 3-year all-cause mortality was evaluated. In addition, we assessed 
the influence of motor disability on the predictive ability of the two instruments. 
materials anD methoDs
study design and participants
This study was part of the HA-ID study. This study addressed the health of 1050 older 
people with ID in the Netherlands. Details about the recruitment and selection process 
have been described elsewhere [22]. Briefly, the study population consisted of clients, 50 
years and over, from three Dutch care provider services offering a broad spectrum of care 
and support to people with ID. All clients aged 50 years and over (N = 2322) were invited 
to participate. Eventually 1050 clients, or their legal representatives, provided informed 
consent, forming a nearly representative study population for the Dutch population of 
older adults (aged 50 and above) with ID who use formal care, albeit with a slight un-
derrepresentation of men, people aged 80 and over, and people living independently. 
Ethical clearance was provided by the Medical Ethics Committee of the Erasmus Medical 
Center Rotterdam (MEC 2008-234) and by the ethics committees of the participating 
care organizations. 
Data collection
Baseline data were collected between February 2009 and July 2010 within three main 
themes: (1) physical activity and fitness, (2) nutrition and nutritional state, and (3) mood 
and anxiety. Within these themes the participants underwent an extensive diagnostic 
assessment including a physical assessment, a fitness test battery, several questionnaires 
(regarding e.g. nutrition, depression, disabilities), and laboratory tests in the addition to 
the collection of health records data. Data on age, gender and residential status were 
collected through the care provider services. Level of ID was obtained from the scores 
of psychologists or test assistants. The diagnosis of Down syndrome was retrieved from 
medical files. Up to July 2013, all-cause mortality data (time of death) were collected 
through the care organizations. 
Frailty phenotype
Previously, frailty phenotype was applied using the criteria of the Cardiovascular Health 
Study [5, 17]. According to these criteria an individual should be classified as frail if 
at least three of the following five are present: weight loss, weakness, slowness, low 
physical activity, and poor endurance or exhaustion. Briefly, weight loss was defined 
as losing more than 3 kg within 3 months. Weakness was assessed using a handgrip 
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dynamometer (Jamar Hand Dynamometer [#5030J1, Sammons Preston Rolyan, Dol-
geville, NY]). Slowness was assessed using comfortable walking speed, measured as the 
average of three recordings of the time to complete a distance of 5 meter. Participants 
in a wheelchair and participants unable to perform the walking test due to physical 
limitations were also classified as having a slow walking speed. Low physical activity 
was defined as walking fewer than 5000 steps/day measured with pedometers (NL-1000; 
New Lifestyles, Lees Summit, MO). Participants in a wheelchair and participants unable 
to perform the test due to physical limitations were also classified as having low physical 
activity. Exhaustion was defined as answering ‘moderate problem’ or ‘severe problem’ to 
the ‘lacks energy’ item from the Anxiety, Depression and Mood Scale [23]. Individuals 
with one or two criteria present were classified as pre-frail. Individuals with no criteria 
present were classified as non-frail or ‘robust’. At least three out of five criteria needed to 
be known before the frailty phenotype could be applied. 
Frailty index
A frailty index was previously created with 51 baseline items from the HA-ID study 
[18]. A standardized procedure was followed to develop the frailty index [24]: all items 
were (1) related to health, (2) positively associated with age, (3) frequently but not too 
often present in the population ( > 5%, < 80%), and (4) measured in at least 70% of the 
participants. Furthermore, the items did not correlate too strongly with each other (r < 
0.7), and together the items covered a range of health problems (physical, psychological 
and social). All items were recoded between 1 (presence of the deficit) and 0 (absence of 
the deficit). Individual deficits and their cut off values are available elsewhere [18]. The 
frailty index score was calculated as the total number of deficits present as a proportion 
of those counted (e.g. 12 deficits in a 51-item frailty index results in a frailty index score 
of 12/51 = 0.24). In the case of missing data, the deficit was removed from both the nu-
merator and the denominator, but at least 30 deficits were required per individual. The 
frailty index is a continuous measure allowing to stratify people by their risk of adverse 
outcomes in as many groups as the data permits [25]. However for the sake of direct 
comparisons with Fried phenotype, we used previously identified cut points: a frailty 
index of less than 0.2 was considered as non-frail or ‘robust’, a score between 0.2-0.35 as 
‘pre-frail’, and a score above 0.35 as ‘frail’ [11, 12]. 
statistical analysis
First, baseline characteristics (gender, age, level of ID, presence of Down syndrome), the 
mean frailty index score and the percentage of non-frail, pre-frail and phenotypic frail 
participants were provided as the percentage for categorical variables and the mean 
(with SD) for continuous variables. Second, the feasibility of the instruments was analyzed 
by calculating the percentage of participants able to complete the frailty assessments. 
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A non-response analysis was performed to compare the participants with and without 
completed data for frailty, using a Pearson Chi-square for categorical data and ANOVA 
for continuous data. Third, the Cohen’s Kappa statistic was used to estimate agreement 
between the instruments. For this analysis the categorized frailty index was compared 
with the frailty phenotype (e.g. non-frail, pre-frail, frail). Agreement was considered as 
poor for Kappa values lower than 0.21, slight for 0.21-0.40, moderate for 0.41-0.60, good 
for 0.61-0.80, and excellent for values 0.81-1 [26]. Fourth, the ability to predict 3-year all-
cause mortality was calculated for both instruments and compared to each other in two 
different ways. In the first analyses, the hazard ratio’s (HR) for mortality were calculated 
for the frailty phenotype and for the categorized frailty index in separate Cox regression 
models. Dummy variables were composed for the pre-frail and frail groups to compare 
their mortality risk with the non-frail group. A comparative analyses was performed 
by including both frailty instruments in the same Cox regression model. This analysis 
was repeated with a frailty index that excluded the criteria that were also used for the 
frailty phenotype. In other words, the deficits walking speed, grip strength, fatigue 
and weight loss were excluded from the frailty index. All models were adjusted for age 
(years), level of ID (with dummy variables for moderate and severe/profound), gender 
and the presence of Down syndrome. A receiver operating characteristics (ROC) curve 
was constructed and the area under the ROC curve (AUC) was calculated to measure the 
discriminative ability of the instruments in relation to survival. These calculations were 
based on the Nearest Neighbor Estimator, which uses time-dependent ROC and AUC, 
to account for censoring. Because the frailty index is not meant to be categorized, and 
forced boundaries may reduce its precision, we performed a second analysis. The rela-
tion between the continuous frailty index and mortality within each strata of the frailty 
phenotype was assessed. Again, these models were adjusted for age, level of ID, gender 
and the presence of Down syndrome. Within each stratus the AUC was calculated. Fifth, 
the influence of motor disability was assessed by including motor disability in a Cox 
regression model. For all survival analyses the data on participants who were lost to 
follow-up were censored and the proportional Hazards assumption was tested with the 
scaled Schoenfeld residuals. Statistical analyses were performed using SPSS version 20.0 
and R version 3.0.0. A two-sided p-value of < .05 was considered significant. 
results
sample characteristics
The mean age of the study population (n = 1050) was 61.6 (SD = 8.0). Nearly half of 
them were female (n = 511, 49%), nearly half of them had a moderate level of ID n = 506 
(48%), and 14% (n = 149) was diagnosed with Down syndrome. According to the frailty 
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phenotype, 230 (27%) were classified as non-frail, 508 (60%) as pre-frail, and 110 (13%) 
as frail. The mean frailty index score was 0.27 (SD = 0.13). 
Feasibility
Less than a third of the participants (n = 307, 29%) could complete the full frailty phe-
notype assessment as intended. By including all participants with at least three known 
frailty phenotype criteria, the frailty phenotype could be applied to 848 (81%) partici-
pants. The 202 excluded participants were on average more intellectually disabled (X2 = 
32.8, p < .001), and had on average a higher frailty index score (M = 0.31, SD = 0.12) than 
those included ([M = 0.27, SD = 0.13], t(982) = 3.28, p = .001). For other baseline charac-
teristics no significant differences between the included and excluded participants were 
found. In 68 participants, there was too much missing data to calculate a frailty index. 
There were no significant differences between the participants with a known frailty 
index score (n = 982, 94%) and those without, with respect to gender, age, level of ID 
and Down syndrome. 
agreement
For 838 participants the frailty phenotype and the frailty index were known. The Cohen’s 
Kappa agreement between the categorized frailty index and the frailty phenotype was 
0.30, corresponding with slight agreement. Four hundred sixty four out of 838 (55%) of 
the participants were identically categorized by both methods (Table 1). 
survival
First, survival analyses were performed for the three frailty states (non-frail, pre-frail, 
frail). Table 2 shows the HR’s for pre-frail and frail individuals, using the non-frail state 
as a reference group. However defined, frailty was significantly related to mortality. 
Those classified as pre-frail or frail using the frailty phenotype were, respectively, 2.40 
and 5.16 times more likely to die during the follow-up period than those classified as 
non-frail. Those classified as pre-frail or frail with the frailty index, were respectively 
3.26 and 16.0 times more likely to die than the non-frail group. If both instruments 
were included in one Cox regression model, the frailty phenotype did no longer predict 
table 1. Agreement among the frailty index and the frailty phenotype based on three frailty categories. 
n = 838 Frailty phenotype
Non-frail Pre-frail Frail Total
Frailty index Non-frail < 0.2 151 146 2 299
Pre-frail 0.2-0.35 68 232 27 327
Frail > 0.35 5 126 81 212
Total 224 504 110 838
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mortality, whereas the frailty index did. If all frailty phenotype items were excluded from 
the frailty index, virtually the same results were obtained. Although the HR for the frailty 
phenotype groups slightly increased, they remained not significant (data not shown). 
The ROC curve showed that the categorized frailty index had a higher discriminative 
ability in relation to all-cause mortality (AUC = 0.78) than the frailty phenotype (AUC 
= 0.64). The advantage of the frailty index is that it is an interval measure, not a point-
measure. Therefore we also looked at the original, continuous scaling, within the strata 
of the three levels of the frailty phenotype. Within these strata, participants with high 
frailty index score had worse survival than those with low frailty index scores (Table 3). In 
addition, the AUC within the strata showed that the frailty index has was still an accurate 
measure to predict mortality. 
motor disability and frailty
Information on mobility was known for 989 participants. At baseline, 731 (74%) partici-
pants walked independently, 151 (15%) walked with support and 107 (11%) were wheel-
chair dependent. Those who walked with support were 2.31 (95%CI = 1.96-3.18, Wald = 
14.3) times, and those who were wheelchair dependent 4.32 (95%CI = 2.81-6.66, Wald = 
44.2) times, more likely to have deceased during the follow-up compared to those who 
walked independently. The last column in Table 2 shows the relation of the two frailty 
approaches with survival, independent of motor disability at baseline. Although both 
approaches remain significantly related with mortality, the frailty phenotype loses much 
of its predictive value. 
table 2. Hazard ratio’s for 3-year all-cause mortality according to the three level frailty index and frailty 
phenotype. 
Frailty 
measure
Single frailty instrument Both frailty instruments Motor disability
Status HR (95%CI) Wald p HR (95%CI) Wald p HR (95%CI) Wald p
Frailty 
phenotype
Pre-frail 2.40 (1.26-4.61) 6.99 .008 1.24 (0.60-2.56) 0.33 .56 1.97 (1.01-3.82) 3.97 .046
Frail 5.16 (2.54-10.5) 20.6  < .001 1.26 (0.56-2.83) 0.32 .57 2.73 (1.26-5.92) 6.44 .011
Frailty 
index
Pre-frail 3.26 (1.54-6.88) 9.56 .002 2.79 (1.26-6.20) 6.35 .012 3.15 (1.49-6.68) 8.98 .003
Frail 16.0 (7.69-33.2) 55.1  < .001 14.1 (6.18-32.3) 39.5 < .001 13.1 (6.09-28.2) 43.3  < .001
Note. HR = hazard ratio, CI = confidence interval, the non-frail state was used a reference category for each 
frailty instrument. All models were adjusted for age, gender, level of ID, and Down syndrome. The model 
motor disability was adjusted for the level of motor impairment, ‘no walking impairment’ was used as a 
reference category. 
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Discussion
We compared two approaches to frailty, the phenotype of frailty and the frailty index, 
in people with ID. However defined, frailty was related with mortality in people with ID. 
Nevertheless overall, the frailty index was more often applicable and showed a stronger 
relation with mortality than the frailty phenotype, specifically after adjustment for mo-
tor disability. Previously, we suggested that the frailty index might be a more suitable 
approach for this population because of lifelong disabilities [17]. The current results 
confirm this suggestion.
The frailty index could be calculated for 94% of the participants, whereas the frailty 
phenotype was applicable to 81%. For less than a third of the participants, all frailty 
phenotype criteria could be measured. This is in agreement with results from studies 
among assisted-living participants, where nearly 40% could not complete the assess-
ment [13, 27]. Dropout for the frailty index appeared to be random, whereas for the 
frailty phenotype, selective dropout was observed: those who dropped out were on av-
erage more intellectually disabled and had higher frailty index scores. These results are 
in line with results observed in the general population: persons in whom the phenotype 
cannot completely be measured are more likely to die, significantly more disabled, have 
more chronic diseases and have a higher frailty index score [28, 29]. In accordance with 
findings in the general population, we found that the predictive value of the frailty index 
is stronger than that of the frailty phenotype [11-15]. There are several explanations for 
these results. 
First, the frailty index has a much broader approach than the frailty phenotype. It 
may include all factors that are considered important for frailty (e.g. nutritional status, 
physical activity, energy, cognition) [9, 30]. Contrary, the frailty phenotype focuses on 
physical frailty only. It appears that, among the highly heterogeneous ID population, 
physical parameters do only explain part of the variance. In other words, the risk for a 
table 3. Characteristics of the frailty index within each phenotypic stratum
Non-frail 
n = 224
Pre-frail
n = 504
Frail
n = 110
Mean FI-score (SD)
FI-score Range
0.17 (0.08)
0.04-0.53
0.28 (0.11)
0.06-0.61
0.43 (0.11)
0.18-0.69
Deceased n (%) 10 (4.3%) 72 (14%) 37 (34%)
HR (95%CI) 1.14 (1.06-1.23) 1.11 (1.08-1.13) 1.06 (1.02-1.10)
AUC 0.67 0.77 0.72 
Note. FI = frailty index, SD = standard deviation, HR = Hazard ratio, AUC = Area under the curve, CI = Confi-
dence interval
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negative health outcome is better predicted by including a broad spectrum of health 
aspects. Second, and in line with the first suggestion, the frailty phenotype seems to be 
too determined by mobility limitations. Indeed, the frailty phenotype had only limited 
additional predictive value to motor disabilities alone. This limits the predictive value of 
the frailty phenotype, because motor disabilities appear to be less strong predictors for 
mortality than observed in the general population [31, 32]. Lifelong or early motor im-
pairment, which is common in this population, is likely to be less predictive than motor 
impairment acquired in later life. Third, the phenotype approach has the advantage that 
it focuses on five core clinical features, that are, in theory, easy to measure. Neverthe-
less, these pre-defined elements are not measurable in all individuals with an ID. This 
appears less of a problem with the frailty index approach, which does not require the 
use of a pre-defined set of variables, or even the same number of variables [33]. We were 
therefore able design a frailty index for the ID population, whereas the elements of the 
frailty phenotype are designed for the general population. Fourth, we were unable to 
apply the exact parameters as those proposed in the Cardiovascular Health Study to 
measure the frailty phenotype. This could have led to an unknown shift in its predictive 
validity. In addition, the analysis was applied to participants with at least three elements 
of the frailty phenotype measured. It is likely that this caused an underestimation of the 
true frailty prevalence. Measurements that are more feasible for the ID population could 
have increased the predictive validity of the frailty phenotype. For example, it is known 
that physical activity is hard to measure with pedometers in people with ID [34]. Using 
an instrument such as the StepWatch or GPS could have led to more valid results for the 
element ‘physical activity’ (Schijndel-Speet et al., unpublished results). 
Nevertheless, overall the frailty phenotype showed a strong relation with mortality, 
indicating that physical fitness and mobility are important to lengthen lifespan. It has 
shown in the HA-ID study that elements from the frailty phenotype (e.g. grip strength, 
walking speed) predict disability in mobility and activities of daily living [35]. In the 
general population, physical activity and fitness can reduce or prevent frailty [36, 37]. 
Whether increased physical fitness and activity will also reduce or delay frailty in people 
with ID needs to be investigated. 
The main strength of our study is its large scale and prospective population-based de-
sign, whereas we used standardized and internationally accepted methods to measure 
frailty. Nevertheless, several limitations need to be taken into account. First, our results 
may not apply to all people with ID. Our study did not include older people with ID who 
do not receive formal care or support. Furthermore, there was a slight underrepresenta-
tion of people with severe or profound ID, people above the age of 80 and males [22]. 
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In conclusion, these results imply that the frailty index is a better approach to measure 
frailty than the frailty phenotype in the population of older people with ID. The wide 
range of frailty factors included in the frailty index are more predictive than physical 
parameters alone. Future research needs to focus on the clinical applicability of the 
frailty index. Particularly, it should be studied whether routinely collected data can be 
used to construct a frailty index for people with ID.
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introDuction
During the past two years, we have reported about our subsequent steps in the develop-
ment of a frailty measurement for people with intellectual disabilities (ID), its predictive 
validity for adverse health outcomes, and the distribution of frailty in this population 
with lifelong disabilities. We performed this work because of the lack of comprehensive 
insight into the effect of ageing on health aspects in this group. Although premature 
ageing and its genetic basis have been established in people with Down syndrome, 
there was no evidence indicating a more rapid aging process in those with other causes 
of ID. The aging process in people with ID was never described in terms of known aging 
mechanisms. 
One method to study aging is trough frailty, a state of increased likelihood of adverse 
health outcomes [1]. We were not certain that the concept of frailty would apply to 
people with early disabilities in the same way as to the general population. Indeed, 
given the characteristics of the population, it could be that once we would have an ap-
plicable diagnostic measure, a majority would be found frail. In that case, frailty would 
not appear a distinctive concept in this population. The relationship between frailty and 
disability, intensively discussed for the general older population [2, 3], seemed to us 
even more complicated for a population with early disabilities. Because, in that case, 
disabilities can be life-long and are more likely to result in frailty than be a result of 
frailty, as seen in the general population [2-4]. 
The Healthy Ageing and Intellectual Disability study (HA-ID) among older participants 
with ID, producing a wealth of data on a broad range of health aspects, offered an op-
portunity to start and investigate the concept of frailty in this group, addressing the 
following comprehensive questions: 1. Is it feasible to measure frailty in people with 
ID?, 2. How frail are people with ID compared to people from the general population?, 
3. Does frailty predict deterioration of health and (relative) independence in the same 
way as it does in the general population?, and 4. Which characteristics are associated 
with frailty? In this review, we will critically consider all outcomes of this study and their 
implications for clinical practice and for future research.  
healthy ageing anD intellectual Disability stuDy
The frailty study was embedded in the HA-ID study, a population-based study on the 
health of 1050 people with ID, aged 50 years and over. All clients receiving care or sup-
port from three care organizations were invited to participate. The participation rate was 
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45% (1050/2332). Assessments included physical examinations, mealtime observations 
of swallowing, nutritional questionnaires, screening questionnaires and standardized 
psychiatric interviews for depression and anxiety, questionnaires on life events, quality 
of life, IADL, ADL, mobility, dementia, social circumstances, and laboratory tests as well 
as the collection of data from the medical and location files. Further information about 
the HA-ID study is available elsewhere [5]. Three years after the baseline measurements, 
all participants were invited for a follow-up study. To limit the burden of participants, 
information was gathered from files or by proxy questionnaires, without client interfer-
ence. From the 1050 participants, 19 moved and 120 were deceased. From the 911 that 
were invited, 84% (n = 763) provided informed consent for participation. 
Frailty was measured with the two internationally most frequently used approaches [6]: 
the frailty ‘phenotype’ developed by Fried and colleagues [7], and the frailty index devel-
oped by Rockwood and Mitnitski [8]. The frailty phenotype is based on five clinical core 
features (unintended weight loss, weakness, slowness, low physical activity, and poor 
endurance or exhaustion). Participants with at least three of these features are defined 
as frail, participants with one or two are considered pre-frail and participants with none 
are called robust. In contrast, the frailty index is a quantitative measure of frailty, based 
on non-specific accumulation of impairments (deficits). These deficits can be symptoms, 
signs, diseases, disabilities or laboratory measurements [8, 9]. Although the content of 
a frailty index is flexible, deficits need to adhere to several rules. A deficit can only be 
included if (1) the deficit can be considered an aspect of health, (2) the deficit is associ-
ated with age, (3) the deficit does not saturate too early or be very rare, (4) together, the 
deficits must cover different health aspects, and (5) at least 20-30 deficits are considered 
[8, 10]. The HA-ID dataset provides over 400 possible deficits, of which 51 fulfilled all in-
clusion criteria and together formed our frailty index [11]. The deficits included a broad 
spectrum of objective measurements (e.g. grip strength, walking speed, serum glucose), 
informer reports (e.g. fatigue, depression symptoms, dressing) and medical information 
(e.g. medication use, general hospital admission, asthma).
recaPitulation oF the results 
Is it feasible to measure frailty in people with ID and how frail are people with ID compared 
to people from the general population?
Both applied frailty approaches were able to identify different levels of frailty: we did 
not find a ceiling effect of frailty in the population people with ID. The characteristics 
of the frailty index for people with ID were comparable to those obtained in the gen-
eral population: positively skewed distribution, correlation with age and an observed 
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maximum score around 0.7 [8, 9, 12]. Furthermore, the index’s correlation with age was 
not influenced by the choice of the deficits, which shows structural validity. There is 
no strict, validated cut off value to determine the prevalence of frailty, but the score is 
used on a continuous scale. Our results showed that the average frailty index score for 
people with ID was 0.27, equivalent to the prevalence of 14 out of 51 deficits. Results 
from general elderly populations usually show a mean score between 0.08 and 0.17 [8, 
9, 13, 14]. We compared our results directly to a general European population (50+) and 
observed that people with ID accumulate more deficits and that this accumulation starts 
at much younger age [14]. Although the frailty index was clearly able to show differ-
ences in frailty levels, we did not detect any person that had no deficits at all, in other 
words belonged to the so-called zero-state [15]. Additionally, only few (6.6%) could be 
classified as ‘least frail’ (frailty index score ≤ 0.10), whereas in the general population this 
percentage ranges between the 43 and 76% [14-16]. According to the frailty phenotype, 
11% of those aged 50-64 years, and 18% of those aged 65 years and over were frail 
[17]. Compared to the general population (7-9% of those aged 65 years and over were 
found to be frail), these percentages are rather high, especially for those aged 50-64 
years [7, 18, 19]. We conclude that frailty can be measured in people with ID, using exist-
ing instruments. The distribution of frailty of the 50+ ID population is comparable with 
the 70+ general population. Compared to the general 50+ population frailty seems to 
start earlier and with higher average frailty index scores. There is an increased health risk 
from a young age onwards compared to the general population. The question remained 
whether frailty would show the same predictive value as observed in the general popula-
tion, because lifelong impairments could have led to early rehabilitations or habituation. 
Does frailty predict deterioration of health and independence? 
The most frequently used adverse outcome measure to validate frailty instruments 
is mortality. We found that, however defined, frailty predicts mortality in people with 
ID during 3 years, but the frailty index showed a stronger relation with mortality, espe-
cially after adjustment for motor disability (Schoufour et al., accepted; Schoufour et al., 
submitted). People classified as pre-frail or frail according to the frailty phenotype, were 
respectively 2.4 (CI = 1.26-4.6) and 5.2 (CI = 2.5-10.5) times more likely to die within three 
years. People classified as vulnerable (frailty index score 0.2-0.3), mildly (frailty index 
score 0.3-0.4), moderately (frailty index score 0.4-0.5) or severely frail (frailty index score 
> 0.5) by the frailty index had respectively 2.2 (CI = 0.9-5.0), 8.0 (CI = 3.7-17.3), 20 (CI = 
9.1-41.2) or 33 (CI = 14.8-73.9) times higher likelihood to die than to those classified as 
relatively fit (frailty index score < 0.2). In the introduction, we mentioned that frailty 
could be influenced by lifelong disabilities, such as motor disabilities. Indeed, we found 
that, if adjusted for motor disability, the frailty phenotype lost much of its predicted 
value, whereas the frailty index remained strongly related with mortality (Schoufour et 
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al., submitted). As hypothesized previously, frailty, defined by the physical orientated 
frailty phenotype, seems to be too determined by motor disabilities in this population 
[20]. This limits its predictive ability, because motor disabilities by themselves predict 
mortality less strong than seen in the general population [21, 22]. Life long, or early 
developed motor disabilities are less predictive than motor disabilities acquired in later 
life. Above mentioned results imply that the frailty index, because of its broad range 
of deficits, is more applicable to the ID population than other known frailty measures, 
as we have argued in detail elsewhere [20, 23]. An additional advantage of the frailty 
index is the relative free choice of deficits, which enabled us to adapt the content to 
the ID population. Therefore, analysis of the predictive validity for outcomes other 
than mortality were only performed using the frailty index. We found that people with 
a higher frailty index scores were more likely to deteriorate in their activities of daily 
function (ADL), instrumental activities of daily function (IADL), and mobility [24] than 
people with low frailty index scores. For example, an individual with a rather high frailty 
index score (frailty index score = 0.5) was estimated to loose 3.6 ADL-points during three 
years, meaning that for example, the person was no longer able to use the toilet inde-
pendently, needed increased help with dressing, and could no longer walk the stairs. 
Furthermore, high frailty index scores were related to an increased number of chronic 
morbidities and medication prescriptions (Schoufour et al., accepted), in line with results 
from the general population [25, 26]. Also, we found that the risk of increased care need 
was exponentially associated with frailty index scores [27]. These results are comparable 
to results found in the general population [28, 29]. Contrary to results from the general 
population, we did not find a relation between high frailty index scores and hospitaliza-
tion [30-33] (Schoufour et al., accepted). The latter could be explained by undiagnosed 
conditions that normally require hospitalization, or that family/caregivers decide that 
hospitalization is not in the best interest for the client. Neither did we found a relation 
between falls, fractures and frailty. 
In conclusion, both the frailty phenotype and the frailty index were able to predict early 
mortality. The frailty index was able to predict deterioration of health and independence 
in the same way as found in the general population, with exception of hospitalization. It 
can therefore be concluded that the frailty index is a valid measure for frailty in this early 
handicapped population. 
which characteristics are associated with frailty? 
As to be expected, we found that high frailty index scores were associated with higher 
age, more severe ID, and Down syndrome. After adjustment for the level of ID, women 
had higher frailty index scores than men, but seem to cope with these deficits better, 
shown by a higher survival probability. These results are in line with results from the 
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general population [34, 35] and underline that women have, somehow, a higher capabil-
ity, or more physiological reserves, to cope with a higher deficit load [36]. Cross-sectional 
results showed that frailty in people with ID is associated with increased inflammation 
markers (CRP and IL-6), anemia, metabolic markers (glucose, cholesterol and albumin) 
and decreased renal functioning (Schoufour et al., submitted). Furthermore we found 
that the least frail participants (frailty index score ≤ 0.10) were characterized by better 
mobility and physical fitness, relative independence, less signs of depression/dementia 
and less chronic diseases [15]. These results provide the first understanding to why 
people with ID are at a relatively young age relatively frail compared to the general 
population. But what exactly is the impact of cognitive limitation, genetic disorders, and 
lifelong disabilities on frailty? Or, is the early onset of frailty simply explained by chronic 
co-morbidities, especially in people with Down syndrome and severe ID? Extensive 
future research is required before definite answers can be provided. Nevertheless in the 
next paragraph we try to draft the differences between our population and the general 
population that could help to understand the early onset of frailty. 
reFlection: unDerstanDing the mechanisms oF Frailty in PeoPle 
with iD
In a recent review by Clegg et al., frailty is said to be the result from lifelong accumula-
tion of molecular and cellular damage, influenced by genetic and environmental factors. 
Up to a certain point, the human body can resist and repair this damage, but eventually 
physiological reserves are depleted and a person becomes frail [1]. Frail individuals have 
little reserves, so that even a minor stressor (e.g. a urinary tract infection) can have serious 
consequences (figure 1). We have found that, in people with ID, frailty is more prevalent 
and starts at a younger age. The question is why, and how can this be prevented? We 
point out several important aspects that could intervene with the early onset of frailty. 
As proposed by Clegg et al., genetic factors, environmental factors and the interaction 
between the two are the origin of frailty. Starting with the former, healthy aging and life 
expectancy are partially explained by genetic predisposition. It has been estimated that 
genetic factors explain around one third of the variation in life expectancy in the general 
population [37-39]. In the ID population, genes could have a much more pronounced 
effect on healthy aging and frailty than observed in the general population. The intel-
lectual disability often has a genetic origin [40]. Early developed or congenital disorders, 
originated from either genetic/chromosomal abnormalities or pre-natal errors could, 
in addition to their effect on childhood cognitive impairment, highly determine the 
frailty status in late adulthood. First of all, the problems themselves add to frailty, trough 
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comorbidity, for example mobility limitations, visual impairments, ADHD, and autism. 
Second, these problems are not isolated, but could lead to a whole cascade of other 
problems, such as fatigue, pain, reduced fitness, decreased health literacy, inadequate 
health behavior, and social isolation. Third, genetic predisposition could lead to a de-
creased defense mechanism or reduced physiological reserves. As a result of childhood 
cognitive impairment, environmental factors are different than in the general popula-
tion. Depending on the level of ID and living circumstances, environmental factors could 
either protect them from becoming frail, or result in a further predisposition to develop 
frailty. It could be that people living within an institution, receiving professional care 
and support, be less exposed to certain stressor events, such as financial problems, or to 
be neglected. On the other hand, it has been shown that, starting at young age, physi-
Figure 1. Schematic rep-
resentation of the patho-
physiology of frailty in 
the general population 
(adapted from frailty in el-
derly people, Clegg et al., 
Lancet 2013 [1])
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cal activity and nutritional quality can be substantially improved in the ID population 
[41-46]. Additionally, life events (e.g. movement, loss of a loved one), social isolation, 
medication (e.g. antipsychotics), disturbed sleep rhythm, and undiagnosed conditions, 
could further add to the high frailty status. An additional remark needs to be made for 
people with borderline or mild levels of ID, who are often living independently, with 
only little support. Their frailty levels were on average less high than people with severe 
ID, because they have less comorbidities and better cognitive functioning. Still, their 
frailty levels are rather high compared to the general population. It is very likely that 
lifestyle more importantly contributes to frailty than genetic predisposition in this sub-
population. Indeed, results from the HA-ID study show that people with borderline and 
mild ID have worse nutritional habits and higher risk for cardiovascular risk factors than 
people with more severe ID. Results from the general population already showed that 
the social-economic status is important for healthy aging [47-51]. 
Summarized, early or congenital disabilities, genetic predisposition, unfavorable envi-
ronmental factors, and their mutual interaction and possible synergetic effect, could 
lead to an early depletion of physiological reserves resulting in the early onset of frailty. 
An important finding to support this hypothesis is the increased inflammatory status 
in people with ID compared to age-matched controls [52] and the association between 
frailty and inflammation (Schoufour, submitted). Although this field seems promising, 
much of research is required before causal relations between above mentioned factors 
and frailty can be shown.
recommenDations For Future research
Fundamental research
The above-mentioned hypothetic pathway of the development of early frailty calls for 
fundamental research. First, the current knowledge in genome sequencing is a promis-
ing field to better understand the genetic vulnerability for the development frailty. In 
addition, as suggested in the previous paragraph, the influence of chronic inflammation 
and reduced physiological reserves needs to be further investigated. 
epidemiologic research
We found that frailty is already frequently seen in people aged 50 years and over, and 
has significant consequences for the health status. If the almost linear line between age 
and the frailty index is extrapolated to younger age categories, frailty could, on average, 
already start around the age of 30. It is therefore important to examine the existence 
of frailty at younger age. People with severe health conditions, or those severely frail at 
190 Chapter 11
young age, are likely to have died before the age of 50. It is unknown if frailty is a useful 
concept for the younger, severely disabled ID population. In addition, it would be inter-
esting to know how the frailty status of people with ID develops over time. Is it possible 
to determine risk groups that deteriorate rather quickly? Or to identify people that stay 
away from frailty during the aging process? This group could add very important knowl-
edge about ‘protective’ variables. Last, up to now we could only study cross-sectional 
associations between possible determinants of frailty. It would be interesting to study 
determinants (specifically modifiable risk factors) that lead to the incidence of frailty.
Above mentioned questions can be answered in a large cohort, with extensive and mul-
tiple measurements over time. Amore applicable and easier way to address these ques-
tions is using routinely collected data. For example, if for each participant a minimum 
amount of variables is collected each year, these data can be used to construct a frailty 
index. Previously it has been demonstrated that a frailty index can, validly, be based on a 
standard comprehensive geriatric assessment [28, 53]. Data that are routinely collected 
within the care organisations could be used to measure frailty, follow people over time 
and identify important determinants. We therefore suggest, that health institutions col-
laborate to use the same, validated, instruments to measure health variables. This would 
not only help to further study frailty, but will provide an enormous dataset that can be 
used to answer various other research questions.
The HA-ID study included participants who received specialized care from care orga-
nizations. Therefore, people with borderline or mild ID that live independently were not 
included in this study. It would be interesting to study frailty in this population and to 
identify associated risk factors that can be used for preventative approaches. 
screening instrument 
To identify frail people there is a need to develop predictive screening instruments that 
are applicable in clinical practice. Our frailty index can be used as a basis for such a 
screening instrument. Nevertheless, several steps are necessary before clinical applica-
bility is justified. First, the used items in our frailty index were selected from validated 
questionnaires, but the validity of these items within the different context of the frailty 
index is unknown. Second, some items might be relevant for frailty but are difficult to be 
clinically implemented, such as the fitness battery and expensive biochemical markers. 
It should be studied whether the frailty index remains valid after the removal of clinically 
less suitable measures. Third, to evaluate the stability of the frailty index, the test-retest 
reliability should be determined. Fourth, the ability of the frailty index to measure 
change in someone frailty status should be evaluated in order to monitor the frailty 
status closely. Last, the sensitivity and specificity of the screening instrument need to 
be evaluated, providing validity on an individual level. Another way to examine frailty 
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would be via biochemical markers. This would be of special interest for people with 
communication difficulties. We showed that several biochemical markers are associated 
with frailty. It should be further studies whether a combination of biochemical measures 
could form a frailty index, as has been recently done for the general population [54]. 
imPlications anD recommenDations For clinical Practice
Frailty can be a slowly progressing state that involves the accumulation of all possible 
health problems, of which many by themselves are no reasons for major concern. One 
simple intervention that prevents or even reverses frailty for a whole population is 
therefore unlikely to exist. Furthermore, congenital disabilities and comorbidities, 
related to the ID, influence frailty but are complicated, if not impossible, to prevent. 
Hence, it is of paramount importance to closely monitor individuals at risk and develop 
an individual health care plan that takes into account all health aspects (social, physi-
cal and physiological) and that aims at the highest quality of life. We recommend that 
more knowledge about frailty is provided to care givers, including physicians and daily 
care givers. One should be aware of the slowly progressing decline in health that could 
eventually lead to the clinical manifestation of frailty. 
Screening and monitoring of frailty should be broadly implemented. Recovering from a 
very frail state is complicated, especially at high age [55]. It is therefore important to be 
able to recognize people at risk to develop frailty. In the long run, it would be very ben-
eficial if, using routinely collected data, a frailty index is automatically calculated yearly 
for each individual. This would enable care givers to notice small changes in health sta-
tus, and intervene at an early stage. Furthermore, frailty indices (either composed from 
routinely collected data or clinical instruments) are advised to be used in the evaluation 
of health interventions.
Furthermore, there are several recommendations for clinical practice that could posi-
tively influence the overall frailty status in the ID population. In recent years, results from 
the HA-ID study and others, showed ample opportunities to improve the care for people 
with ID. Some examples: 1. levels of physical fitness and physical activity are extremely 
low [46, 56], and dietary habits are poor [42], both offer much room for improvement, 2. 
Depression and anxiety symptoms are often present but inadequately recognized [57, 
58]. Early detection, the limitation of life events, sufficient social support and proper 
treatment are therefore important, 3. To limit the severe side-effects of antipsychotics, 
discontinuation should be considered [59-61] and regularly medication reviews are 
advised to limit the number of prescription errors [62], 4. Cardiovascular risk factors 
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(e.g. high serum triglyceride, elevated blood pressure) are frequently present but often 
undiagnosed [63-65]. Pro-active screening and treatment is therefore recommended. 
These recommendations show the complexity of frailty, but also show many opportuni-
ties to improve the ID care. Nevertheless, in large and complex organizations such as 
those taking care of people with ID, the implementation of lifestyle interventions is com-
plex and several aspects need to be taken into account. First of all, as mentioned before, 
it is of paramount importance to create awareness of the frailty problem and possible 
solutions throughout the care organization. Without understanding, care givers will not 
be motivated to implement interventions, or adapt their everyday care. Second, screen-
ing for the areas that ask for improvement (e.g. nutrition, physical activity, depression), 
obtained by scientific research need to be implemented. Third, effective interventions, 
with corresponding protocols need to be readily accessible. Fourth, time and money 
need to be made available to actually offer the required care. It is therefore required that 
clearance is provided about who is responsible for what in the ID sector. 
These points are already complicated within specialized ID organizations, but may be 
even more complicated outside the organizations. People with borderline or mild ID 
who do not use any form of formal care will not benefit from interventions offered by 
the care organization. This group will further increase in years to come because of a 
recent change in health care legislation that assigns the care for this group to general 
practitioners, geriatricians and informal caregivers in municipalities. In addition, a large 
degree of self-management among this group of older people with ID is now expected. 
Education about frail older people with ID and related problems for physicians and other 
formal and informal caregivers is essential to raise awareness for frailty. Furthermore, it 
is important that physicians can discuss their cases with specialized ID physicians. In the 
Netherlands, this has been taken care of in terms of specialized ID outpatient clinics. 
But this option needs to be further implemented, apparent from the indication of gen-
eral practitioners that they lack knowledge about this specific group [66]. Additionally, 
people with ID that do not use any form of formal care or support, need to be educated 
themselves about a healthy lifestyle. This will ask for specific and carefully designed 
programs, because it is known that people from lower social classes are difficult to reach 
with interventions. 
conclusion
In line with others, we predict that frailty is, and will increasingly become a major health 
care concern, that not only threatens the quality of life of older people with ID but 
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also leads to increased health care costs. People with ID are already the most expen-
sive diagnostic group in the Netherlands [67] and these costs have been growing in 
recent years (2007-2012) [68]. Results from the HA-ID study show that frailty is a useful 
method to measure overall health, also in people with life-long physical and cognitive 
disabilities. The accumulation of molecular and cellular damage may have a higher 
frequency in people with ID, leading to an earlier depletion of physiological reserves. 
Additionally, people with ID may have less redundancy or repair mechanisms to limit 
the accumulation of damage. Early developed or congenital disorders, originated from 
either genetic/chromosomal abnormalities or pre-natal errors contribute, via cognitive 
limitation and comorbidities, strongly to frailty in people with ID. Nevertheless, there 
are ample opportunities to improve the environmental factors. In addition, we suggest 
that awareness is created about the accumulation of health problems that lead to frailty. 
Future research should be performed to develop a valid screening instrument, study 
trajectories of frailty and evaluate the suggested mechanisms of frailty in people with ID.
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chaPter 1: introDuction
As the number of older persons is increasing, healthy aging becomes a major challenge 
for individuals, care givers and health care policy makers. To maintain a high quality of 
life for elderly people and to limit the burden on the health care system, knowledge on 
healthy aging and its trajectories is essential. 
Improved health care, knowledge, advocacy and services have also increased the life 
expectancy of people with intellectual disabilities (ID). People with ID are characterized 
by limitations in both intellectual functioning and adaptive behavior that start before 
the age of 18 (diagnostic criteria DSM, 2000). The prevalence of people with ID has been 
estimated to be 1.5 to 2% in the Western countries. Although people with ID reach a 
higher age, it has long been a common understanding that people with ID are already 
showing clear signs of old age at the age of 50, because there seems to be an early onset 
of functional decline. A better understanding in this observed so-called ‘early aging’ 
would provide targets for preventive medicine and could identify specific risk groups.
A useful method for studying the ageing process and the transition from health to 
disease is frailty. Frail individuals are more likely to deteriorate in their daily functioning, 
develop mobility limitations, are more often hospitalized, develop more often chronic 
diseases and have shorter survival probabilities. To a large extent, frailty is preventable 
and reversible. This thesis focuses on the measurement, frequency, determinants, and 
consequences of frailty in older people with ID. This thesis is part of the large Healthy 
Ageing and Intellectual Disability’ (HA-ID) study that has been performed among 1050 
people with ID, aged 50 years and over, who received formal care from an ID specialized 
care organization. Participants were followed for a period of three years. 
chaPter 2: Frailty anD intellectual Disability: a DiFFerent 
oPerationalization?
Frailty has been broadly recognized as a state of increased vulnerability for adverse 
health outcomes. 
Nevertheless, there is yet not one generally accepted definition or measurement 
strategy. In this chapter we describe the most commonly used instruments and their 
possible applicability for the ID population. One frequently applied, physically oriented 
operationalization, developed by Fried et al, is the frailty phenotype that defines frailty 
as the presence of three out of five clinical symptoms (unintentional weight loss, weak-
ness, slow walking speed, self-reported exhaustion, and low physical activity). We 
hypothesized that this frailty definition would be too much influenced by motor dis-
ability and, because of the frequently prevalent chronic comorbidities, social isolation, 
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medication use, life events and disabilities, a broader definition of frailty would be better 
suited. The Tilburg Frailty Indicator by Gobbens et al., is a valid measure for frailty in the 
general population that includes a social, physical and psychical domain. Nevertheless, 
we concluded that most items of this questionnaire are complicated to be filled in by, or 
for, people with moderate to severe ID and items will not sufficiently discriminate (e.g. 
education level). We argued that, possibly, the frailty index, developed by Rockwood 
and Mitnitski, would be a suitable measure for frailty in people with ID. The frailty index 
is based on a-specific accumulation of health problems, called deficits. It does not focus 
on a specific set of variables and can therefore be adapted to the ID population. 
chaPter 3: DeveloPment oF a Frailty inDex 
Based on data from the Healthy Aging and Intellectual Disability study, we developed 
a frailty index with 51 health related deficits. The 51 deficits include a broad spectrum 
of objective measurements (e.g. grip strength, walking speed, serum glucose), informer 
reports (e.g. fatigue, depression symptoms, dressing) and medical information (e.g. 
medication use, general hospital admission, asthma). A frailty index score was calculated 
taking the number of deficits present, divided by 51, resulting in a score between 0 (no 
deficits present) and 1 (all deficits present). The characteristics of our frailty index were 
comparable to frailty indices designed for the general population: skewed distribution, 
correlation with age and an observed maximum frailty index score of around 0.7. Further 
robustness was demonstrated by correlating 50 frailty indices based on random selec-
tions of 75% of the deficits, with age, showing that the index’s correlation with age was 
not influenced by the choice of deficits, which shows structural validity. 
Results with the frailty index showed that the mean frailty index score for people with 
ID was 0.27, equivalent to the prevalence of 14 out of 51 deficits. The frailty index score 
was positively correlated with age and the presence of Down syndrome. More severe ID 
was associated with higher frailty index scores. Results from the general elderly popula-
tion show usually a mean score between 0.08 and 0.17. Compared to a general European 
population (50+), people with ID accumulate more deficits and this accumulation starts 
at much younger age.
chaPter 4: characteristics oF the least Frail 
Most ageing research focus on the question “what causes pathology?” This so-called 
‘negative biology’ perspective has led to advances in the understanding, and treatment, 
of the age-related diseases. Nevertheless, understanding why some people age without 
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diseases and in good health, (or ‘positive biology’) could yield important insights into 
successful ageing and maintenance of health in older age. In line with the positive biol-
ogy perspective, we studied the characteristics of the least frail (frailty index score ≤ 
0.10) participants. Our first conclusion was that there were very few participants with 
such low frailty index scores: 6.6%, whereas in the general population this percentage 
is estimated to be at least 43%. Second, we concluded that the health of the least frail 
participants was better in several health domains: they were characterized by better 
mobility and physical fitness, relative independence, less signs of depression/dementia 
and less chronic diseases. 
chaPter 5: biochemical measures anD Frailty 
We examined several biological measures that could help to identify pathophysiological 
pathways involved in the observed early onset of frailty in people with ID. We found 
that frailty was associated with inflammation (CRP and IL-6), anemia, metabolic mark-
ers (glucose, cholesterol and albumin) and renal functioning (cystatin-C). These results 
imply that mainly inflammation and nutritional state are important contributors of 
frailty. Furthermore they provide an important basis for future research into both the 
understanding of frailty in people with ID and the possibility to identify frailty using 
biochemical measures. We only measured a selective set of biochemical measures, but 
many more are known to be associated with frailty (e.g. oxidative stress and TNF), and 
need to be studied in people with ID as well. Furthermore, the possibility to measure 
frailty using a set of biochemical measures should be studied. This could be of special 
interested for those with communication difficulties. 
chaPter 6: PreDicting Disabilities in Daily Functioning 
In the general population it has been shown that frailty leads to disabilities in daily 
functioning such as activities of daily living (ADL), instrumental activities of daily living 
(IADL) and mobility. On the contrary, in people with ID, disabilities in daily function can 
be life-long and are more likely to result in frailty than the other way around. Even so, 
frailty could lead to a further decrease in dependency. Therefore we evaluated the rela-
tion between the frailty index and deterioration of ADL, IADL and mobility over a three 
year follow-up period. As suspected, the frailty index was not related with decreased 
daily functioning in people with no or limited independence at baseline. For people who 
could further decrease their dependence we found a strong relation between the frailty 
index score and deterioration of ADL, IADL and mobility. 
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chaPter 7: PreDicting aDverse health outcomes
Longstanding disabilities in people with ID may not only effect their frailty status, but 
also its consequences. In addition to the effect of frailty on disability (chapter 6), we were 
interested in its relation with falls, fractures, chronic comorbid conditions, medication 
use and hospitalization. We did not find a relation between frailty and falls, fractures and 
hospitalization three years onwards. In the general population, the former two show 
inconsistent results. However, in the general population, frailty is frequently related to 
hospitalization and increased hospital stay. Our results could be explained by the fact 
that, conditions that normally require specialist services remain sometimes undiag-
nosed, or that family, personal caregivers or hospital staff may have decided that hos-
pital treatment was not in the best interest of the client. We did find a relation between 
frailty and an increased number of prescribed medication and comorbid conditions. This 
implies that frailty is related to an increased risk for negative health outcomes, also in a 
population with lifelong disabilities.
chaPter 8: the imPact oF Frailty on care intensity 
We argued that, because frailty in people with ID is related to adverse health outcomes, 
it will also be related to increased health care costs. To study this, we evaluated the rela-
tion between frailty and an increase in care intensity three years later. Care intensity was 
estimated using Care Intensity Packages (in Dutch = Zorg Zwaarte Pakket [ZZP]). In total 
there are 8 ZZP packages, ranging from minimal support (ZZP1) to intensive all-day care 
and support (ZZP8). For each individual classified in a ZZP category an allocated annual 
budget is available for care and support. For 26% of the participants, care intensity had 
increased during a follow-up of three years. Increased care was related with high frailty 
index scores, independent of the level of ID, age, gender and Down syndrome. These 
results show that frailty does not only effect individual health, but also increases the 
burden on the health care system. 
chaPter 9: PreDicting 3-year survival 
In this study we focused on whether the frailty index predicts survival in people with 
ID. We divided the sample in five frailty groups: relatively fit (frailty index score < 0.20), 
vulnerable (frailty index score 0.20-0.29), mildly frail (frailty index score 0.30-0.39), mod-
erately frail (frailty index score 0.40-0.49) and severely frail (frailty index score ≥ 0.5). 
Significantly more participants in the frailty groups died than those who were classified 
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as relatively fit. These results are congruent with other studies that also show strong rela-
tions between the frailty index score and survival. A difference was that, in the general 
population, individuals with a score around 0.2 already have a higher mortality risk than 
people with a score around 0.10. We did not find significant differences in mortality risk 
between the relatively fit and the vulnerable group. These results suggest that older 
people with ID can manage more deficits than the general population before their mor-
tality risk increase. It could be that lifelong disabilities are less predictable for mortality 
than disabilities acquired in later life.
chaPter 10: comParing two Frailty measures 
To evaluate which frailty method was most applicable and most valid to the ID popu-
lation, we directly compared two frequently used frailty instruments: the frailty index 
and the frailty phenotype. Additionally, we were interested whether motor disability 
influenced the relation between frailty and mortality. Because it could be expected that 
frailty is influenced by lifelong motor disabilities. 
We found that the frailty index was more often applicable (94%) than the frailty phe-
notype (81%). Both frailty measures were related to mortality three years later, although 
the frailty index showed a stronger relation than the phenotype. If adjusted for motor 
disability, the frailty phenotype lost much of its predicted value, whereas the frailty 
index remained strongly related with mortality. It seems that the frailty phenotype is too 
much determined by motor disabilities in this population and is therefore less predictive 
of mortality. Furthermore, we were able to adapt the frailty index to the ID population, 
which could have increased its validity. 
chaPter 11: general Discussion 
In this final chapter, the most important results are summarized, the implications for 
clinical practice and future research are discussed. Frailty seems to start earlier and is 
more severe in people with ID than observed in people in the general population, but 
consequences on health outcomes and care are similar. The observed early frailty in 
people with ID could be explained by both genetic and environmental factors, their in-
teraction, and possible synergetic effect. The high frequency and serious consequences 
of frailty ask for immediate action for people living within the care organization, but also 
for those living independently. Congenital problems and comorbidities are complicated 
and are likely to influence frailty without many opportunities for prevention. Never-
theless, improvement of lifestyle and sleep quality, the early recognition of treatable 
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conditions, and the prevention of life events (e.g. trauma’s) could prevent or delay frailty 
to some extent. Future longitudinal research should address the causality between risks 
(e.g. chronic inflammation, low physical activity) and the onset of frailty. Furthermore, 
there is a need to develop a predictive screening instrument for clinical practice.
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introDuctie 
De levensverwachting van mensen met een verstandelijke beperking neemt steeds 
verder toe en hierdoor stijgt ook het totaal aantal ouderen met een verstandelijke 
beperking [3]. Ondanks de toename in de levensverwachting lijkt er sprake te zijn van 
een vroegtijdige functionele achteruitgang. Ouderen met een verstandelijke beperking 
hebben aanzienlijk meer gezondheidsproblemen dan andere ouderen, wat mogelijk 
consequenties heeft voor hoge zorgconsumptie en kosten. Tot in het eerste decennium 
van deze eeuw was de wetenschappelijk onderbouwde kennis over de gezondheid 
van deze groeiende groep ouderen beperkt. In 2008 is daarom gestart met het `Ge-
zond Ouder met een verstandelijke beperking (GOUD)’-onderzoek, een grootschalig 
onderzoek naar de gezondheid van cliënten van 50 jaar en ouder, van gespecialiseerde 
zorgaanbieders in Nederland. Resultaten uit dit GOUD-onderzoek bevestigen de vroeg-
tijdige ongezondheid. Zo blijkt de gemiddelde fitheid van 50ers vergelijkbaar met die 
van 70-80 jarigen in algemene populaties [6]. Ook werd gevonden dat veel cliënten een 
verstoord slaap-waak ritme hebben [7, 8], evenals al hoge preventies van sarcopenie, 
diabetes en obesitas [9-11]. 
Deze resultaten tonen de hoge urgentie van detectie van specifieke bedreigingen van de 
gezondheid en van passende zorg gericht op preventie. Zowel vanuit de wetenschap als 
de verstandelijk gehandicaptenzorg rees daarom de vraag of het mogelijk was gezond-
heid te meten met een overkoepelende publieke gezondheidsmaat. Voorbeelden van 
veelvuldig toegepaste gezondheidsmaten zijn multimorbiditeit, polyfarmacie en kwets-
baarheid. Uit het GOUD-onderzoek bleek dat multimorbiditeit, gedefinieerd als twee of 
meer chronische aandoeningen die een negatieve invloed hebben op het functioneren 
van het dagelijks leven, voorkomt bij 80% van de deelnemers [13]. Deze prevalentie is 
vergelijkbaar met die van de Nederlandse verpleeghuispopulatie. Polyfarmacie, in het 
GOUD-onderzoek gedefinieerd als het chronisch gebruik van 5 of meer middelen, kwam 
bij 40% van de studiepopulatie voor. Slechts 11% gebruikte helemaal geen medicijnen, 
en 6% gebruikte 10 of meer medicijnen. Voordat er uitspraken gedaan konden worden 
over de derde overkoepelende gezondheidsmaat, kwetsbaarheid, moest eerst worden 
onderzocht welke operationalisering toepasbaar was en of kwetsbaarheid op dezelfde 
wijze als in de algemene bevolking een achteruitgang in gezondheid en zelfstandigheid 
voorspelt [14]. Hier vatten wij de belangrijkste resultaten samen. Verder, beschrijven 
we via welke route wij tot een keuze zijn gekomen van een geschikt kwetsbaarheids-
instrument, wat de resultaten waren van cross-sectionele metingen binnen de GOUD-
populatie, en hoe voorspellend deze methode was voor gezondheid en zelfstandigheid 
in een follow-up van drie jaar. Op basis hiervan gaan wij kort in op de toekomstige stap-
pen die genomen kunnen worden om kwetsbaarheid en de gevolgen te verminderen. 
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het gouD-onDerzoeK
Het GOUD-onderzoek is een grootschalig epidemiologisch onderzoek naar de gezond-
heidstoestand van 1050 mensen met een verstandelijke beperking (50 jaar en ouder) 
[15]. Deelnemers werden verworven bij drie Nederlandse zorgaanbieders (Ipse de 
Bruggen, Abrona & Amarant), die gespecialiseerd zijn in ondersteuning voor mensen 
met een verstandelijke beperking, variërend van ambulante ondersteuning of dagbe-
steding tot woonbegeleiding met intensieve zorg en begeleiding. Alle cliënten van 
50 jaar of ouder werden uitgenodigd (N = 3222), waarvan 1050 toestemming gaven 
voor deelname. De deelnemers vormden een vrijwel representatieve populatie voor 
de gehele Nederlandse populatie mensen met een verstandelijke beperking die zorg 
ontvangen van een gespecialiseerde zorginstelling. Het onderzoek werd opgezet vanuit 
het perspectief van preventie. Binnen drie thema’s (Lichamelijke activiteit en Fitheid, 
Voeding en Voedingstoestand, Depressie en Angst) werd een breed scala aan gegevens 
verzameld. Binnen deze thema’s werden de deelnemers uitvoerig onderzocht met 
onder andere een fitheidstestbatterij, slaap-waakonderzoek (actiwatch), stappentellers, 
voedingsdagboeken, lichamelijk onderzoek, bloedonderzoek en een breed scala aan 
vragenlijsten, onder andere over voedingstoestand, zelfstandigheid, angst en depressie. 
Tevens werden er gegevens verzameld uit het (medisch) dossier.
Drie jaar na de baseline metingen zijn er vervolgmetingen verricht. Tijdens dit vervolg-
onderzoek werden er door woonbegeleiders vragenlijsten ingevuld over de huidige 
zelfstandigheid en mobiliteit van de cliënten. Zelfstandigheid werd uitgedrukt in activi-
teiten van het dagelijks leven (ADL; b.v. naar het toilet gaan, eten) en de instrumentele 
activiteiten van het dagelijkse leven (IADL; b.v. huishoudelijke klussen, telefoneren). Bij 
de arts werden ziekenhuisopnamen over de afgelopen 3 jaar en het huidige medicatie 
gebruik opgevraagd. Tot slot werd nagezocht welke cliënten overleden waren. 
oPerationalisering van KwetsbaarheiD 
Onderzoekers zijn het er over eens dat een kwetsbaar individu een grotere kans heeft 
op achteruitgang van de gezondheid vergeleken met een niet kwetsbaar individu van 
dezelfde leeftijd [16]. Er zijn de afgelopen decennia verschillende conceptuele en opera-
tionele definities van kwetsbaarheid in gebruik geraakt [17]. Elk van deze definities heeft 
zijn voor- en nadelen. Wij zochten de operationalisering die toepasbaar was voor men-
sen met een verstandelijke beperking. Brehmer en Weber in Wenen waren de eersten die 
kwetsbaarheid in kaart brachten bij mensen met een verstandelijke beperking. Hiervoor 
maakten ze gebruik van een zelf ontworpen vragenlijst, de Vienna Frailty Questionnaire 
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for people with ID, die bestaat uit vier domeinen (sociaal, cognitief, fysiek en psychisch) 
[18]. Zij vonden dat ruim een kwart van de 50+ deelnemers kwetsbaar was. Echter, de 
studiepopulatie was zeer klein en de uniekheid van de vragenlijst maakt vergelijking 
met de algemene populatie niet mogelijk. Voor de algemene Nederlandse populatie 
wordt de Tilburg Frailty Indicator (TFI) veelvuldig gebruikt, waarbij kwetsbaarheid 
omschreven wordt als “het resultaat van tekorten in diverse domeinen van lichamelijk, 
cognitief, sensorisch en psychosociaal functioneren” [19]. De vereiste zelfrapportage 
maakt echter dat dit instrument voor mensen met een matige of ernstige verstandelijke 
beperking of communicatieproblemen niet toepasbaar is. De twee operationaliseringen 
die internationaal het meest worden gebruikt zijn het kwetsbaarheidsfenotype van 
Fried et al. en de kwetsbaarheidsindex van Rockwood en Mitnitski. Beide zijn toegepast 
tijdens het GOUD-onderzoek. Bij de eerste wordt kwetsbaarheid gedefinieerd als de 
aanwezigheid van tenminste drie van de volgende vijf criteria: onbedoeld gewichtsver-
lies, lage spierkracht, langzame wandelsnelheid, lage lichamelijke activiteit en slecht 
uithoudingsvermogen [20]. In de algemene populatie blijkt dat ouderen die kwetsbaar 
zijn volgens het fenotype een hogere kans hebben om te overlijden [21]. Het kwets-
baarheidsfenotype bleek toepasbaar bij 81% van de GOUD-populatie. Van de totaal 
geïncludeerde populatie bleek 13% kwetsbaar te zijn, een gemiddelde dat hoger is dan 
dat gevonden bij de algemene populatie. Van de mensen met een lichte verstandelijke 
beperking was 6% kwetsbaar. Zoals verwacht hing de gevonden kwetsbaarheid sterk 
samen met mobiliteit [22]. 
De tweede operationalisering, de kwetsbaarheidsindex is gebaseerd op de aspecifieke 
opeenstapeling van gezondheidsproblemen [1, 23]. De keuze van items en het exacte 
aantal items is vrij mits er minstens 30 items worden gekozen, de items gerelateerd 
zijn aan leeftijd, er voldoende variatie is (geen plafond-of bodemeffect) en alle 
gezondheidsdomeinen (lichamelijk, functioneel, sociaal en psychologisch) zijn verte-
genwoordigd. De kwetsbaarheidsindex is valide gebleken, in de zin van voorspellend 
voor achteruitgang van gezondheid, in verschillende populaties, inclusief zeer oude en 
functioneel beperkte groepen [17, 23]. Wij vermoedden dat de kwetsbaarheidsindex, 
bij mensen met een verstandelijke beperking, beter toepasbaar en sterker voorspellend 
zou zijn dan het kwetsbaarheidsfenotype. De belangrijkste reden hiervoor was dat het 
kwetsbaarheidsfenotype puur gericht is op fysieke gezondheid, terwijl de heterogene 
problematiek die wordt gezien bij mensen met een verstandelijke beperking leek te 
vragen om een multifactoriële operationalisering van kwetsbaarheid. Ten tweede, daar 
waar het kwetsbaarheidsfenotype gebruik maakt van een vaste set van variabelen kan 
de kwetsbaarheidsindex flexibel worden ingevuld en daarmee worden aangepast aan 
een specifieke populatie. Tijdens het GOUD-onderzoek is onderzocht of de kwetsbaar-
heidsindex daadwerkelijk toepasbaar was bij mensen met een verstandelijke beperking. 
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Van de ruim 400 mogelijke items, alle verzameld tijdens het GOUD-onderzoek, bleken 
er 51 te voldoen aan alle eisen die aan een kwetsbaarheidsindex gesteld worden: cor-
relatie met leeftijd, geen bodem of plafondeffect, voldoende vaak gemeten ( > 30%), 
gezondheidsaspect [1, 5]. Deze items kwamen veelal overeen met items die in kwets-
baarheidsindexen voor de algemene populatie zitten, maar een aantal was specifiek 
voor deze populatie, zoals slikstoornissen en scoliose. Alle 51 items werden gecodeerd 
naar een score tussen de 0 (deelnemer heeft dit probleem niet) en 1 (deelnemer heeft 
dit probleem). Alle item-scores werden bij elkaar opgeteld en gedeeld door het totale 
aantal items. Zo werd voor elke deelnemer een kwetsbaarheidsscore berekend die liep 
van 0 (totaal niet kwetsbaar) tot 1 (extreem kwetsbaar). Er kon een kwetsbaarheidsindex 
berekend worden voor 97% (n = 982) van de deelnemers. Voor 68 deelnemers hadden we 
te weinig gegevens om een kwetsbaarheidsindex score te berekenen. De gemiddelde 
score was 0.27 [5]. Uitgaande van de vele problemen bij mensen met een verstandelijke 
beperking, verwachtten wij een hoger gemiddelde te vinden dan dat in de algemene 
populatie. Dit bleek te kloppen: de gemiddelde kwetsbaarheidsscore van 50-plussers 
met een verstandelijke beperking kwam overeen met die van de algemene 70-plus 
populatie (figuur 1). We vonden dat kwetsbaarheid vaker voorkwam bij mensen met een 
ernstige mate van verstandelijke beperking en bij mensen met het Down syndroom en 
toenam met de leeftijd (tabel 1). Dit was te verwachten, omdat ernstige verstandelijke 
beperking gepaard gaat met een hoge comorbiditeit, terwijl, zoals bekend is, mensen 
met het Down syndroom een verhoogd risico hebben op vroeg optredende zintuiglijke 
stoornissen, hypothyreoïdie en Alzheimer dementie.
Het feit dat reeds vanaf 50 jaar regelmatig sprake is van kwetsbaarheid, maakt aan-
nemelijk dat problemen zich al voor het 50ste levensjaar opstapelen. Dit is begrijpelijk, 
gezien de in de inleiding genoemde vroege beperkingen en multimorbiditeit. Omdat 
niet eerder kwetsbaarheid is onderzocht in een vroeg-gehandicapte populatie, vroegen 
wij ons af of de kwetsbaarheidsindex op dezelfde wijze als in de algemene populatie 
voorspellend zou zijn voor een (verdere) achteruitgang in gezondheid. 
De risico’s voor Kwetsbare ouDeren
Figuur 2 laat de Kaplan Meier survival curves zien voor verschillende maten van kwets-
baarheid. Het risico op overlijden stijgt significant bij een kwetsbaarheidsscore van 0.3 
en neemt daarna exponentieel toe [4]. In de algemene populatie ligt dit punt rond de 
0.2 [2]. Desalniettemin was de sterfte onder mensen met een kwetsbaarheidsindex tus-
sen de 0.2-0.3 twee keer zo hoog als onder mensen met een score onder de 0.2. 
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Figuur 1. Verdeling van de kwetsbaarheidsindexscore voor drie verschillende populaties (links 754 deelne-
mers uit de algemene (gezonde) populatie (70+) [1], in het midden de GOUD-populatie bestaande uit 982 
ouderen (50+) met een verstandelijke beperking [5] en rechts een Europese (n = 29905) 50+ populatie [12]. 
tabel 1. Kenmerken van de deelnemers van het GOUD-onderzoek en bijbehorende kwetsbaarheidsindex-
score op baseline
Kenmerken n Gemiddelde 
KI-score
SD p-waarde
Totale populatie 982 0.27 0.13 -
Geslacht .159a
 Mannen 507 0.27 0.13
 Vrouwen 475 0.28 0.13
Ernst verstandelijke beperking  < .001b
 Zwakbegaafd 29 0.19 0.11
 Licht 191 0.21 0.12
 Matig 432 0.26 0.12
 Ernstig 147 0.33 0.12
 zeer ernstig 82 0.41 0.10
Leeftijdscategorie  < .001b
 50-59 jaar 458 0.25 0.12
 60-69 jaar 344 0.28 0.12
 70-79 jaar 156 0.34 0.12
 80-89 jaar 21 0.41 0.14
 90 jaar en ouder 3 0.42 0.03
Oorzaak verstandelijke beperking .007a
 Andere oorzaken 732 0.27 0.13
 Down syndroom 142 0.31 0.13
KI = Kwetsbaarheidsindex, SD = standard deviatie
aVerschil tussen de categorieën getest op signifi catie met een t-toets voor onafhankelijke steekproeven 
bVerschil tussen de categorieën getest op signifi catie met een univariaat regressie model
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Naast een verhoogd risico op overlijden vonden we dat deelnemers met een hogere 
kwetsbaarheidsindex meer achteruitgingen in hun zelfstandigheid [2], overeenkomstig 
de bevindingen in de algemene ouderen populatie [24-26]. Voor mensen die op base-
line al de minimale score voor zelfstandigheid hadden op de gebruikte ADL, IADL en 
mobiliteit vragenlijsten, kon geen verdere achteruitgang gemeten worden. Anderzijds, 
mensen die een maximaal hoge score hadden konden relatief verder achteruitgaan 
gedurende de follow-up periode. Om hiervoor te corrigeren, werd een interactieterm 
tussen de kwetsbaarheidsscore en de baseline IADL of mobiliteitsscore toegevoegd aan 
een lineair regressiemodel (voor ADL bleek dit niet nodig). Figuur 3 geeft de geschatte 
relatie tussen de kwetsbaarheidsindex en achteruitgang in IADL en mobiliteit weer, 
gestratifi ceerd voor verschillende baseline IADL en mobiliteitsscores. De kwetsbaarhe-
idsindex kon geen achteruitgang voorspellen bij deelnemers die op baseline al volledig 
afhankelijk waren of gebruik maakte van een rolstoel. De sterkste voorspellende waarde 
had de kwetsbaarheidsindex voor mensen die relatief onafhankelijk waren en zonder 
hulpmiddelen konden lopen. Het ontbreken van een relatie tussen kwetsbaarheid en 
Tijd tot overlijden in maanden 
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Figuur 2. Kaplan-Meier curve gestratifi ceerd voor verschillende kwetsbaarheidsindexscores op base-
line. De relatief fi tte groep (bovenste, zwarte lijn; score < 0.2) heeft de hoogste overlevingskans, de ern-
stig kwetsbare groep (score > 0.5) heeft de laagste overlevingskans, de licht, matig, en ernstig kwetsbare 
groepen zitten daar tussenin. De pre-kwetsbare groep heeft geen signifi cant hogere kans op overlijden. 
De licht, matig en ernstig kwetsbare groepen hebben alleemaal een signifi cant hogere kans te overlijden 
vergeleken met de relatief fi tte groep (p < .001). Figuur gebaseerd op een eerdere publicatie in the Journal 
of the American Geriatrics Society [4].
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achteruitgang bij de functioneel slechtste groep wil niet zeggen dat deze er niet is. Maar 
de gebruikte IADL en mobiliteit vragenlijsten maakten het meten daarvan niet mogelijk. 
In tegenstelling tot wat vermeld wordt in literatuur over de algemene populatie vonden 
we geen relatie tussen kwetsbaarheid en aantal ziekenhuisopnamen [24, 27-29]. Dit zou 
verschillende oorzaken kunnen hebben. Enerzijds is het mogelijk dat aandoeningen 
die normaliter behandeling in het ziekenhuis vereisen, minder snel gediagnostiseerd 
worden in deze populatie. Anderzijds kunnen familie, persoonlijk begeleiders of zieken-
Figuur 3. Relatie tussen de kwetsbaarheidsindex op baseline en de geschatte IADL (A) en mobiliteit (B) 
achteruitgang drie jaar later. De lijnen vertegenwoordigen verschillende baseline IADL/mobiliteit scores 
voor een man van 55 jaar met een matige verstandelijke handicap en geen Down syndroom. Figuur gebas-
eerd op een eerdere publicatie in Research in Developmental Disabilties [2]. 
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huispersoneel besluiten dat ziekenhuisopname te belastend is voor de cliënt, of dat de 
verzorging bij voorkeur plaats vindt in de zorginstelling in plaats van het ziekenhuis. 
We vonden tevens dat de hoogte van de kwetsbaarheidsindex gerelateerd was aan een 
toename van het aantal medicamenten [27]. Dit resultaat werd eerder gevonden in de 
algemene ouderen populatie [30, 31]. Tot slot vonden we dat mensen met een hoge 
kwetsbaarheidsindex een grotere kans hadden meer zorg te gaan gebruiken binnen drie 
jaar [32]. Samenvattend kunnen we zeggen dat in deze vroeg gehandicapten populatie 
de kwetsbaarheidsindex een sterke voorspeller is voor overlijden en achteruitgang van 
zelfstandigheid mobiliteit en gezondheid. 
oPsPoring en behanDeling van Kwetsbare ouDeren 
De kwetsbaarheidsindex is een geschikt instrument gebleken om epidemiologisch, 
populatiegericht onderzoek te doen. De klinische toepasbaarheid van het instrument 
in de verstandelijk gehandicapten populatie is nog onbekend. Echter, de sterke relatie 
tussen kwetsbaarheid en achteruitgang van zelfstandigheid, mobiliteit, toename van 
medicatiegebruik en overlijden, maakt individuele opsporing essentieel. Temeer omdat 
uit de algemene populatie bekend is dat kwetsbaarheid een dynamisch proces is, dat 
geremd kan worden of zelfs reversibel is door effectieve interventies [17, 33-35]. Er 
zou dus een instrument moeten komen dat, vroegtijdig, mensen identificeert die een 
grote kans hebben kwetsbaar te worden of te zijn. De gebruikte kwetsbaarheidsindex 
in het GOUD-onderzoek was gebaseerd op vele informatiebronnen waaronder breed 
lichamelijk, psychisch en laboratorium onderzoek, dit kan te belastend en duur zijn 
voor routinematig klinisch gebruik. Bovendien is de index alleen nog gevalideerd op 
populatieniveau, op basis van gemiddelde scores. Voor klinisch individueel gebruik is 
besliskundige analyse noodzakelijk (sensitiviteit en specificiteit). Door te analyseren 
welk van de 51 items zowel klinisch gemakkelijk toepasbaar zijn als sterk samenhangen 
met de volledige kwetsbaarheidsindex, wordt er op dit moment door ons onderzocht of 
een kortere versie van het instrument mogelijk en valide is. Bepaald moet worden of de 
korte versie net zo voorspellend is voor een achteruitgang in gezondheid en zelfstan-
digheid als de volledige kwetsbaarheidsindex. 
Intussen kan beleidsmatig al gestart worden met de preventie van vroege kwetsbaar-
heid. Resultaten uit het GOUD-onderzoek laten zien dat de minst kwetsbare groep vaak 
relatief mobiel en actief is, minder vaak ziektes heeft en minder medicatie gebruikt [36]. 
In figuur 4 is een door ons opgesteld hypothetisch model weergegeven over de opeen-
stapeling van ongunstige factoren die kunnen bijdragen tot het vroegtijdig ontstaan 
van kwetsbaarheid bij mensen met een verstandelijke beperking. Een aantal van de 
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genoemde ongunstige factoren zou kunnen dienen als leidraad voor interventies. Zo 
zou een breed geïmplementeerd beweegprogramma, gericht op behoud van mobiliteit 
en verbeteren van fitheid, zoals gezien in de algemene populatie, kwetsbaarheid kun-
nen remmen. De toepasbaarheid en effectiviteit van een beweegprogramma, specifiek 
ontworpen voor ouderen met een verstandelijke beperking, werd eerder al aangetoond 
[37]. Daarnaast zullen ook andere componenten van gezondheid aandacht moeten 
krijgen. Uit het GOUD-onderzoek blijkt bijvoorbeeld dat mensen met een verstandelijke 
beperking veel life events (bijvoorbeeld een verhuizing, overlijden van een dierbare, 
verandering van persoonlijk begeleider) ondervinden, wat samenhangt met depres-
sie- en angstsymptomen [38]. Life events zullen beter gemonitord moeten worden, en 
natuurlijk zoveel mogelijk moeten worden voorkómen. Het systematisch invoeren van 
medicatiereviews en een proactieve aanpak van specifieke clusters van comorbiditeit 
[13] zouden ook kunnen bijdragen aan de preventie van kwetsbaarheid. Daarnaast zou 
er meer aandacht moeten komen voor gezonde voeding. 
In aanvulling op het beleid van zorginstellingen zou ook de gemeente een belangrijke rol 
kunnen spelen. Binnenkort gaan lichtere vormen van zorg en ondersteuning uit de Alge-
mene Wet Bijzondere Ziektekosten (AWBZ) over naar de Wet maatschappelijke ondersteu-
ning (Wmo). Dit betekent dat gemeenten voor een groot deel verantwoordelijk worden 
voor de zorg voor mensen met een lichte of matige vorm van verstandelijke beperking. 
Door aanvullingen op het beroepsonderwijs voor verzorgenden en verplegenden kan 
Figuur 4. Een hypothetisch model over de opeenstapeling van ongunstige factoren die kunnen leiden tot 
het vroegtijdig ontstaan van kwetsbaarheid bij mensen met een verstandelijke beperking. Figuur eerder 
gepubliceerd in het Nederlands Tijdschrift voor Geneeskunde [40].
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meer kennis en bewustwording worden gecreëerd bij beroepsbeoefenaren die nu of 
binnenkort met deze doelgroep te maken krijgen. Daarnaast is het zaak dat de huisarts 
of geriater met vragen terecht kan bij een arts voor verstandelijk gehandicapten (AVG). 
De circa 80 AVG-poliklinieken kunnen hierbij een belangrijke rol spelen (www.nvavg.nl). 
DruKKe tiJDen voor onDerzoeKers
Het voorkómen en bestrijden van gezondheidsproblemen van ouderen met een ver-
standelijke beperking zou hoog op de prioriteitenlijst moeten staan, zoals blijkt uit het 
GOUD-onderzoek. Echter, veel kennis ontbreekt nog. Allereerst, zoals eerder vermeld, is 
er een klinisch toepasbaar instrument met een goede sensitiviteit en specificiteit nodig 
om kwetsbare ouderen te selecteren. Daarnaast moet er worden onderzocht welke 
interventies effectief zijn in deze populatie.
Ook kunnen andere relevante gezondheidsuitkomsten zoals specialistische consulten 
en kosten onderzocht worden om inzicht te krijgen in de financiële gevolgen van kwets-
baarheid. Omdat het voorkómen van kwetsbaarheid dienend is voor een goede oude 
dag, moet ook gekeken worden naar welbevinden en kwaliteit van het levenseinde.
Belangrijk is ook te onderzoeken waar het vroegtijdig ontstaan van kwetsbaarheid 
precies vandaan komt. Onderzoek dat zich richt op het ontstaan van kwetsbaarheid 
bij jongvolwassenen en de ontwikkeling van kwetsbaarheid gedurende het leven kan 
veel informatie verschaffen over de oorzaken van het vroege ontstaan. Ook liggen er 
fundamentele vraagstukken met betrekking tot het vroegtijdig ontstaan van kwets-
baarheid. Zo is het bijvoorbeeld bekend dat mensen met een verstandelijke beperking 
een hogere ontstekingsstatus hebben dan de algemene populatie [39]. In het GOUD-
onderzoek werd gevonden dat een verhoogd inflammatoire niveau (IL-6 en CRP) vaker 
voorkomt bij mensen met een hoge kwetsbaarheidsindex. Onderzoek naar de causale 
relatie tussen inflammatie en het ontstaan van kwetsbaarheid is van belang. 
conclusie en aanbevelingen
Uit de resultaten van het GOUD-onderzoek blijkt dat een groot aantal mensen met een 
verstandelijke beperking al op relatief jonge leeftijd kwetsbaar is. Kwetsbaarheid, geme-
ten met een kwetsbaarheidsindex, leidt ook in deze vroeg-gehandicapte populatie tot 
een sterke achteruitgang in zelfredzaamheid en mobiliteit, tot een toename van ziektes 
en medicijngebruik en tot eerder overlijden. 
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De ontwikkeling van kwetsbaarheid kan een langdurig proces zijn, waarbij verschillende 
problemen zich opstapelen. Los vormen deze problemen niet altijd een reden voor 
ongerustheid, waardoor kwetsbaarheid pas in een laat stadium wordt geobserveerd. 
Kwetsbaarheid is een dynamisch proces. Echter, hoe hoger de mate van kwetsbaarheid 
is, des te lastiger is het te keren [35]. Het is daarom essentieel dat kwetsbare ouderen 
vroegtijdig worden geïdentificeerd en effectieve interventies worden gestart om te ko-
men tot meer gezonde, zelfstandige en kwalitatief bevredigende levensjaren voor deze 
groep. 
Toekomstig onderzoek zal zich moeten richten op een valide screeningsinstrument en 
het ontwerpen van effectieve interventies. Daarnaast zou aanvullend epidemiologisch 
onderzoek gedaan kunnen worden naar de oorzaken van kwetsbaarheid bij mensen 
met een verstandelijke beperking. Tot slot is het van belang dat mensen die werken in 
de zorg (zorgverleners en beleidsmedewerkers) zich bewust zijn van de jonge leeftijd 
waarop mensen met een verstandelijke beperking kwetsbaar worden, de frequentie van 
het probleem en de ernstige gevolgen, zodat er eerder gestart wordt met maatregelen. 
Preventief beleid en toekomstig onderzoek zullen moeten bijdragen aan het terug 
dringen van de effecten van kwetsbaarheid op zowel het individu als de zorg. 
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Systematic Literature Retrieval 2014 0.5
specific courses (nihes research school)
Biostatistics for Clinicians (EWP22) 2012 1.0
Regression Analysis for Clinicians (EWP23) 2012 1.8
Survival Analysis for Clinicians (EWP24) 2013 1.9
seminars, presentations and workshops
Department presentations (oral presentation)
Follow-up study HA-ID study introduction presentations 
(management, personal care givers, team leaders)
Workshop AVG AIOS science day
Workshop GOUD symposium
Workshop AVG AIOS science day
NPO (Nationaal Programma Ouderenzorg), 2 workshops
2011-2015
2011-2012
2011
2013
2014
2014
3.0
5.0
1.0
1.0
1.0
1.0
(inter)national conferences
The 8th IAGG-ER congress, Dublin (oral presentation) 2015 2.0
The 10th congress of the EUGMS, Rotterdam (poster 
presentation)
2014 1.0
The 9th congress of the EUGMS, Venice (poster presenta-
tion)
2013 1.0
The IASSID world congress, Halifax (oral presentation) 2012 2.0
Congress ‘Focus on Research’, Utrecht (oral presentation) 2011 1.0
NPO (Nationaal Programma Ouderenzorg), Rotterdam 
(poster presentation)
2011 0.6
2. teaching
supervising master’s theses 
4 Master Medical Science students research projects 2011-2015 8.0
other
Supervising student sessions ‘how to judge a paper’ 2011-2014 0.5
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Dit proefschrift is het resultaat van 3.5 jaar data verzamelen, analyseren, schrijven en 
samenwerken. Er op terugkijkend waren het mooie en leerzame jaren. Maar zonder hulp 
van veel mensen had ik dit onderzoek nooit tot een einde kunnen brengen. Daarom wil 
ik op deze plaats een aantal mensen bedanken. 
Allereerst wil ik graag iedereen bedanken die betrokken is geweest bij het onderzoek 
‘Gezond Ouder met een Verstandelijke Beperking’ (GOUD). Alle cliënten van Abrona, 
Amarant en Ipse de Bruggen die hebben deelgenomen aan het GOUD onderzoek, 
familieleden, begeleiders, en medewerkers die geholpen hebben met de metingen en 
de logistiek, jullie hebben allemaal een enorm belangrijke bijdrage geleverd aan het 
in kaart brengen van de gezondheid van ouderen met een verstandelijke beperking. 
Zonder jullie inzet, tijd en betrokkenheid had het GOUD onderzoek nooit kunnen plaats-
vinden, hartelijk dank hiervoor. 
Vervolgens wil ik graag mijn promotor Prof.dr. Heleen Evenhuis heel hartelijk bedanken. 
Heleen, ik bewonder jouw toewijding voor je vak en je blik op de praktijk. Je hebt mij 
altijd gemotiveerd om net wat meer mijn best te doen, verder te kijken dan de resul-
taten en altijd de praktijk in mijn achterhoofd te houden; iets wat onderzoek tastbaar 
en waardevol maakt. Bedankt voor al je opbouwende, zorgvuldige commentaar op 
artikelen en presentaties. 
Michael Echteld, mijn top copromotor, ik ben blij dat jij mijn dagelijkse begeleider bent 
geweest. Je stond altijd voor me klaar met een vriendelijk en enthousiast woord, je keek 
verder dan het project, maar ook naar mij als persoon. Je hebt me geleerd te denken in 
oplossingen. Als ik, lichtelijk in paniek, met een probleem kwam, bleef je rustig en zei 
“dat heb je precies op tijd geobserveerd”, terwijl het in mijn ogen al vrij laat was. Je nam 
vervolgens alle tijd een oplossing te bedenken, die er ook kwam. Bedankt voor al je tijd 
en aandacht. 
Het eerste deel van het GOUD onderzoek was goed geland en georganiseerd binnen 
de drie betrokken zorgorganisaties maar toch moest er nog het een en ander geregeld 
worden voordat er gestart kon worden met de follow-up. Tijdens het inlichten van de 
organisaties, de toestemmingprocedure en het verzamelen van de data kon ik rekenen 
op veel betrokkenheid en inzet van allerlei medewerkers, hartelijk dank hiervoor. In het 
bijzonder André de Meij voor het invoeren van de vragenlijsten, en de AVG-artsen en 
persoonlijk begeleiders voor het invullen van de vragenlijsten. Ook wil ik natuurlijk graag 
de managers, bestuurders en directeuren van Amarant, Abrona en Ipse de Bruggen be-
danken voor hun inspiratie en kun keuze bij te dragen aan wetenschappelijk onderzoek. 
In het bijzonder, Ronald Helder, Jan Duenk, Jan van Hoek, Ditte van Vliet, Frank Brouwer 
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en Marcel Schellart, jullie kritische vragen en enthousiaste bijdragen tijdens de GOUD 
bijeenkomsten hebben ervoor gezorgd dat GOUD, maar ook de follow-up van GOUD 
goed verlopen is. Veel dank ook voor de interne coördinatoren van de zorginstellingen. 
Ineke Bootsman, bedankt voor je adviezen en ondersteuning. Anemone Linthorst, be-
dankt voor je tijd en snelle geregel. Je advies om maar vooral heel snel een auto aan te 
schaffen heeft heel wat efficiëntie opgeleverd. Joris van Erp, bedankt dat ik altijd bij Ipse 
de Bruggen terecht kon voor het versturen van stapels brieven en vragenlijsten, voor 
je tijd en oplossingen. Erwin van Hout, bedankt voor je altijd positieve insteek op het 
onderzoek en je duidelijke kijk op de haalbaarheid ervan. 
Dear Arnold and Kenneth, thank you so much for the opportunity to visit and work with 
you. You are very inspiring researchers and it was an honor to write, discuss and prepare 
four papers together. I hope to be able to visit you again and learn more about your me-
thods and theories. Ook de overige co-auteurs heel erg bedankt voor jullie meedenken, 
schrijven en input. 
Prof.dr. J.P. Mackenbach, Prof.dr. C.M. van Duijn en Prof.dr. J.M.G.A. Schols wil ik bedan-
ken voor hun snelle beoordeling van dit proefschrift en hun bereidheid deel te nemen 
in de promotiecommissie. Prof.dr. P.J.E. Bindels, Prof.dr. D.J.H Deeg en Prof.dr. A.B. Maier, 
bedankt voor jullie bereidheid deel te nemen in de grote commissie. 
Ik mag mezelf gelukkig prijzen met het geweldige onderwijs dat ik de afgelopen jaren 
gehad heb, een betere voorbereiding op een promotie had ik niet kunnen hebben. Vanaf 
basisschool de Kinkerhoek werd al geleerd zelfstandig te werken in een hele prettige 
omgeving met top leerkrachten (vooral de huidige directrice natuurlijk ;)). Het Montes-
sori Lyceum Amsterdam waar je eigen ontwikkeling belangrijker was dan hoge cijfers. 
En de laatste jaren in Wageningen, waar heel veel aandacht besteed werd aan kritisch 
nadenken, statistiek en onderzoekvaardigheden, waardoor het zo veel gemakkelijker 
was het promotietraject te volbrengen. 
Natuurlijk ben ik de collega’s van Huisartsgeneeskunde en Geneeskunde voor Verstan-
delijk Gehandicapten dankbaar voor al hun input en fijne samenwerking, jullie zijn echt 
topcollega’s! De sfeer op de afdeling is heel goed, zodat ik me thuis voelde en met veel 
plezier naar Rotterdam reisde (nou ja als de treinen reden dan). Thessa, Marieke, Heidi & 
Luc, de GOUD onderzoekers van het eerste uur: jullie enthousiasme, praktijkgerichtheid, 
en doorzettingsvermogen waren enorm inspirerend, motiverend en jullie vormden een 
super voorbeeld. De manier waarop GOUD door jullie opgezet is binnen de organisaties 
maakte het voor mij zoveel makkelijker de follow-up te regelen. Thessa, je ambitie en 
doorzettingsvermogen zijn geweldig en aanstekelijk! Heel veel plezier en succes in Chi-
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cago. Marieke, bedankt voor je geduldige uitleg over hoe de praktijk in elkaar zat en hoe 
de follow-up het best uitgevoerd kon worden. Heidi, je statistische inzicht en nuttige 
feedback heeft dit proefschrift enorm geholpen. Luc, allereerst bedankt voor de midda-
gen die je hebt opgeofferd om de follow-up data te controleren, je input bij presentaties 
en artikelen! Daarnaast natuurlijk heel erg bedankt voor je gezellige aanwezigheid. Ik 
kon altijd mijn ei bij je kwijt onder het genot van een kopje cappuccino, je bent écht 
bijzonder! Alyt, (speciaal voor jou in t Amsterdams) attenoje, ik zeg tegen m’n eigen dat 
ik toch flink bof met een collega met zoveel sjoege. Heerlijk om met je te discussiëren en 
te spuien over het onderzoek, maar ook om samen te borrelen en te sporten (mocht je 
ooit besluiten voor het Nederlands kampioenschap hardlopen te gaan; ik ben je eerste 
fan). Cis, jammer dat je naar Nijmegen verhuisde. Het was een gezellig jaar. Sonja, succes 
met de laatste afrondende fase, alle liften en gastvrijheid. Marieke W, super knap hoe je 
je promotietraject samenvoegt met je drukke baan en leven! Bedankt voor alle gezellige 
maandagen, en misschien zwemmen/fietsen/rennen we volgend jaar ooit de triatlon 
nog (of een klein stukje). Dederieke, jammer dat ik maar zo kort met je heb kunnen 
werken! Sandra, Channa, Fleur, Annefloor, Ellen en alle andere collega’s en studenten, 
bedankt voor jullie input tijdens de overleggen en de gezelligheid op de afdeling. 
Pauline, Mylène en Renske, succes met het GOUD 2 onderzoek, goed om te zien dat het 
onderzoek doorgaat. Judith, Jiska, Lisanne en Hanne bedankt voor jullie hulp met het 
verzamelen en analyseren van de GOUD gegevens! 
Ook alle andere collega’s van de afdeling Huisartsgeneeskunde bedankt voor jullie mee-
denken tijdens de spreekkamer en gezelligheid tijdens de lunchpauzes en afdelings-
uitjes. Kamer NA-1923 en co, fijn dat we mochten mee genieten van jullie gezelligheid, 
de traploopwedstrijden, het giraffe-avontuur, mini-dance-workouts en de (geslaagde ?) 
flash mop. 
Mijn nieuwe collega’s van ErasmusAGE wil ik bedanken voor het warme welkom en jullie 
bereidheid altijd mijn vragen te willen beantwoorden. Jolien, het was heel fijn om de 
promotie-regel-dingen en opstart van een nieuwe baan te bespreken samen. Edith, 
Jessica, Trudy & Ester, bedankt voor het inwerken en de gezelligheid op de kamer. Oscar, 
bedankt voor deze kans om me verder te ontwikkelen op het gebied van voeding en 
veroudering. 
Gelukkig heb ik de afgelopen jaren veel afleiding en gezelligheid gehad bij lieve vrien-
den en familie. De Wageningse miepen bedankt voor de gezellige etentjes, weekendjes 
weg en nachtelijke eetfestijnen! In het bijzonder Rianne B, Rianne S en Pauline! Al wonen 
we niet meer in de zelfde straat (dorp), als we elkaar zien is het altijd weer als vanouds. 
Montessori gang, Julia, Samira, Myra, Lisa en Winke, ik ben blij dat we elkaar toch nog 
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regelmatig zien, al wonen (woonden) we door heel Nederland en Zuid-Afrika. Nikkie en 
Annelies, mijn lieve Rotterdamse vriendinnetjes en mede promotiekandidaten. Het was 
echt super dat ik bij jullie altijd even kon klagen, advies kon vragen over tijdschriften, 
statistiek of Engels. Het pauze houden (lekkere koffie), lunchen, leuke uitstapjes en spel-
letjes avonden, hielpen enorm om te ontspannen en te lachen. Nik, alleen maar achter 
de computer zitten is niks, gelukkig zijn we regelmatig gaan skaten (gelukkig met val-
cursus en zonder lantarenpaal), zwemmen, fitnessen, wintersporten en de agressie er 
uit te slaan tijdens het squashen. We wonen/scholen/werken stiekem al ons hele leven 
bij elkaar in de buurt, hopelijk blijft dat nog even zo! Bedankt dat je mijn paranimf wilt 
zijn, als er ingewikkelde statistiek vragen komen laat ik ze aan jou over ;). Lieve Nikki, 
Winke en Merel, jullie zijn een van de belangrijke redenen dat ik zo graag terug wilde 
naar Amsterdam. Vanaf nu kom ik jullie weer veel regelmatiger lastig vallen! Bedankt 
voor jullie luisterende oren, weekendjes, etentjes, stapavonden en telefoongesprekken 
tussen Den Haag en Rotterdam. Nik, je bent zo attent, lief, en vergeet nooit wat! Ik ben 
heel blij je al zo lang te kennen, al zo veel samen te hebben mee gemaakt en om straks 
weer bij je om de hoek te wonen! Wink, je vrolijkheid werkt aanstekelijk, het is heerlijk 
zo’n enthousiaste vriendin te hebben, die met zo veel aandacht kan luisteren. Meer, zo’n 
beetje mijn hele leven ken ik je al, en het is zo fijn een vriendin te hebben die alles van 
me weet, waar ik altijd bij terecht kan en waar ik me nooit anders voor hoef te doen. 
Super bedankt dat je je creativiteit wilde gebruiken voor de voorkant van dit boekje! 
Ik wil ook mijn lieve schoonfamilie, Herma, Tom, Léonore, Anne-Claar, Wouter, Arjan en 
Fenna, bedanken voor hun interesse in het onderzoek en de vele gezellige avonden en 
weekendjes. 
En dan natuurlijk mijn familie van drie kanten! Texel, Bosschenhoofd, Amsterdam, 
Capelle aan den IJssel, Alkmaar. Het is een groot voorrecht om zo’n grote, betrokken, 
heerlijke familie te hebben. Lieve Jos en Josien, heerlijk om me bij jullie zo welkom en 
prettig te voelen. De twijfels over wat ik met werk wilde, studeren, welke richting, om 
alles met jullie te kunnen bespreken. En natuurlijk bedankt voor de luxe logeerpartijtjes 
als ik weer eens vroeg in ‘t Zuiden moest zijn voor een presentatie. Elisabeth, Richard, 
Jaap, Liesbet, dank voor jullie interesse, hulp bij het huis en het schrijven van artikelen. 
Alle (!) bewoners van de vroegere Tromp. Papa, mama, mama, met jullie als ouders heb ik 
het zo getroffen dat ik het ongelofelijk moeilijk vind om jullie hier, op deze plek, ooit vol-
doende te kunnen bedanken! Als mijn ‘jeugdtrauma’ de papier en glasbak wegbrengen 
is, mag ik toch nergens over klagen. Bedankt voor het eeuwige vertrouwen, de liefde, 
en het gevoel dat ik nog altijd thuis kom, jullie zijn geweldig. Mam, bedankt dat je me 
leerde om naar mezelf te luisteren, voor de rust die je uitstraalt, je leerde me bang te zijn, 
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en natuurlijk bedankt voor jouw input vanuit het veld! Pap (of zoals je t liever hoort, Jan), 
je bent mijn stoere papa en nog steeds schep ik regelmatig over je op. Zonder woorden 
kan je zo veel zeggen. Mam, je bent zo herkenbaar (klunzig), af en toe hou je me echt 
een spiegel voor, bedankt dat je me altijd gestimuleerd hebt mijn gevoel te volgen, 
risico’s te nemen en te starten met dit promotietraject. Lieve Bram, m’n grote, slimme, 
grappige broertje, altijd stoer, maar stiekem heel erg lief. Lieve An, mijn kleine zusje, je 
bent echt geweldig! Zo slim en ambitieus en dan ook nog sociaal en lief, je mag enorm 
trots op jezelf zijn (dat ben ik in elk geval wel!). Ik ben heel blij dat je mijn paranimf wilt 
zijn en nog veel blijer dat je mijn zusje bent. 
Tot slot, Thomas, mijn allerliefste Tommie (als je dit leest ;)) bedankt voor alles de afgelo-
pen jaren. Dat je me soms verplichtte even niks te doen, je vertrouwen, je nuchtere doch 
zeer kritische kijk op dingen, alle heerlijke avonden, weekendjes en vakanties. Vooral de 
afgelopen maanden was je degene die me rustig maakte en me de tijd en ruimte gunde 
dit proefschrift af te ronden. Met jou wil ik verder (in ons nieuwe paleisje). 



